Quantitative Mass Spectrometric Analysis of RNA-Protein Cross-Links by Qamar, Saadia
 
 
QUANTITATIVE MASS SPECTROMETRIC 





for the award of the degree 
“Doctor of Philosophy” (Ph.D.) 
Division of Mathematics and Natural Sciences 
of the Georg-August-Universität Göttingen 
within the doctoral program Biology 













Members of the Thesis Committee 
 
Prof. Dr. Henning Urlaub 
(Supervisor & Reviewer) 
Department of Cellular Biochemistry, 
Bioanalytical Mass Spectrometry Group, 
Max-Planck-Institute for Biophysical Chemistry, 
Göttingen, Germany. 
Bioanalytics, 
Institute for Clinical Chemistry, 
University Medical Center, 
Göttingen, Germany. 
 
Prof. Dr. Heike Krebber 
(Second Reviewer) 
Department of Molecular Genetics, 








Further members of the Examination Board: 
 
Prof. Dr. Markus T. Bohnsack Institute for Molecular Biology, 
University Medical Center, 
Göttingen, Germany. 
 
Prof. Dr. Reinhard Lührmann Department of Cellular Biochemistry, 
Max Planck Institute for Biophysical Chemistry, 
Göttingen, Germany. 
 
Prof. Dr. Jörg Stülke Department of General Microbiology, 




Prof. Dr. Peter Schu Department of Cellular Biochemistry, 











This thesis is dedicated to:  
Almighty Allah, my Creator and my Master, 
My great teacher and messenger, Prophet Mohammed (PBUH),  
who taught us the purpose of life, 
My beloved homeland Pakistan, the warmest womb; 
My dear parents, who never stop giving of themselves 
unconditionally in countless ways, 
My sweet sisters, who support and stand by me,  
when things look bleak, 
My friends who encourage and support me, 











Prima facie, I am grateful to ALMIGHTY GOD who granted me strength and 
courage to complete this task. 
I wish to extend my sincere thanks to Prof. Dr. Henning Urlaub, for providing 
valuable guidance and sharing expertise. 
Besides my supervisor, I am indebted to the rest of the thesis committee 
members: Prof. Dr. Heike Krebber and Prof. Dr. Claudia Höbartner for their 
insightful comments which incented me to broaden my research from various 
perspectives and the members of the examination committee for their time.  
I am gratefully indebted to Fanni Laura Bazsó & Kuan-Ting Pan, who were 
involved in the validation survey for this research. Their passionate participation 
and suggestions helped in overcoming the hurdles faced during the work. 
With a special mention to Dr. Klaus Hartmuth, Dr. Olexandr Dybkov, Dr. Sergey 
Bessonov, Dr. Jana Schmitzová, Juliane Moses, and Lab staff Uwe Pleßmann, 
Monika Raabe, Thomas Conrad, Irene Ӧchsner, Hossein Kohansal, Gabi Heyne, 
Marion Killian, Ulrich Steuerwald, it was nice to have an opportunity to work with 
you in your facilities.  
Last but by no means least, also to everyone in the impact hub Dr. Christof Lenz, 
Dr. Carla Schmidt, Dr. He-Hsuan Hsiao and all the lab fellows, it was good 
experience sharing the laboratory with you. 
I intend to express gratitude to all the friends, Dr. Aneela Javed, Rabia, Naila, 
Sunit Mandad, Sara, Dr. M. Qasim, Altaf Sahab, Shahida aapi and Jusra who 
supported me throughout this venture. 
Finally, I must express my sincere and profound appreciation and gratitude for 
my parents especially my dearest Mother, whom I missed a lot throughout this 
venture but her invisible constant prayers and countless love has always been 
and will remain with me forever. My Father, his concern and patience were 
remarkable and I am thankful to him, also for giving me confidence and 
unceasing encouragement throughout this period of study. My sisters for their 
everlasting love and moral support, without them this accomplishment would not 









































TABLE OF CONTENTS 
 
1 INTRODUCTION ............................................................................................ 1 
1.1 Proteomics ............................................................................................... 1 
1.2 Mass Spectrometry .................................................................................. 2 
1.2.1 Ion Source ............................................................................................. 3 
1.2.1.1 Electrospray Ionization (ESI) ........................................................... 4 
1.2.1.2 Matrix-assisted Laser Desorption Ionization (MALDI) ...................... 5 
1.2.2 Mass Analyzer ....................................................................................... 5 
1.2.2.1 Time of Flight (TOF) ........................................................................ 5 
1.2.2.2 Quadrupole ...................................................................................... 6 
1.2.2.3 Ion Trap ........................................................................................... 6 
(A) Quadrupole Ion Trap (QIT) ................................................................ 6 
(B) Linear Ion Trap (LIT) .......................................................................... 7 
(C) Orbitrap.............................................................................................. 7 
1.2.2.4 Fourier Transform Ion Cyclotron Resonance (FT-ICR) .................... 7 
1.2.3 Ion Detector ........................................................................................... 8 
1.2.4 Tandem Mass Spectrometry .................................................................. 9 
1.2.5 Mass Spectrometric Analysis ............................................................... 10 
1.2.6 Mass Spectrometry Based Fragmentation ........................................... 12 
1.2.7 Proteomic Data Analysis ...................................................................... 14 
1.3 Quantitative Proteomic Studies .............................................................. 15 
1.3.1 Quantitation Based on Extracted Ion Chromatogram (XIC) ................. 16 
1.4 Quantitative Nucleic Acid Studies .......................................................... 17 
1.5 Qualitative Studies ................................................................................. 18 
1.5.1 Protein-Nucleic Acid Cross-linking ....................................................... 19 
1.5.1.1 UV-Induced Protein-Nucleic Acid Cross-linking ............................. 19 
1.5.1.2 Purification of Peptide-Oligonucleotide Heteroconjugates ............. 20 
1.5.1.3 Mass Spectrometric Analysis of Protein-Nucleic Acid Cross-links . 21 
1.5.1.4 Protein-Nucleic Acid Cross-links Data Analysis ............................. 22 
1.6 Biological Complexes Studied Using UV-Induced Cross-linking and Mass 
Spectrometry .................................................................................................... 25 
1.6.1 Brat-NHL-hb RNA Complex ................................................................. 25 
1.6.2 CWC2-U6/U4 snRNAs Complex .......................................................... 26 
1.6.3 RNP Complexes from HeLa Nuclear Extract ....................................... 27 
1.7 Aim of the Study ..................................................................................... 29 
2 MATERIALS AND METHODS ..................................................................... 31 
2.1 Materials................................................................................................. 31 
2.1.1 Chemicals and Reagents ..................................................................... 31 
2.1.2 Commercial Buffers, Solutions and Kits ............................................... 32 
2.1.3 Enzymes and Enzyme Inhibitors .......................................................... 33 
2.1.4 Nucleotides .......................................................................................... 33 
2.1.5 Plasmids .............................................................................................. 34 
2.1.6 Cell line ................................................................................................ 34 
2.1.7 Cell Culture Materials .......................................................................... 34 
2.1.8 Chromatographic Materials and Consumables .................................... 35 
2.1.9 Solutions and Buffers ........................................................................... 35 
2.1.10 Softwares ........................................................................................... 36 
2.1.11 Laboratory Consumables ................................................................... 37 
2.1.12 Laboratory Equipment and Instruments............................................. 37 
2.2 Methods ................................................................................................. 39 
2.2.1 Standard Molecular Biology Methods....................................... ............39 
2.2.1.1 Preparation of Competent Cells .................................................... 39 
2.2.1.2 Transformation of DH5α Cells ....................................................... 39 
2.2.1.3 Determination of Nucleic Acid Concentration ................................ 40 
2.2.1.4 Restriction Digestion of Plasmid DNA ........................................... 40 
2.2.1.5 Phenol Chloroform Isoamyl Alcohol (PCI) Extraction .................... 41 
2.2.1.6 Ethanol Precipitation ..................................................................... 41 
2.2.1.7 Agarose Gel Electrophoresis......................................................... 41 
2.2.1.8 In Vitro Transcription ..................................................................... 41 
2.2.1.9 Denaturing Polyacrylamide Gel Electrophoresis for RNA ............. 43 
2.2.1.10 Silver Staining of PAGE Gels ...................................................... 43 
2.2.2 Standard Protein Biochemical Methods                                                44 
2.2.2.1 Determination of Protein Concentration ........................................ 44 
2.2.2.2 Denaturing Polyacrylamide Gel Electrophoresis for Proteins ........ 44 
2.2.2.3 Colloidal Coomassie Staining........................................................ 44 
2.2.3 Cell Culturing and Nuclear Extract Preparation................ ....................45 
2.2.3.1 HeLa S3 Cell Culturing .................................................................. 45 
2.2.3.2 HeLa Nuclear Extract Preparation ................................................. 45 
2.2.3.3 HeLa Nuclear Extract Dialysis ....................................................... 46 
2.2.4 Expression, Isolation and Purification of Proteins and RNA-Protein 
Complexes ................................................................................................... 46 
2.2.4.1 MS2-MBP Fusion Protein Overexpression and Purification .......... 46 
2.2.4.2 CWC2 Protein Overexpression and Purification............................ 47 
2.2.4.3 Brat-NHL Protein Overexpression and Purification ....................... 49 
2.2.4.4 In Vitro RNA–Protein Complex Assembly from HeLa Nuclear 
Extract and Purification ............................................................................. 49 
2.2.5 UV-Induced Cross-linking in RNA-Protein Complexes......................... 50 
2.2.5.1 UV-Cross-linking of Brat-NHL protein with hb RNA ....................... 50 
2.2.5.2 UV-Cross-linking of CWC2 protein with U4 and U6 snRNAs ........ 51 
2.2.5.3 UV-Cross-linking of RNA-Protein Complex from HeLa Nuclear 
Extract Assembled on PM5/MINX pre-mRNAs ......................................... 51 
2.2.6 Quantitative Analysis of RNA-Protein Cross-links................................ 54 
2.2.6.1 Quantitative Analysis of CWC2-U4 snRNA and U6 snRNA Cross-
links ........................................................................................................... 54 
2.2.7 Mass Spectrometry Methods................................................................ 54 
2.2.7.1 In-Gel Digestion of Proteins .......................................................... 54 
2.2.7.2 Extraction of Peptides ................................................................... 55 
2.2.7.3 LC-ESI-MS/MS .............................................................................. 55 
(A) Nanoflow-Liquid Chromatography Separation (Nano-LC) ............... 56 
(i) Nano-LC Separation (Agilent nano-LC system) ........................ 56 
(ii) Nano-LC Separation (Thermo EASY-nLC II system) ................ 56 
(B) ESI-MS/MS Analysis ....................................................................... 57 
(i) LTQ Orbitrap XL Mass Spectrometer ....................................... 57 
(ii) LTQ Orbitrap Velos Mass Spectrometer ................................... 57 
(iii) Q-Exactive Mass Spectrometer ................................................ 57 
2.2.8 Data Analysis........................................................................................ 58 
2.2.8.1 Proteome Analysis by MaxQuant .................................................. 58 
2.2.8.2 RNA-protein Cross-linking Analysis by OpenMS ........................... 58 
 
2.2.8.3 Quantitative Analysis by Skyline .................................................... 59 
2.2.8.4 Statistical Analysis ......................................................................... 60 
2.2.8.5 Interactome Analysis ..................................................................... 60 
3 RESULTS ..................................................................................................... 61 
3.1 Identification of Cross-links from Brat-NHL-hb RNA Complex................ 62 
3.2 Identification of Cross-links from CWC2-U4 and U6 snRNAs 
Complexes................................................................................................. .......68 
3.3 Quantitative Analysis of CWC2-U4 snRNA and U6 snRNA Cross-links . 74 
3.4 Identification of Cross-links from MS2-MBP Protein ............................... 83 
3.5 Identification of Uracil Fragments and Adducts ...................................... 88 
3.6 Identification of RNP Complexes Isolated from HeLa Nuclear Extract and 
their Cross-linking Analysis ............................................................................ 103 
4 DISCUSSION ............................................................................................. 129 
4.1 Cross-links from Brat-NHL-hb RNA Complex ....................................... 131 
4.2 Cross-links from CWC2-U4 and U6 snRNAs Complexes ........................ 133 
4.2.1 Identification of Cross-links from CWC2-U4 and U6 snRNAs 
Complexes .................................................................................................. 133 
4.2.2 Quantification of Cross-links from CWC2-U4 and U6 snRNAs 
Complexes .................................................................................................. 134 
4.3 Cross-links from HeLa Nuclear Extract ................................................ 136 
4.3.1 Identification of Cross-links from MS2-MBP Protein .......................... 136 
4.3.2 Identification of Uracil Fragments and Adducts.................................. 137 
4.3.3 Identification of RNPs Isolated from HeLa Nuclear Extract and their 
Cross-linking Analysis ................................................................................. 139 
4.4 Conclusion and Future Perspectives .................................................... 142 
5 REFERENCES ........................................................................................... 144 












LIST OF FIGURES 
 
Figure 1.1: Components of a mass spectrometer. ............................................... 3 
Figure 1.2: Schematic representation of peptide fragmentation and nomenclature 
of fragments ................................................................................................. 13 
Figure 1.3: Schematic representation of RNA fragmentation and nomenclature of 
fragments ..................................................................................................... 14 
Figure 1.4: Workflow of cross-linking protocol.................................................... 24 
Figure 3.1: The top electropositive surface of the Drosophila Brat-NHL domain 
interacts with hb RNA ................................................................................... 63 
Figure 3.2: Cross-links identified from in vitro assembled Brat-NHL-hb RNA 
complex ........................................................................................................ 66 
Figure 3.3: Mapping of cross-linked peptides on the crystal structure of Brat-NHL 
domain with small stretch of RNA................................................................. 67 
Figure 3.4: Structure of CWC2 protein ............................................................... 69 
Figure 3.5: Identified cross-linked peptides of CWC2-U4 snRNA and CWC2-U6 
snRNA complexes. ....................................................................................... 73 
Figure 3.6: Workflow for relative quantification of U4/U6 snRNA-CWC2 cross-
links. ............................................................................................................. 75 
Figure 3.7: MS/MS spectrum of peptide NCGFVK cross-linked to U+152. ........ 76 
Figure 3.8: Normalization graphs. ...................................................................... 79 
Figure 3.9: Example of Extracted ion chromatogram and isotopic distribution of a 
cross-link showing the mass difference due to labeling. ............................... 81 
Figure 3.10: Bar diagrams of Mean of log2 ratios of CWC2-U4/U6 snRNA cross-
links. ............................................................................................................. 82 
Figure 3.11: Bar diagram of Mean of log2 ratios of individual cross-linked 
domain/motif to U4/U6 snRNA. .................................................................... 82 
Figure 3.12: MS2-MBP fusion protein and MS2 RNA stem-loop........................ 83 
Figure 3.13: Identified cross-linked peptides of MS2-MBP fusion protein. ......... 85 
Figure 3.14: Crystal structure of MS2 coat protein along with the MS2 stem-loop 
RNAs ............................................................................................................ 87 
Figure 3.15: Uracil nucleotides........................................................................... 90 
Figure 3.16: The MS2 spectra of the peptide 375DYAFVHFEDR384 cross-linked to 
U................................................................................................................... 93 
Figure 3.17: The predicted structural formulae of the Uracil nucleotide fragment 
(m/z 179.0447). ............................................................................................ 95 
Figure 3.18: The MS2 spectra of the peptide 215YQVIGK220 cross-linked to U-
H2O. ............................................................................................................. 98 
Figure 3.19: The predicted structural formulae of the Uracil nucleotide fragment 
(m/z 175.0714) ........................................................................................... 100 
Figure 3.20: The predicted structural formulae of the Uracil nucleotide fragment 
observed as a U adduct in Figure 3.18 resulting in the shift of b ion series by 
the mass of 208 Da. ................................................................................... 102 
Figure 3.21: The structure of MS2-tagged (PM5 & MINX) pre-mRNA. ............ 104 
Figure 3.22: Coomassie stained 4-12% Bis-Tris Gel. ...................................... 105 
Figure 3.23: Interactome of RNP complex (after cross-linking, purification and 
enrichment) from HeLa nuclear extract assembled on PM5 pre-mRNA. .... 106 
Figure 3.24: Interactome of RNP complex (after cross-linking, purification and 
enrichment) from HeLa nuclear extract assembled on MINX pre-mRNA. .. 107 
 
Figure 3.25: Silver stained gels with their respective size exclusion 
chromatograms ........................................................................................... 109 
Figure 3.26: The graphical representation of distribution of the cross-linking sites 
within RNA-binding proteins along with their domains. ............................... 111 
 
 
LIST OF TABLES 
 
Table 3.1: Cross-links identified from Brat-NHL-hb RNA complex. ..................... 65 
Table 3.2: Cross-links identified from CWC2-U4 snRNA and CWC2-U6 snRNA 
complexes. ................................................................................................... 70 
Table 3.3: U4/U6 snRNA-CWC2 cross-links identified in relative quantification 
experiments. ................................................................................................. 77 
Table 3.4: Cross-links from MS2-MBP protein. ................................................... 84 
Table 3.5: List of Uracil nucleotide (fragment) adducts with their assigned 
abbreviations and calculated masses. .......................................................... 89 
Table 3.6: List of Uracil nucleotide marker ions with their symbols and calculated 
m/z. ............................................................................................................... 89 














LIST OF ABBREVIATIONS 
 
2D Two dimensional 
2DE Two dimensional gel electrophoresis 
3D Three dimensional 
ACN Acetonitrile 
ADC Analog to digital converter 
AGC Automatic gain control 
APS Ammonium peroxodisulfate 
AUC Area under the curve 
BRAT Brain tumor 
BSA Bovine serum albumin 
CID Collision-induced dissociation 
CLIP Cross-linking and immunoprecipitation 
CRM Charge residue model 
Cryo-EM Cryo-electron microscopy 
CSD Cold shock domain 
CTD C-terminal domain 
DDA Data dependent acquisition 
DHB 2,5-dihydroxybenzoic acid 
DIA Data independent acquisition 
DMEM Dulbecco’s Modified Eagle’s Medium 
DNA Deoxyribonucleic acid 
dsRBDs Double-stranded RNA-binding domain 
DTT Dithiothreitol 
ECD Electron capture dissociation 
E. coli Escherichia coli 
EDTA Ethylene diamine tetraacetic acid 
ELISA Enzyme linked immunosorbent assay 
EMSA Electrophoretic mobility shift assay 
ESI Electrospray ionization 
ESI-MS Electrospray ionization mass spectrometry 
ETD Electron transfer dissociation 
FA Formic acid 
FDR False discovery rate 
FT-ICR Fourier transform ion cyclotron resonance 
Hb Hunchback 
HCD Higher energy collision dissociation 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
hnRNP Heterogeneous nuclear ribonucleoprotein 
HPLC High performance liquid chromatography 
HRAM High resolution and accurate mass 
IEM Ion evaporation model 
IM Immonium ion 
kDa Kilo daltons 
LB Lysogeny broth 
 
LC Liquid chromatography 
LIT Linear ion trap 
LTQ Linear trap quadrupole 
m/z Mass-to-charge (ratio) 
MALDI Matrix assisted laser desorption ionization 
MBP Maltose binding protein 
MCP Microchannel plate 
MRM Multiple reaction monitoring 
mRNA Messenger RNA 
MS Mass spectrometry 
MS/MS Tandem mass spectrometry 
Nano-ESI Nano-electrospray ionization 
Nano-LC Nano-liquid chromatography 
NMR Nuclear magnetic resonance 
Nos Nanos 
NREs Nanos response elements 
NTC Nineteen complex 
OMSSA Open mass spectrometry search algorithm 
PAGE Polyacrylamide gel electrophoresis 
PCI Phenol-chloroform-isoamyl alcohol 
PCV Packed cell volume 
PMSF Phenylmethylsulfonyl fluoride 
ppm Parts per million 
PRM Parallel reaction monitoring 
PTM Post-translational modification 
Pum Pumilio 
QIT Quadrupole ion trap 
RBD RNA binding domain 
RBP RNA binding protein 
rf Radio frequency 
RNA Ribonucleic acid 
RNP Ribonucleoprotein 
RP Reversed phase 
RP-LC Reverse phase liquid chromatography 
rpm Rounds per minute 
RRM RNA recognition motif 
SDS Sodium dodecyl sulphate 
SE Size exclusion 
SEC Size exclusion chromatography 
sno Small nucleolar 
snRNA Small nuclear RNA 
snRNP Small nuclear RNP 
SR Serine and arginine rich 
SRM Selected reaction monitoring 
SRPs Signal recognition particles 
TDC Time to digital converter 





TFA Trifluoroacetic acid 
TOF Time of flight 
TRIM Tripartite motif 
tRNA Transfer RNA 
UTP Uridine-5'-triphosphate 
UTR Untranslated region 
UV Ultraviolet 
XIC Extracted ion chromatogram 
ZnF Zinc finger 




Discoveries made in recent years have revealed that a copious number of RNAs 
get associated with miscellaneous number of RNA-binding proteins throughout 
their life cycle in a eukaryotic cell. Together they constitute the Ribonucleoprotein 
(RNP) complexes. The structural studies of these RNP complexes provide a 
valuable insight into the binding modes and functional implications of their 
interactions within the complexes. Most of the RNA-binding proteins have more 
than one binding domain and various kinds of RNA binding motifs (RBM) that 
recognize the specific RNA sequence. The identification and characterization of 
these RNA binding domains/motifs is utmost essential for the better 
understanding of the function of RNP complexes. 
To investigate the interactions of the RNA-binding proteins within RNP 
complexes, UV-induced cross-linking followed by mass spectrometry (MS) has 
proved to be a promising and straightforward technique. During the course of this 
study, the protocol is modified and optimized for the interaction analysis of large 
RNP complex assemblies which led to the identification of predicted as well as 
unknown RBMs. However, by using the conventional protocol, relatively less 
complex RNP assemblies have also been analyzed. 
The first part of the research work mainly emphasized on the qualitative analysis 
of the protein-RNA cross-links. One of the protein-RNA complex studied is in vitro 
assembled Brat-NHL-hb RNA complex. Six hb RNA contact sites have been 
found in Brat-NHL protein by UV-induced cross-linking followed by mass 
spectrometric analysis which provided the basis for mutation studies to confirm 
the binding activity of Brat protein with hb RNA during embryogenesis in 
Drosophila. 
Another protein-RNA complex studied by the aforementioned technique is 
comprised of yeast splicing factor CWC2 along with U6 and U4 snRNAs. 
Seventeen probable contact sites within CWC2 protein have been identified that 
have undergone cross-linking reaction with U6 and U4 snRNAs. Later on this 
  Summary 
 
 
CWC2-U6/U4 snRNAs complex is also used as a model system for the 
quantitative studies of the cross-links. 
Based on the qualitative analysis of CWC2-U6/U4 cross-links, the quantitative 
analysis of protein-RNA cross-links has been established. For this, relative 
quantitative approach has been adopted by using isotope labeled RNAs. The 
results have been used to determine the stoichiometry of the cross-links. 
In the last part of the research work, the UV-induced cross-linking approach has 
also been utilized to investigate the interaction sites within large RNP complexes 
(H/E complex) isolated from the HeLa nuclear extract by assembling on MS2-
tagged pre-mRNAs. It has led to the identification of several contact sites within 
the known RNA binding regions as well as in the regions which have not been 
reported before as RNA binding regions.  
The studies conducted during the research work have contributed in the 
identification and characterization of protein-RNA interactions within the 
aforementioned complexes and also provided the quantitative insight into the 
protein-RNA interactions. The results will also contribute in improving the data 
analysis approach for protein-RNA cross-links and will serve as an outlook to 
future directions of this project. 
 
 








The major challenge in cell biology is to reveal the mechanisms occurring within 
the cells. In addition to the knowledge provided by the genome in the form of 
genetic information, the detail comprehension of the proteins and metabolites is 
extremely necessary for the understanding of the biological processes (Angel et 
al., 2012; Hsu & Chen, 2016). The term proteome first emerged in 1994. It was 
designated to the whole set of proteins that is been encoded by the organism’s 
genome (Wilkins et al., 1996). Proteomics refers to the study of proteome 
explicitly involving the protein identification, characterization and quantification as 
well as interactions of proteins with each other and with other biomolecules such 
as nucleic acids or lipids etc. present in their surrounding environment (Lane, 
2005). These interactions lead to the formation of large macromolecular 
assemblies that play a vital role in many cellular processes (Alberts, 1998). 
Therefore it is indispensable to understand the structure of protein complexes in 
order to have detailed insight in the mechanism of the cellular processes 
occurring in living organisms (Sali et al., 2003; Robinson et al., 2007; Walzthoeni 
et al., 2013).  
Over the past few decades the conventional structural techniques like nuclear 
magnetic resonance (NMR) spectroscopy, X-ray crystallography and cryogenic 
electron microscopy (cryo-EM) have been developed to generate the structural 
information of the large macromolecular complexes (Grassucci et al., 2007; Faini 
et al., 2016). These techniques however have their limitations. Both NMR and X-
ray crystallography require relatively large quantity of materials usually in 
milligrams (mg) (Svergun et al., 1997). Many times the high concentration of 
protein results in its precipitation in NMR. Also NMR is limited to complexes of 
molecular weight approximately 40-50 kDa. On the other hand the X-ray 
crystallography provides high resolution protein structures but all the proteins do 





not easily get crystallized (Loo, 1997). As compared to the X-ray crystallography, 
cryo-EM requires less material (~10 µg/ml) for crystallization (Sjӧberg et al., 
2005) however the resolution obtained is relatively lower than that obtained by 
the NMR spectroscopy and X-ray crystallography (Grassucci et al., 2007). 
Recently, with the development of mass spectrometry (MS) based methods along 
with advanced computational approach, can generate low resolution structural 
information of macromolecular assemblies (Chen et al., 2010; Jennebach et al., 
2012). Generally, the mass spectrometry technique is relatively fast and not 
limited by the size of the protein complex to be analyzed requiring nanogram (ng) 
to microgram (µg) of sample amount (Walzthoeni et al., 2013). Although the 
information obtained by the mass spectrometry based methods about the three 
dimensional (3D) structure of the protein complex is not complete but in 
combination with other structural techniques and computational approaches, it 
can be used to determine the structure of these large macromolecular 
assemblies. 
 
1.2 Mass Spectrometry 
Much credit has been given to the studies carried out by Sir J. J. Thomson (1906 
physics Nobel Laureate for the discovery of electron) and his student F. W. Aston 
(1922 chemistry Nobel laureate for establishing mass spectrograph and 
element’s isotope measurements) which lead to the development of mass 
spectrometry (Thomson, 1921; Aston, 1933). Mass spectrometry that is regarded 
as a microanalytical technique is applied for the detection and determination of 
the composition, molecular structure and the amount of an analyte (Watson & 
Sparkman, 2007). It is an accurate way of measuring the mass to charge ratios 
(m/z) of ions. During last 30 years, it has proved to be significant for the structural 
characterization and analysis of biomolecules (Griffiths et al., 2001). 
Every mass spectrometer is comprised of three components: An ion source ─ to 
convert the molecules into gas phase ions; Mass analyzer ─ to separate the ions 
according to their m/z ratios through electric or magnetic fields; A detector ─ to 





detect the number of emerging ions. These detected signals are proportional to 
the abundance of each species. In addition to these components the mass 
spectrometer also has an inlet device e.g. liquid chromatography or a direct 
injecting probe for introducing the analyte into an ion source and a computer for 
controlling the instrument, processing the data and producing the mass spectrum 
in a suitable format (Figure 1.1) (Lane, 2005; Girolamo et al., 2013). 
 
 
Figure 1.1: Components of a mass spectrometer. The mass spectrometer is comprised of three 
basic components: An ion source ─ to generate ions, Mass analyzer ─ to separate ions on the 
basis of m/z ratios and a detector ─ to detect ions and their abundance. The mass analyzer and 
the detector are always under vacuum. The mass spectrometer is usually coupled to an inlet 
device to introduce sample into an ion source and a computer for processing of the data  
 
1.2.1 Ion Source 
It is a first component of a mass spectrometer where the sample is first vaporized 
and then ionized. For ionization, a low amount of internal energy is transmitted to 
the molecule. There are two widely used soft ionization techniques for the 
analysis of proteins and peptides, electrospray ionization (ESI) (Yamashita & 
Fenn, 1984) and matrix-assisted laser desorption ionization (MALDI) (Karas & 
Hillenkamp, 1988; Tanaka et al., 1988; Hillenkamp & Karas, 1990) which has 
revolutionized the field of biology. This pioneering work on ESI and MALDI was 
recognized and 2002 Nobel prize was awarded in chemistry to John Fenn and 
Koichi Tanaka. 





1.2.1.1 Electrospray Ionization (ESI) 
In electrospray ionization, the ions are transferred from solution into gaseous 
phase at atmospheric pressure. The sample is sprayed at low flow rates (nl/min 
to µl/min) via thin needle to which high voltage (1-6 kV) is applied. This electric 
field is built up between needle and a counter electrode. The positive potential 
results in the accumulation of positive ions at the tip surface and drawn out 
attaining a cone-like shape known as "Taylor cone" (Lane, 2005). This cone turns 
into a filament as it holds more electric charge. When the surface tension 
exceeds the applied electrostatic force, fine positively charged droplets are 
produced. These droplets fly towards the counter electrode and pass through 
either a heated capillary or film of heated nitrogen resulting in the evaporation of 
solvent. The electric charge density increases at the surface of the droplets and 
when the electrostatic repulsion becomes higher than the surface tension they 
split into even more smaller droplets (Lane, 2005). The process continues until 
the solvent is completely removed or an ion desorbs from a droplet (Griffiths et 
al., 2001). The ions are produced in the gas phase by either of the two known 
mechanisms: the ion evaporation model (IEM) (Iribarne & Thomson, 1976; 
Thomson & Iribarne, 1979; Nguyen & Fenn, 2007) and the charge residue model 
(CRM) (Dole et al., 1968; Willoughby et al., 1998). Generally, the ions produced 
are in the form [M+H]+ or [M+nH]n+ (or [M-H]-/[M-nH]n-). Since large 
macromolecules have several ionizable sites, multiply charged ions will also be 
produced. 
The advent of nano-electrospray ionization (nano-ESI) has extended the 
electrospray ionization mass spectrometry (ESI-MS) applications. It has 
considerably increased the sensitivity for high concentration low volume samples. 
In nano-ESI-MS low flow rate 10-300 nl/min is used which improves the ionization 
efficiency by generating smaller droplets (Griffiths et al., 2001). Now-a-days mass 
spectrometers are online coupled to separation techniques like liquid 
chromatography (LC) etc. bringing together the advantages of separation 
techniques and nano-ESI to biological mass spectrometry (Karas et al., 2000). 





1.2.1.2 Matrix-assisted Laser Desorption Ionization (MALDI) 
Since MALDI technique has not been used in the current study so it has been 
briefly described here. The sample to be analyzed is mixed and co-crystallized 
with an excess of matrix material and is irradiated with a nitrogen laser at a 
wavelength of 337 nm. It sublimates and ionizes the analyte without 
fragmentation. Highly accepted ionization mechanism includes proton transfer in 
gas phase to the expanding plume from photoionized matrix molecules (Lane, 
2005; De Hoffmann & Stroobant, 2007). The ions are then accelerated towards 
an analyzer by an electrostatic field. 
 
1.2.2 Mass Analyzer 
It is a second component of mass spectrometer which is specified for the 
separation and detection of ions. The mass analyzer performance and its utility 
can be assessed based on several parameters including mass resolution, mass 
accuracy, mass range and MS/MS acquisition and precision. Presently, four main 
types of mass analyzer are widely used in proteomics: time of flight (TOF), 
quadrupole, ion trap, and Fourier transform ion cyclotron resonance (FT-ICR) 
analyzers. These mass analyzers can be used both as stand-alone analyzers or 
in combination in tandem mass spectrometer (Girolamo et al., 2013). 
1.2.2.1 Time of Flight (TOF) 
It separates ions on the basis of their velocity. The m/z ratios are based on the 
measurement of the time required by the ions to travel from the source to the 
detector. All ions are produced at the same time and are accelerated by applying 
a fixed potential into TOF drift tube. As all ions with similar charge carry identical 
kinetic energy, therefore the ions with lower m/z value achieve higher velocities 
and reach the detector earlier than the ones carrying higher m/z value, after 
travelling through a fixed distance of 0.5-2 meters (Guilhaus, 1995; Mamyrin, 
2001; Glish & Vachet, 2003). The performance of TOF instrument is improved by 
using two techniques. Firstly, by creating a time delay between an ion formation 





and its extraction from the source, also known as "delayed extraction" (Kovtoun, 
1997; Kovtoun & Cotter, 2000). Secondly, by including ion mirrors, or reflectrons 
that create a retarding field and deflect the ions, sending them back to the 
detector through the flight tube. Thereby compensating for the minor differences 
in the velocities of ions with the same m/z ratios (Mamyrin, 1994; Scherer et al., 
2006). 
1.2.2.2 Quadrupole 
The quadrupole mass analyzer consists of four equally spaced parallel rods 
arranged around a central axis. Direct voltage is applied to two of the rods and an 
alternating current or radio frequency (rf) potential to the other two rods. The flight 
of the ions between these rods depends upon the voltages applied. The specific 
direct and alternating current voltages allow only ions defined with certain m/z 
ratio to travel through the analyzer to the detector (Glish & Vachet, 2003; 
Dawson, 2013). 
1.2.2.3 Ion Trap  
(A) Quadrupole Ion Trap (QIT) 
In ion trap, the ions are first trapped and then detected on the basis of their m/z 
ratios. An ion trap may be conceptualized as a quadrupole that has been bent 
around on itself to configure a closed loop. The ions are trapped inside the three 
hyperbolic electrodes, the ring electrode, the entrance cap electrode and the exit 
cap electrode. Thus the ion trap is also referred as the "quadrupole ion trap". The 
ions are subjected to the oscillating electric field in an ion trap. This electric field 
is generated by a radio frequency (rf) voltage applied to the ring electrode. Inside 
ion trap, the Helium gas is responsible for removing excess energy from the ions 
by collision and "dampens" the ions into the center of trap. The oscillation 
frequency of the ions depends upon their m/z ratios therefore the ions with 
different m/z ratios will exit the ion trap at different voltages and time. The ions 
are then transferred to the detector (March, 2000; March & Todd, 2005).  





(B) Linear Ion Trap (LIT) 
The linear ion trap (LIT) is also referred as two-dimensional quadrupole ion trap 
(2D-QIT). It consists of two pairs of parallel mounted planar electrodes and a pair 
of z-electrodes that are used as the endcaps (Song et al., 2006). The radio 
frequency (rf) potential is applied for ion trapping in the radial and axial directions. 
The ions are confined radially in x and y directions by two dimensional rf field and 
axially in z direction by potentials applied to the endcaps, thus limiting the 
longitudinal flow of ions which are later detected by conventional means (Tabert 
et al., 2006). Linear ion traps have high injection and trapping efficiencies and 
high storage capacities that enhance the sensitivity, resolution and mass 
accuracy (Hager, 2002). 
(C) Orbitrap 
The orbitrap mass analyzer works by orbital trapping of ions. It is comprised of an 
outer barrel like electrode and a central spindle-like electrode along the axial axis. 
The outer electrode serves two purposes, ion excitation and detection. For the 
efficient ion introduction the electric field is modified at the injection port by using 
field compressor, a small portion of the outer electrode (Zubarev & Makarov, 
2013). The electric field created by applying the voltage to outer and central 
electrodes allow the injected ions to cycle around the central electrode and at the 
same time oscillate along the horizontal axis (Hu et al., 2005; Eliuk & Makarov, 
2015). The image current from the coherently oscillating ions is detected on the 
receiver plates as a time domain signal. This signal is Fourier transformed into 
frequency domain as in FT-ICR and is converted into a mass spectrum 
(Scigelova & Makarov, 2006). 
1.2.2.4 Fourier Transform Ion Cyclotron Resonance (FT-ICR) 
It uses the magnetic field to determine the m/z ratios of ions. It consists of an ESI 
ion source, ion optics to transfer ions into the magnetic field and an ICR cell or 
Penning trap. The ions are trapped, exposed to the magnetic field, oscillated with 
a cyclotron frequency that is inversely related to the m/z ratio, analyzed and 





finally detected. The use of a Penning trap enhances the detection time and thus 
sensitivity and resolution (Marshall et al.,1998; Marshall & Chen, 2015). 
 
1.2.3 Ion Detector 
It is the last component of mass spectrometer. After passing through the mass 
analyzer, the ion beam strikes the detector. The ions separated on the basis of 
m/z ratio are electrically detected by the detector. There are various types of ion 
detection systems based on sensitivity, accuracy and response time.  
Electron multiplier is an extensively used detection system. Whereby the 
secondary electrons are repeatedly emitted as a result of constant collisions of 
energized particles at suitable surface leading to the escalation of ions’ signal 
intensity. The electron multiplier can be either of discrete dynode type or a 
continuous dynode type (Niessen & Falck, 2015). It can be used in combination 
with quadrupole and ion trap instruments. 
Microchannel plate (MCP) is other type of ion detector that has its application in 
combination with time of flight instruments. The MCP is an array of miniature 
electron multipliers aligned parallel to one another, mostly along a small angle 
with the surface. It is backed up by the time to digital (TDC) or analog to digital 
(ADC) converters that enable the high speed acquisition of data (Dubois et al., 
1999). 
In FT-ICR and Orbitrap based mass spectrometers, the ion detection is based on 
the detection of high frequency image currents generated by the coherent 
movement of ions. The signals of all ions with different m/z ratios are detected 









1.2.4 Tandem Mass Spectrometry 
Tandem mass spectrometry (MS/MS) involves minimum two stages of mass 
analysis coupled with either a chemical reaction or a dissociation process that 
brings the difference in ion mass or charge (De Hoffmann & Stroobant, 2007). In 
tandem mass spectrometry (MS/MS) experiment, the first analyzer is used to 
isolate the precursor or parent ion, which undergoes fragmentation to yield 
product or daughter ions and neutral fragments which are then analyzed by a 
second mass analyzer (Madeira & Florêncio, 2012). The widely used types of 
fragmentations in tandem mass spectrometry are collision induced dissociation 
(CID), high energy collision dissociation (HCD) and electron transfer dissociation 
(ETD). 
Hybrid mass spectrometers utilize different types of analyzers for the first and 
second stages of mass analysis. The general purpose of designing these hybrid 
instruments is to combine various performance attributes exhibited by discrete 
types of analyzers into single mass spectrometer i.e. mass resolving power, the 
ion kinetic energy for dissociation and speed of analysis etc.(Glish & Burinsky, 
2008). 
The MS/MS instruments can be classified in two categories: "tandem in space" 
mass spectrometers by coupling of two physically distinct analyzers like TOF 
analyzers and quadrupole mass filters and "tandem in time" mass spectrometers 
through conducting an appropriate sequence of events within an ion storage 
device like QIT, FT-ICR and orbitraps (Glish & Vachet, 2003). 
For the current studies, linear trap quadrupole (LTQ)-Orbitrap (Velos and XL) 
mass spectrometer has been used. It is a Fourier transform hybrid mass 
spectrometer equipped with ESI source that is-line coupled to nano-flow reverse 
phase liquid chromatography (RP-LC) system. The LTQ-Orbitrap instrument 
consists of dual cell linear ion trap coupled to rf-only C-shaped "C-trap", HCD 
collision cell and the orbitrap mass analyzer. The linear ion trap selectively fills 
the C-trap with ions of interest. The C-trap stores and collisionally cools the ions 
before injecting into the orbitrap. The orbitrap analyzer utilizes the image current 





detection and Fourier transformation for mass analysis (Olsen et al., 2005; 
Makarov et al., 2006a).  
The precursor ion scan (MS1) is carried out by orbitrap whereas product ion scan 
(MS2) is performed with CID fragmentation in LTQ simultaneously. However, if 
desired, the CID generated fragments can be transferred to the orbitrap for the 
measurement. Depending upon the experimental necessity, HCD fragmentation 
can also be performed in HCD collision cell of the selected ions which are then 
measured in orbitrap (Olsen et al., 2009). Thus the combination of the strengths 
of two different mass analyzers i.e. high sensitivity and high scan rates of LTQ 
mass analyzer and high mass resolution and high mass accuracy of orbitrap 
mass analyzer, has led to high throughput, high accuracy (≤ 5 ppm) and high 
resolution (> 100,000) of the LTQ-Orbitrap mass spectrometer (Makarov et al., 
2006b).  
The other Fourier transform based hybrid instrument used during the course of 
study is Quadrupole-Orbitrap (Q Exactive) mass spectrometer. The instrument is 
equipped with quadrupole which serves as a precursor ion selection device 
configured with high-efficiency C-trap, HCD collision cell and the orbitrap mass 
analyzer (Michalski et al., 2011). Both MS1 and MS2 measurements are carried 
out by orbitrap. Hence, the instrument combines the high performance 
quadrupole precursor selection with high resolution (up to 140,000 FWHM) and 
accurate mass (better than 1 ppm) (HRAM) orbitrap detection (Kelstrup et al., 
2012). 
 
1.2.5 Mass Spectrometric Analysis 
The tandem mass spectrometry coupled with liquid chromatography and the 
availability of genome sequence information has revolutionized the field of mass 
spectrometry. There are two main strategies used in proteomics for protein 
identification by mass spectrometry: top-down proteomics and bottom-up 
proteomics. In top-down approach, the intact proteins, mostly selected multiple 





charge ions generated by ESI as precursor ions, are subjected to gas phase 
fragmentation. Conversely the bottom-up approach involves the enzymatic 
digestion of proteins into peptides. The peptides can be separated using reverse 
phase liquid chromatography which is coupled online/offline to ESI-MS/MALDI. 
The data generated by mass spectrometer is used for the identification and 
quantification of specific peptides (Niessen & Falck, 2015; Gillet et al., 2016; 
Zhang et al., 2013).  
The bottom-up proteomics is comprised of three main approaches: data-
dependent acquisition (DDA) or shotgun approach; targeted data acquisition by 
selected reaction monitoring (SRM)/multiple reaction monitoring (MRM)/parallel 
reaction monitoring (PRM); and data-independent acquisition (DIA). 
In DDA based methods, a complete and unbiased coverage of proteome is 
achieved by acquiring the mass spectra at MS1 level of the most abundant 
precursor ions, co-eluting at a specific point in gradient elution and MS2 level of 
the fragment ions, generated by the sequential isolation and fragmentation of the 
precursor ions (Aebersold & Mann, 2016). Instruments with quadrupole-orbitrap 
or TOF analyzers are most suitable for DDA approach. 
In targeted data acquisition, the proteins of interest are preselected and known. 
In the first stage the precursor ion of particular mass is isolated which is then 
fragmented and product ion of certain mass is selected in the second stage for 
detection. The targeted analysis can be carried out by SRM/MRM/PRM 
approach. The SRM involves the monitoring of single fixed ion mass while MRM 
is the parallel acquisition of multiple SRM transitions (Bauer et al., 2014). In PRM, 
the full scan of each transition by a precursor ion is performed (Law & Lim, 2013). 
The SRM, MRM and PRM experiments are carried out on triple quadrupole and 
quadrupole-orbitrap mass spectrometers (Gallien et al., 2012). 
In DIA, all the ions within selected m/z range of precursors are fragmented at the 
same time thus generating the MS/MS records of all the analytes in the biological 
sample (Doerr, 2015; Hu et al., 2016). Mass spectrometers with quadrupole, TOF 





or orbitrap analyzers like Q-TOF and Q-Orbitrap are appropriate for the DIA 
approach. 
 
1.2.6 Mass Spectrometry Based Fragmentation 
Tandem mass spectrometry helps in providing detail information about the 
structure, composition and sequence of biomolecules. During this process, the 
selected ions of interest are fragmented on interaction with the collision gas such 
as nitrogen or helium or argon (Platner, 2013). There are several fragmentation 
techniques. For the current studies CID and HCD methods have been used for 
the analysis of samples containing RNA and proteins. 
For the MS analysis of proteins, bottom up approach has been adopted. For this, 
trypsin is widely used protease to digest complex protein sample. Trypsin cleaves 
proteins C-terminally at arginine (R) or lysine (K) amino acid residues, except 
when either of it is followed by proline (P) amino acid (Wang, 2011). Usually the 
peptides from acidic solution are fragmented in positive ion mode (Seidler et al., 
2010). The fragmentation occurs along the peptide backbone (C-N, N-C and C-C 
bonds) (Frese, 2013). To annotate peptide sequence ions, Roepstorff and 
Fohlman nomenclature (Roepstorff & Fohlman, 1984) is widely used which was 
later modified by Biemann (Biemann, 1990). As a result of fragmentation, if the 
charge is retained on N-terminus of the ion, it is designated as b-ion whereas if 
the charge is retained on C-terminus of the ion, it is designated as y-ion. 
Depending on type of fragmentation method used, relatively less common a, c, x 
and z ions can also be created (Newton et al., 2004) (Figure 1.2). In addition to 
these, the mass spectrum can also has the signals generated by the neutral loss 
of NH3 or H2O from ions, immonium ions and the a-type ions, formed by the loss 
of CO from b-ions (Griffiths et al., 2001; Kapp et al., 2003). The peptide mass 
spectrum is interpreted by calculating the difference in mass between the 
adjacent peaks that corresponds to the mass of an amino acid of either b or y 
ions series (Niessen & Falck, 2015). 






Figure 1.2: Schematic representation of peptide fragmentation and nomenclature of fragments 
(Biemann, 1990). The collision induced dissociation mainly generates b and y ions due to the 
fragmentation of the peptide bond. 
 
Besides the tandem mass spectrometry has frequently been used for the 
elucidation of structure and sequences of proteins, it has proven its potential for 
the investigation of nucleic acids. The fragmentation of RNA has been relatively 
less studied than that of DNA. The studies using MALDI have revealed that the 
RNA is more stable than DNA (Kirpekar & Krogh, 2001). For mass spectrometric 
analysis, the RNA is digested with RNase. The nucleic acids from basic solutions 
are usually fragmented in negative ion mode. The oligonucleotide fragment ions 
are annotated according to the nomenclature, similar to the one used for 
peptides, proposed by McLuckey, Berkel and Glish (Mcluckey et al., 1992). The 
5‘-terminus fragment ions a, b, c and d and their complementary 3‘-terminus 
fragment ions z, y, x and w respectively are generated upon cleavage of 
phosphodiester chain (Figure 1.3). Regardless of the type of fragmentation 
method used, there is nucleobase loss due to the cleavage of N-glycosidic bond 
between the nucleobase and the sugar moiety followed by the dissociation of 
phosphodiester bond of the nucleotide that undergoes base loss. The mass 
difference in the series of 5‘-terminus and 3‘-terminus fragment ions can be used 
to determine the nucleotide sequence (Huber & Oberacher, 2001). 
 






Figure 1.3: Schematic representation of RNA fragmentation and nomenclature of fragments 
(Mcluckey et al., 1992). The cleavage of phosphate backbone results in the generation of 5‘-
terminus fragment ions a, b, c and d and their complementary 3‘-terminus fragment ions z, y, x 
and w. 
 
1.2.7 Proteomic Data Analysis 
Bottom-up approach leads to considerable increase in the sample complexity 
which in turn makes the data analysis complicated. Therefore, prior purification, 
separation, fractionation and enrichment of the protein sample is necessary to 
reduce the complexity. For this the protein samples are usually processed by gel 
electrophoresis and chromatography. The peptides obtained are then analyzed 
by liquid chromatography coupled to mass spectrometry (LC-MS) (Lane, 2005; 
Gillet et al., 2016).  
The data generated is comprised of information regarding m/z, retention time and 
intensities of the observed peptides along with fragment ion spectra (Schmidt et 
al., 2014). The correct assignment of the spectrum to the peptide sequence is the 
primary and crucial step for proteomic data processing. Several computational 
softwares are available for the automatic assignment of the peptide sequence to 
the spectrum (Nesvizhskii et al., 2007). 
The chromatographic peak of the peptide can be used to calculate the area under 
the curve (AUC) for quantification of a peptide (Schmidt et al., 2014). To identify 
the peptide sequence, the MS2 spectrum is scanned using the search algorithm 
such as Andromeda (Cox et al., 2011) or Open Mass Spectrometry Search 





Algorithm (OMSSA) (Geer et al., 2004) etc. against protein sequences database. 
The acquired peptide spectrum is searched and correlated with in silico 
generated peptide spectrum from protein sequences database (Lane, 2005; 
Nesvizhskii et al., 2007; Gillet et al., 2016). These searches are made according 
to the user specified filtering criteria like protease and labels used, mass 
tolerance and types of post translational modifications expected etc. A target-
decoy based false discovery rate (FDR) approach is used to limit the coincidental 
peak matches to a certain number. The score is calculated, based on the 
statistical significance of the match between the acquired and the theoretical 
peptide spectrum. It helps in differentiating the correct from incorrect 
identifications. Generally, the peptide hits with only best scores are further 
considered for the statistical analysis (Lane, 2005; Nesvizhskii et al., 2007). 
 
1.3 Quantitative Proteomic Studies 
In the past centuries mass spectrometry (MS) has been evolved as technique 
used not only for providing the qualitative information of proteins but also their 
abundance in the sample (Urban, 2016). Quantitative proteomics can be defined 
as a technique for determining the global protein levels (Yan & Chen, 2005). 
Quantitative protein profiling has proven to be essential for the investigation of 
biological processes. In addition to mass spectrometry, various kinds of 
techniques have been developed for quantitative analysis like two dimensional 
gel electrophoresis (2-DE), fluorescence microscopy and enzyme-linked 
immunosorbent assay (ELISA) etc. (Wilm, 2009). In certain cases, such as in the 
presence of multiple isoforms and modified forms of proteins, the proteins are 
undetectable and unmeasurable by immunological or other techniques. The mass 
spectrometry has the ability to distinguish between various isoforms and modified 
protein and also to quantify them (Hale, 2013).  
In shotgun proteomics, the peptides are quantified by determining the signals of 
their precursors at both MS1 and MS2 levels (Gillet et al., 2016). Numerous 





strategies have been developed for quantitative analysis by mass spectrometry 
(Frese, 2013). These strategies can be divided into two major categories: 
absolute and relative quantification. Absolute quantification is the determination 
of precise amount of a biological molecule under study e.g. copy number of 
protein per cell whereas the relative quantification is the determination of relative 
levels of biomolecules between two or more states/samples e.g. percentage or 
fold change increase or decrease in protein abundance in response to some 
treatment (Ong & Mann, 2005; Hale, 2013). 
These quantitative measurements can be carried out either with or without 
labeling, referred as labeled quantitation and label-free quantitation respectively. 
In labeled quantitation, the labels (2H, 13C, 15N or 18O as heavy labels and 1H, 
12C, 14N and 16O as light labels) are incorporated either metabolically in vivo or 
chemically or enzymatically in vitro in the samples to be analyzed. In label-free 
quantitation, peak intensities or identification frequency of peptides is used for the 
calculation of protein abundance (Kito & Ito, 2008; Bruce et al., 2013). For the 
comparative studies of assembled RNP complex, the relative quantification has 
been carried out by using technique explained below. 
 
1.3.1 Quantitation Based on Extracted Ion Chromatogram (XIC) 
After mass spectrometric analysis, the ion chromatograms of certain mass to 
charge ratio of the peptides are extracted and used for quantification. The area 
under the curve (AUC) of the peptide peak with a particular m/z at a given time is 
directly related to the amount (Ong & Mann, 2005). This process of peak area 
determination is called ion extraction and its resulting chromatogram is referred 
as extracted ion chromatogram (XIC). Different peptides have different ionization 
efficiency, therefore for relative quantification, the peak area of same ion species 
from different samples are compared. For protein correlation profiling, the 
alignment of total ion chromatograms belonging to different samples is carried 
out. The ion species, for which MS2 spectra have been generated and their 
respective peptide sequences have been identified are correlated on the basis of 





their chromatographic retention times to the ones of other samples either with or 
without any MS2 spectra. This method provides relatively reliable estimation of 
protein ratios (Schulze & Usadel, 2010). It is also cost effective as no labeling 
reagents are used and is versatile and can be applied to any type of sample. 
However, there are some limitations of XIC-based relative quantification 
approach. It can be error-prone due to variations that can occur during sample 
processing and analysis as well as the ion suppression effect because of co-
detected ions or interfering substances like abundant background proteins etc. 
Some of these limitations can be minimized by spiking in the calibrant or the 
identical amount of standard peptide into the samples to be compared and by 
developing an algorithm that can align multiple runs and compare the XIC of each 
peptide ion (Ong & Mann, 2005; Kito & Ito, 2008). 
 
1.4 Quantitative Nucleic Acid Studies 
Mass spectrometry has been recognized as an emerging powerful tool for the 
identification, characterization and quantification of nucleic acids. Recently, the 
electrophoretic separation of RNA followed by in-gel RNase digestion and LC-MS 
analysis has been successfully developed for the identification of RNA along with 
its post-transcriptional modifications. Like proteins, the nucleic acids can also be 
subjected to isotope labeling. The stable isotope labeling of RNA can be carried 
out chemically, enzymatically or metabolically by using heavy isotopes such as 
2H, 13C and 15N. Without altering the biochemical and biophysical properties of 
the oligoribonucleotide, it facilitates the accurate quantification. The known 
concentrations or certain ratio of light and heavy isotopically labeled RNAs are 
combined together and are digested with RNase and analyzed by LC-ESI-MS. In 
the MS spectrum generated, the light and heavy peptide pairs separated by a 
specific mass difference can be observed. The mass difference between the 
differentially labeled oligonucleotides correspond to the number of atoms of the 
elements present. Therefore, this method can be used for the deduction of the 
partial elemental composition as well as the quantification of the 





oligoribonucleotides. The relative quantification is achieved by comparing the 
area under the curve (AUC) or signal intensities of light and heavy isotopically 
labeled oligoribonucleotide pair. Compared to some other polymers, the data 
generated by nucleic acids fragmentation is very complex leading to the limited 
success in the nucleic acid studies by mass spectrometry (Waghmare & 
Dickman, 2011; Borland & Limbach, 2017). Few strategies have been developed 
for the identification and quantification of nucleic acids but still there is a room for 
further advancements (Meng & Limbach, 2005; Popova & Williamson, 2014; 
Paulines & Limbach, 2017). 
 
1.5 Qualitative Studies 
Various classes of proteins like histones, helicases, ligases, polymerases, 
transcription factors and ribosomal proteins interact with nucleic acids to play a 
crucial role in gene expression, gene regulation as well as cell function. Some 
proteins recognize and bind to a specific sequence motif of single-stranded 
nucleic acids whereas others recognize and bind to that of double-stranded 
nucleic acids or they bind to nucleic acids with a particular three dimensional 
structure (Steen & Jensen, 2002). The post-genomic era has faced one of the 
major challenges regarding mapping of these biological interactions. For 
identification and characterization of these interactions a variety of techniques 
have been established including the direct binding methods like electrophoretic 
mobility shift (Hellman & Fried, 2007) and fluorescence anisotropy assays 
(Heyduk et al., 1996), RNA-mapping methods such as chemical probing (Duval et 
al., 2017) and cross-linking and immunoprecipitation (CLIP) (Ule et al., 2003), 
genetic methods such as yeast three-hybrid system (SenGupta et al., 1996), 
microarray-based methods (Tenenbaum et al., 2000) and mass spectrometry 
methods (Kvaratskhelia & Grice, 2008). Every method has its own strengths and 
limitations however these limitations can be compromised by using the 
combination of these techniques (Gordiyenko & Robinson, 2008; Hegarat et al., 
2008; Nakamura et al., 2012). 





1.5.1 Protein-Nucleic Acid Cross-linking 
In order to study the protein-RNA interactions, the complexes assembled either in 
vivo or in vitro by using recombinant components or by incubating the cellular or 
nuclear extracts with in vitro transcribed tagged RNA are purified for further 
analysis (Schmidt et al., 2012; Faoro & Ataide, 2014). The assembled protein-
nucleic acid interactions are oftenly held together by weak non-covalent 
interaction forces resulting in the dissociation of interaction partners during the 
ionization process. In order to stabilize the protein nucleic acid complex, covalent 
bonds are generated between the interaction partners with cross-linking 
technique. The cross-linking along with mass spectrometry furnishes information 
about interacting partners of the complex more quickly and with great sensitivity 
and can subsequently be used for predicting the three-dimensional molecular 
modeling of protein-nucleic acid interfaces (Steen & Jensen, 2002). 
The protein-nucleic acid complex can be cross-linked either by using chemical 
cross-linking reagents such as formaldehyde and nitrogen mustard etc. that 
connects the reactive groups of the interacting partners present within a certain 
distance range (Tretyakova et al., 2015) or by photoactivation using UV light that 
generates a so called zero-length cross-link, connecting the reactive groups of 
the interacting partners lying in close proximity with each other. It makes use of 
the natural reactivity of nucleobases on excitation by UV light (Meisenheimer & 
Koch, 1997). Moreover, there are some photo-inducible cross-linkers such as 2-
iminothiolane and DTT etc. that can get activated on UV light exposure and 
connects the reactive groups of the interacting partners present adjacent to each 
other (Wower et al., 1981; Zaman et al., 2015). After cross-linking, the cross-
linking site up to amino acid residue and nucleotide level can be determined by 
mass spectrometric analysis and bioinformatics. 
1.5.1.1 UV-Induced Protein-Nucleic Acid Cross-linking 
During the course of current studies, the UV-induced photo cross-linking along 
with mass spectrometry techniques have been used to study the interactions of 
protein-RNA complexes. The proteins and nucleic acids can absorb the radiation 





of wavelength in the 250-280 nm range to generate photochemical cross-links 
between the interacting partners without distorting the protein-nucleic acid 
complex conformation (Steen & Jensen, 2002). However, the low cross-linking 
yield (1-5%) is the major limitation of this approach (Kramer et al., 2011) which 
can be overcome by using photosensitive analogs such as halonucleotides e.g. 
4-thiouridine, 6-thioguanosine and 5-bromouracil etc. can be used. These 
photoactivable nucleotide analogs can be incorporated during in vivo or in vitro 
synthesis of oligonucleotides. They can enhance the cross-linking yield and 
minimize the structural distortions of the ligands (Meisenheimer & Koch, 1997; 
Kramer et al., 2011). In principle, all nucleotides and amino acids can undergo 
cross-linking reaction, however they vary in their reactivity. According to cross-
linking studies, lysine, tryptophan, tyrosine, phenylalanine and cysteine are the 
most reactive amino acids whereas uracil is the most reactive nucleotide followed 
by guanine, cytosine and adenine (Shetlar et al., 1984a; Shetlar et al., 1984b; 
Schmidt et al., 2012). 
Sample preparation, cross-linking reaction and its resulting heterogeneous 
mixture of products and ionization are the major challenges in structural analysis 
of peptide-oligonucleotide heteroconjugates by using MS-based approach. 
1.5.1.2 Purification of Peptide-Oligonucleotide Heteroconjugates 
The purification of the assembled complex is one of the important steps for the 
analysis of protein-nucleic acid interactions. The purification can be carried out by 
using biochemical techniques such as gradient centrifugation etc. or by affinity-
based purification methods using genetically epitope-tagged proteins or tagged 
nucleic acids as a bait for macromolecular complex or by using antibodies 
against one of the nucleic acid interacting proteins and nucleic acid (Schmidt et 
al., 2012). 
Depending upon the complexity of the sample, the peptide-oligonucleotide 
heteroconjugates are purified from non-cross-linked components by using 
combination of various chromatographic techniques. The peptide-nucleic acid 
heteroconjugates derived by the hydrolysis of highly complex protein-nucleic acid 





cross-linked sample with endoproteinase can be subjected to size exclusion 
chromatography under denaturing conditions to separate cross-linked peptide-
nucleic acid heteroconjugates and non-cross-linked nucleic acid from the non-
cross-linked peptides (Urlaub et al., 1995; Urlaub et al., 2002). Thereafter, the 
nucleic acid is hydrolyzed with nucleases and the peptide-oligonucleotide 
heteroconjugates are separated from the non-cross-linked oligonucleotides by 
C18 reversed phase liquid chromatography (RP-LC). The peptide-oligonucleotide 
heteroconjugates are more hydrophobic and bind to the C18 RP column whereas 
the non-cross-linked oligonucleotides do not bind and are easily removed (Urlaub 
et al., 2008). Owing to the nucleic acid phosphate backbone, the peptide-
oligonucleotide heteroconjugates behave the same as phosphopeptides. 
Therefore, to enrich the heteroconjugates the same enrichment protocols can be 
adopted as for phosphopeptides for example TiO2 solid-phase extraction (Larsen 
et al., 2005; Luo et al., 2008). The peptide-oligonucleotide heteroconjugates can 
be enriched by adsorbing to the titanium dioxide beads in the presence of DHB, 
providing the acidic environment for the competitive binding of the peptide-
oligonucleotide heteroconjugate against unphosphorylated peptides (Richter et 
al., 2009) (Figure 1.4). 
The relatively less complex samples composed of few proteins and short nucleic 
acid, after reconstitution and cross-linking, can be hydrolyzed by endoproteinases 
and nucleases and the peptide-oligonucleotide heteroconjugates are purified 
directly by using C18 RP-LC and TiO2 solid-phase extraction (Kramer et al., 
2011).  
1.5.1.3 Mass Spectrometric Analysis of Protein-Nucleic Acid Cross-links 
Since peptide-oligonucleotide heteroconjugate is composed of two different types 
of polymers, exhibiting different physicochemical properties therefore they require 
different conditions for ionization in MS. The peptides and oligonucleotides are 
ionized in positive and negative ion modes respectively. During the current 
studies the interest lies in the identification of the protein region interacting with 
RNA therefore the ionization is performed in positive ion mode (Schmidt et al., 





2012). However, the presence of excess of non-cross-linked components 
hampers the ionization of the cross-links. The increased hydrophilicity of peptide-
oligonucleotide heteroconjugates due to presence of oligonucleotide moiety 
cross-linked to the peptide in comparison to the unmodified non-cross-linked 
peptides may cause lower ionization efficiency. For the relative ionization 
improvement, the oligonucleotide part of the cross-linked heteroconjugate should 
be made as small as possible, maximum up to four nucleotides by using 
nucleases (Steen & Jensen, 2002; Qamar et al., 2015). 
For the mass spectrometric analysis of peptide-oligonucleotide heteroconjugates, 
the HCD fragmentation has proved to be better than the CID fragmentation 
methods. The mass spectrometers with orbitrap analyzers carry out the HCD 
fragmentation with high accuracy. It helps in differentiating the distinct signals 
generated by peptide and nucleotide fragmentation such as the signals of 
immonium ion of tyrosine (m/z 136.0762) and the RNA marker ion of adenine 
(m/z 136.0623). In addition, the peptide-oligonucleotide heteroconjugate 
spectrum generated by HCD fragmentation usually has long y-ion series, high 
intensity signals of a2 and b2 ions, signals of immonium and internal ions and 
nucleic acid marker ions that improve its identification. 
1.5.1.4 Protein-Nucleic Acid Cross-links Data Analysis 
The low signal intensity in MS/MS spectrum and the wide variety of potentially 
cross-linked nucleotide fragments has made the interpretation of the data 
obtained by the mass spectrometric analysis of protein-nucleic acid cross-linking, 
very challenging and laborious. The cross-linking is usually an additive reaction. 
The molecular weight of the peptide-oligonucleotide heteroconjugate is the sum 
of the molecular weight of the peptide and the oligonucleotide moiety cross-linked 
to it. The MS/MS spectra obtained are usually prevailed by the signals of peptide 
fragments. In this case, the cross-linked nucleotide moiety can only be deduced 
by calculating the mass difference between the experimental peptide-
oligonucleotide heteroconjugate and the peptide (Kramer et al., 2011).  





In recent years, a semi-automated data analysis approach has been developed 
for the unbiased analysis of peptide-oligonucleotide heteroconjugates. It is 
comprised of RNPxl tool (Kramer et al., 2014) in OpenMS environment (Sturm et 
al., 2008; Bertsch et al., 2011) using OMSSA (Geer et al., 2004) as the search 
engine. The oligonucleotide fragment mass is dealt as variable modification while 
searching for PTM against database. After endonuclease digestion and TiO2 
enrichment, the heteroconjugates with maximum four nucleotides are possible. 
Taking this into consideration, 69 different mass combinations out of four different 
nucleotides and 829 different mass combinations out of four different nucleotides 
along with RNA/DNA modifications like loss of H2O and HPO3 etc. are possible. 
During the database search, these mass variants are used to generate the 
theoretical precursor fragment spectra for every original spectrum. By subtracting 
the molecular weight of the oligonucleotide from the experimentally determined 
molecular weight of heteroconjugate, the molecular weight of the peptide can be 
deduced. The sum of combination of oligonucleotide fragment mass along with 
peptide mass and spectrum which fits to the experimental precursor mass along 
with its candidate spectrum will yield a most probable hit. Additionally, different 
filters can be applied according to the experimental design such as for comparing 
the experimental sample with the control one and also for removing the pure 
peptide hits etc. (Kramer et al., 2014). The manual inspection of the MS/MS 
spectrum is immensely important to screen the exact amino acid and nucleotide, 
undergone cross-linking reaction. The presence of signals of marker ions of 
nucleic acid base resulting by the nucleic acid fragmentation and the shift of b or 
y ion series or signals of immonium and internal ions by the mass of cross-linked 
nucleotide fragment or adduct, indicate the cross-linked amino acid along with 
cross-linked nucleotide (Qamar et al., 2015). Oftenly, the cross-linking bond 
formed between peptide and oligonucleotide is labile to HCD fragmentation 
resulting in the identification of the cross-linked peptide but the identification of 
the single cross-linked amino acid residue is no longer possible. So far, the 
unavailability of a software that can handle all the aspects of peptide-
oligonucleotide heteroconjugate fragment spectra makes the requirement of the 





completely automated system for protein-nucleic acid cross-linking data 
indispensable. 
 
Figure 1.4: Workflow of cross-linking protocol (Figure adapted from Qamar et al., 2015). The in 
vitro transcribed MS2-tagged pre-mRNA is incubated with HeLa nuclear extract for the RNP 
complex assembly. The assembled RNP complex is purified. The purified RNP complex is then 
UV-cross-linked. The proteins in the sample are digested with trypsin. The cross-links are isolated 
and the non-cross-linked peptides are removed by administering the sample to the SEC. The 
RNA is hydrolyzed by the RNases. The non-cross-linked RNA oligonucleotides are removed by 
RPC. The RNA-protein cross-links are subsequently enriched by using TiO2 solid phase 
extraction. The sample is then subjected to LC-ESI-MS/MS analysis. The RNPxl pipeline in an 
OpenMS environment is used to analyze MS data. 





1.6 Biological Complexes Studied Using UV-Induced 
Cross-linking and Mass Spectrometry 
 
1.6.1 Brat-NHL-hb RNA Complex 
The post transcriptional gene regulation plays a crucial role in the regulation of 
metabolism and development. Generally, the RNA binding proteins (RBPs) 
interact by recognizing the cis-acting sequences in the 3’ UTR of target mRNAs 
and regulate their translation, stability and localization. Embryogenesis in 
Drosophila, is one of the context in which the translational regulation of 
maternally encoded mRNAs is indispensable. The translational repression of 
maternal hunchback (hb) mRNA at the posterior results in the development of the 
anterior–posterior axis (Irish et al., 1989; Struhl, 1989). Pumilio (Pum) along with 
two cofactors binds to the specific sequences (Nanos response elements, NREs) 
located in the hb mRNA’s 3’ untranslated region (UTR) to repress the translation 
of hb mRNA (Wharton et al., 1998; Sonoda & Wharton, 1999; Sonoda & 
Wharton, 2001; Wang et al., 2002). These cofactors include Nanos (Nos) protein 
that plays role in generation of abdominal segmentation (Wang & Lehmann, 
1991) and Brain Tumor (Brat) protein, which is a NHL domain protein (named 
after NCL-1, HT2A, and LIN-41), and is recruited through interactions with Pum 
and Nos (Slack & Ruvkun, 1998; Adams et al., 2000; Arama et al., 2000). The 
NHL domain of TRIM-NHL proteins has been reported as RBD (Kwon et al., 
2013). It is arranged in six-bladed β propeller structure, similar to the WD40 fold 
(Edwards et al., 2003) and has a positively charged top surface showing the 
ability to interact negatively charged molecules like nucleic acids. The two Nanos 
Response Elements (NREs) located in the hb mRNA’s 3′UTR has found to be 
responsible for the regulation of hb mRNA translation by BRAT-PUM-NOS 
complex. Each NRE is comprised of two sequence motifs designated as BoxA 
and BoxB. The Pum protein binds to the BoxB motif, containing PUM consensus-
binding site, UGUANAUA where N = A/C/G/U via conserved RNA-binding domain 
(RBD), PUM’s C-terminal PUF-homology domain. The previous studies suggest 





that Pum and Nos proteins directly and Brat protein indirectly interact with NREs 
(Wharton & Struhl, 1991; Murata & Wharton, 1995; Sonoda & Wharton, 2001). 
Recently it has been reported that Brat protein’s C-terminal NHL domain directly 
binds to the sequences in and around hb’s BoxA motifs in a PUM-independent 
manner (Loedige et al., 2015). 
 
1.6.2 CWC2-U6/U4 snRNAs Complex 
The eukaryotic mRNA processing involves the removal of introns from pre-mRNA 
by the spliceosomes. There are five main components of spliceosomes: U1, U2, 
U4, U5 and U6 snRNPs (small nuclear RNPs). In addition to this, the splicing 
reaction requires various protein complexes. The NTC (nineteen complex) which 
is comprised of scaffold protein Prp19 and a number of associated splicing 
factors is essential for the stable association of the U5 and U6 snRNPs with 
spliceosome (Chan et al., 2003). It specifies the interactions among RNAs and 
between RNA and protein (Villa & Guthrie, 2005; Hogg et al., 2010). The yeast 
NTC contains minimum ten components (Ajuh et al., 2000), out of which only 
CWC2/NTC40 (hereafter referred to as CWC2), has a tendency to bind to RNA. 
The CWC2 protein is known to contain two N-terminal RNA-binding motifs i.e. 
CCCH-type ZnF (zinc finger) and an RRM (RNA recognition motif) and a flexible 
C-terminus that can interact with Prp19 protein’s WD40 domain (Vander et al., 
2010). The CWC2 protein as a whole, exhibits the normal capacity to bind RNA 
with low sequence specificity, whereas this binding affinity has found to be 
reduced by RRM along with flexible C-terminus region of CWC2 (McGrail et al., 
2009). However, the exact CWC2-RNA interaction mechanism is unclear. In 
yeast, the CWC2 has found to be interacting with U6 snRNA during splicing 
(McGrail et al, 2009). It has been observed that the CWC2 can cross-link to many 
catalytically significant RNA regions like U6-ISL, a region upstream to the 
ACAGAGA box, and the pre-mRNA intron close to the 5’ SS, arranging the 
CWC2 at or near the catalytic center of the purified catalytically active 
spliceosome. In vitro, the absence of CWC2 results in the assembly of 





catalytically inactive Bact-like complex (Rasche et al, 2012). Hence the CWC2 
may involve in the generation of an active conformation of the spliceosome’s 
catalytic center by interacting with various catalytic inter RNA interaction network 
sites. 
 
1.6.3 RNP Complexes from HeLa Nuclear Extract 
In eukaryotic cells mRNA, an intermediary between transaction of information 
and execution of information, is a highly regulated molecule subjected to RNA 
processing and regulation (Mitchell & Parker, 2014). It is an established fact that 
mRNA concentrations and protein concentrations are less than perfectly 
correlated and protein synthesis regulates the gene expression (Sonenberg & 
Hinnebusch, 2009; Schwanhausser et al., 2011). RNA biology is contrived by the 
interplay of RNA with RNA binding proteins in (RBPs) in ribonucleoproteins i.e. 
RNPs (Glisovic et al., 2008; Li, 2008). mRNA control modulation is driven through 
interactions between individual mRNA and proteins. The resultant assemblies are 
comprised of complex structures designated as mRNPs. Importance of 
ribonucleoproteins is accentuated by the fact that they perform major functions of 
expression and regulation including but not limited to protein synthesis by 
ribosomes, telomerase RNP targeted chromosome maintenance, editing of 
mRNA by spliceosome, RNase P directed leader sequence removal from tRNA, 
small nucleolar (sno)RNPs administered synthesis of ribosomal RNAs and small 
nuclear RNAs (snRNAs), translocation of protein by signal recognition particles 
(SRPs), editing complex involvement in RNA editing and finally gene silencing by 
siRNPs or miRNPs which contain small interfering RNAs and microRNAs 
respectively (Li, 2008). Disruption and dysregulation of proper expression and 
function of RBPs can contribute to major human diseases like cancer, metabolic 
disorders, neurodegenerative and myotonic dystrophy etc. (Castello et al., 2012). 
The understanding of eukaryotic mRNAs is subjected to the understanding of 
constituents, assemblage, rebuilding processes and function of mRNPs. 





Underlying molecular functions can be unrevealed by the precise knowledge 
about RBP binding sites. 
Past decades present robust interplay between innovative method development, 
analysis and establishment regarding RNA biology (McHugh et al., 2014). 
Different traditional and state of the art technologies are adopted for both in vitro 
and in vivo methods, to study RNAs bound by individual RBPs, or vice versa. 
RNA-protein complexes are the valuable source of insight information about the 
plethora of binding modes and structural implications of interactions (Hall, 2002). 
In addition to the conventional way of identifying mRNA binding protein through 
analysis of RNA processing, translation and degradation, more dynamic way of 
identifying them is by means of RNA binding domains. RNA-interacting proteins 
can be categorized according to the RNA motifs with which they interact (Li, 
2008). 
It is quite appreciable that although most RNA binding proteins are comprised of 
few RNA associating modules, the functional repertoire of these proteins is 
broadened through copies of multitude structural variability of RNA binding 
domains (RBDs) to manage the great structural diversity of the substrate i.e. 
RNA. There are specific combinations of RNA binding modules that structurally 
and functionally arrange to facilitate myriad of different interactions and regulatory 
matters (Lunde et al., 2007). Multiple copies of modules confer proteins with 
attributes of enormous affinity and specificity in comparison to the individual 
domains that may offer weak affinity for short stretches of RNA. Consequently, 
through various modules option, interaction surfaces can be created presenting 
more affinity and specificity for a specific target. Interactions of such sort bear the 
privilege of controlling the formation of complexes through disassembling 
whenever is required. Not only specificity of individual domain is important but 
also the relative arrangement of domains is key to proper functionality. 
The RNA recognition motif (RRM) or RNA binding domain/Ribonucleoprotein 
domain can modulate its fold in order to cater the task of identifying many RNA 





and proteins so as necessary to perform biological functions relevant to post 
transcriptional gene regulation (Maris et al., 2005). 
Examples of classical RBDs include RNA-recognition motif (RRM), K-homology 
(KH), double-stranded RNA-binding domain (dsRBDs), RGG box, cold shock 
domain (CSD), Zinc finger and the Pumilio (PUM) domain (Lunde et al., 2007; 
Castello et al., 2016) etc.  
The studies conducted by using HEK298 (Baltz et al., 2012), HeLa (Castello et 
al., 2012) and mESC (Kwon et al., 2013) cells, suggest that in addition to 
classical RBDs, several RNA-interacting proteins possess non-classical RBDs. 
 
1.7 Aim of the Study 
In recent times much emphasis has been laid on revealing the composition and 
regulation of various RNP complexes. In order to have detailed insight into the 
RNA-protein interactions governing the gene regulation, various mass 
spectrometric approaches have been developed. But the limitation of most of the 
purification methods such as sample degradation, loss of interacting partners of 
the RNP complexes and low overall yields etc. as well as the intricate mass 
spectrometric data analysis have hampered the study of these RNP complexes.  
During the course of study, much attention has been paid to overcome the 
aforementioned limitations. In addition to RNP complexes comprised of one or 
few proteins, highly complex RNP assemblies composed of several 
macromolecules have been studied by using the UV-induced cross-linking 
approach coupled with mass spectrometry.  
Generally, the low cross-linking yield and the presence of non-cross-linked 
peptides and oligonucleotides after endoproteinase and nuclease digestion, pose 
hurdle in mass spectrometric analysis of RNA-protein heteroconjugates. One of 
the aims is to optimize the existing protocols described by Deckert et al., 2006 for 
isolation of RNP complex and by Urlaub et al., 2002 and Luo et al., 2008 for 





purification and enrichment of cross-links, so that they can be used to study the 
interactions of the proteins of highly complex sample like RNP complex 
assembled from HeLa nuclear extract which can later be detected by mass 
spectrometric approach. 
Various proteins may or may not interact differently with miscellaneous RNAs 
within RNP complexes. In order to have a detailed insight, the quantitative 
analysis of the RNA-protein cross-links has been established during the current 
study. The relative quantification approach can help in the comparative analysis 
of different domains and motifs of single or multiple proteins, acting differently 
with different RNAs. 
 
 





2 MATERIALS AND METHODS 
 
2.1 Materials 
All media and buffers were prepared in deionized distilled water. The solutions 
and buffers used for cross-linking and MS analysis were prepared in LiChrosolv® 
water. The media were sterilized by autoclaving at 121 °C and 15 lbs/in2 pressure 
for 15 min. All buffers and solutions were filter sterilized by using filter of 0.20 μm 
pore size. Cell culture grade plasticware was also used. All the glassware and 
plasticware were sterilized at 180 °C for 1 h by using hot air oven. 
 
2.1.1 Chemicals and Reagents 
Acetic acid Merck, Darmstadt 
Acetone Merck, Darmstadt 
Acetonitrile (LiChrosolv) Merck, Darmstadt 
Agarose, Ulra Pure  Invitrogen, Carlsbad 
Ammonium bicarbonate Fluka, Switzerland 
Ammonium hydroxide solution (28–30% (v/v)) Merck, Darmstadt 
Ammonium peroxydisulfate Merck, Darmstadt 
Boric acid Merck, Darmstadt 
Bovine serum albumin (BSA) Sigma-Aldrich, Steinheim 
Bromophenol blue (sodium salt) Sigma-Aldrich, Steinheim 
Calcium chloride dihydrate Merck, Darmstadt 
Chloroform Merck, Darmstadt 
Coomassie Brilliant Blue G-250 Fluka, Switzerland 
2,5-Dihydroxybenzoic acid (DHB) Sigma-Aldrich, Steinheim 
di-Potassium hydrogen phosphate trihydrate  Merck, Darmstadt 
di-Sodium hydrogen phosphate Merck, Darmstadt 
Dithiothreitol (DTT) Roth, Karlsruhe 
Ethanol  Merck, Darmstadt 
Ethidium bromide Roth, Karlsruhe 
Ethylenediaminetetraacetic acid (EDTA-Na2 salt) Roth, Karlsruhe 
Formaldehyde Merck, Darmstadt 
Formaldehyde-d2 solution (D2O) Sigma-Aldrich, Steinheim 
Formamide Merck, Darmstadt 
Formic acid Fluka, Switzerland 
Glycerol Merck, Darmstadt 





Glycogen Roche, Mannheim 




Iodoacetamide Sigma-Aldrich, Steinheim 
Magnesium acetate Merck, Darmstadt 
Magnesium chloride Sigma-Aldrich, Steinheim 
Maltose Merck, Darmstadt 
Methanol (LiChrosolv) Merck, Darmstadt 
N,N,N’,N’-Tetramethylethylendiamine (TEMED) Sigma-Aldrich, Steinheim 
NP-40 Sigma-Aldrich, Steinheim 
Ortho-Phosphoric acid Merck, Darmstadt 
Phenylmethylsulfonyl fluoride (PMSF) Roche, Mannheim 
Potassium acetate  Merck, Darmstadt 
Potassium chloride Merck, Darmstadt 
Potassium dihydrogen phosphate Merck, Darmstadt 
Potassium hydroxide Merck, Darmstadt 
Silver nitrate Merck, Darmstadt 
Sodium acetate Merck, Darmstadt 
Sodium carbonate Merck, Darmstadt 
Sodium chloride Merck, Darmstadt 
Sodium dihydrogen phosphate monohydrate  Merck, Darmstadt 
Sodium dodecyl sulfate (SDS) Merck, Darmstadt 
Sodium hydroxide Merck, Darmstadt 
Trifluoroacetic acid (TFA) Roth, Kalsruhe  
Tris (hydroxymethyl) aminomethane (Tris base) Roth, Kalsruhe  
Urea Sigma-Aldrich, Steinheim  
Water (LiChrosolv) Merck, Darmstadt 
Xylene cyanol FF Fluka, Switzerland 
 
 
2.1.2 Commercial Buffers, Solutions and Kits 
1 M Triethylammonium bicarbonate (TEAB) pH 8.5  Sigma-Aldrich, Steinheim 
10 X CutSmart® buffer New England Biolabs, USA 
10 X NEBuffer 3.1 New England Biolabs, USA 
100 bp DNA Ladder, extended Roth, Kalsruhe 
5 X Transcription buffer Promega, Mannheim  
6 X DNA gel loading dye New England Biolabs, USA 
Bradford solution (Bio-Rad Protein Assay) Bio-Rad, Munich  
NuPAGE® Antioxidant Invitrogen, USA 
NuPAGE® LDS sample buffer (4 X) Invitrogen, USA 
NuPAGE® MOPS SDS Running buffer (20 X) Invitrogen, USA 
NuPAGE® Sample reducing agent (10 X) Invitrogen, USA 
Phenol:Chloroform:Isoamyl alcohol (PCI) (25:24:1) Roth, Karlsruhe 
Pre-cast 4-12% Bis-Tris Gel Invitrogen, USA 
Precision Plus ProteinTM Standards Bio-Rad, Munich  





PureLink® HiPure Filter Plasmid Maxiprep Kit Invitrogen, USA 





2.1.3 Enzymes and Enzyme Inhibitors 
BamHI enzyme New England Biolabs, USA 
BamHI-HF enzyme New England Biolabs, USA 
Benzonase Novagen, DE 
DNase I Roche, Mannheim 
EDTA-free Protease Inhibitor Cocktail Roche, Mannheim 
RNase A 
Ambion, Applied Biosystems, 
Darmstadt 
RNaseT1 
Ambion, Applied Biosystems, 
Darmstadt 
RNAsin Promega, Mannheim 
RQ1 RNase-Free DNase Promega, Mannheim 
SP6 RNA polymerases Promega, Mannheim 
StyI enzyme  New England Biolabs, USA 
T7 RNA polymerases 
Department of Cellular 
Biochemistry, MPI-BPC, 
Goettingen 
Trypsin, modified (sequencing grade) Promega, Mannheim 




Adenosine-5’-Triphosphate (rATP, 100 mM) Promega, Mannheim 
Cytosine-5’-Triphosphate (rCTP, 100 mM) Promega, Mannheim 
Guanosine-5’-Triphosphate (rGTP, 100 mM) Promega, Mannheim 
Uridine-5’-Triphosphate (rUTP, 100 mM) Promega, Mannheim 
m7G(5’)ppp(5’)G cap Kedar, Warsaw  
Uridine-13C9-5′-Triphosphate, sodium salt solution 
(100 mM) 
Sigma-Aldrich, Steinheim 
Uridine-13C9,15N2- 5′-Triphosphate, sodium salt 
solution (100 mM) 
Sigma-Aldrich, Steinheim 
Uridine-5’-Triphosphate, ammonium salt solution 











All plasmids were obtained by the courtesy of Department of Cellular 




pMS2-MBP         





2.1.6 Cell line 
Following Escherichia coli (E.coli) strains used during the study were provided by 
Department of Cellular Biochemistry, Max Planck Institute for Biophysical 





HeLa S3 cell line (human cervical cancer, Computer cell culture center, BE) was 
kindly provided by Thomas Conrad (Facility for Cell Production, Max Planck 
Institute for Biophysical Chemistry, Goettingen, Germany). 
 
 
2.1.7 Cell Culture Materials 
100 X L-Glutamine PAA Laboratories, Colbe 
100 X Penicillin/Streptomycin PAA Laboratories, Colbe 
Ampicillin Sigma-Aldrich, Steinheim 
Chloramphenicol Roth, Karlsruhe 
Dialyzed Fetal Bovine Serum PAA Laboratories, Colbe 
High Glucose Dulbecco’s Modified Eagle’s Medium 
(DMEM) 
PAA Laboratories, Colbe 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Sigma-Aldrich, Steinheim 
L-Arginine (Arg0) Sigma-Aldrich, Steinheim 
LB-Agar  MP Biomedicals, USA  
LB-Medium  MP Biomedicals, USA  









2.1.8 Chromatographic Materials and Consumables 
HiPrep 26/10 desalting cartridge GE Healthcare, Freiburg  
Gravity flow disposable chromatography columns Bio-Rad, Munich 
Amylose resin New England Biolabs, USA 
Heparin Sepharose HiTrap column, 5 ml GE Healthcare, Freiburg  
Reprosil-Pur basic C18-AQ, 120 Å, 5 μm  Dr. Maisch, Ammerbuch  
TiO2 titansphere 5 μm GL Sciences, Tokyo 
Superdex 75 PC 3.2/30  GE Healthcare, Freiburg  
 
 
2.1.9 Solutions and Buffers 
10 X PBS 1300 mM NaCl, 200 mM KPO4 (pH 7.4) 
10 X TBE 890 mM Tris base, 890 mM Boric acid, 20 mM 
EDTA-NaOH (pH 8) 
5% Polyacrylamide gel solution 12.5 ml Rotiphorese gel 40, 8 M Urea, 1 X TBE 
Amylose matrix wash buffer 20 mM HEPES-KOH (pH 7.9), 150 mM NaCl, 
0.05% NP-40 
Colloidal Coomassie Staining 0.12% (w/v) Coomassie Brilliant Blue G-250, 
20% (v/v) Methanol, 10% (v/v) Ortho-
Phosphoric acid, 10% (w/v) Ammonium sulfate 
Gradient buffer 150 mM NaCl, 20 mM HEPES-KOH (pH 7.9), 
1.5 mM MgCl2 
Heparin elution buffer 20 mM HEPES-KOH (pH 7.9), 100 mM KCl, 
10% (w/v) Glycerol 
MC buffer 10 mM KOAc, 10 mM HEPES-KOH (pH 7.6), 
0.5 mM Mg(OAc)2 
MS2-MBP lysis buffer 20 mM Tris-Cl (pH 7.4), 200 mM NaCl, 1 mM 
DTT, 3 tablets EDTA-free protease inhibitor 
cocktail, 1 mM MgCl2, Few corns of DNase I 





Na-P buffer 5 mM Na2HPO4 
RNA sample loading buffer 80% (w/v) Formamide, 1 mM EDTA, 0.05% 
(w/v) Bromophenol blue, 0.05% (w/v) Xylene 
cyanol 
Roeder C buffer 20 mM HEPES-KOH (pH 7.9), 0.2 mM EDTA 
(pH 8), 420 mM NaCl, 1.5 mM MgCl2, 25% 
(w/v) Glycerol 
Roeder D buffer 20 mM HEPES-KOH (pH 7.9), 0.2 mM EDTA 
(pH 8), 100 mM KCl, 1.5 mM MgCl2, 0.5 mM 
DTT, 0.5 mM PMSF, 10% (w/v) Glycerol 
Size exclusion running buffer 20 mM Tris base, 1.5 mM MgCl2, 150 mM NaCl 
Tio2 Buffer A 200 mg of 2,5-dihydroxybenzoic acid in 1 ml 
buffer B 
Tio2 Buffer B 80% (v/v) Acetonitrile, 5% (v/v) Trifluoroacetic 
acid 
Tio2 Buffer C 0.3 N Ammonium hydroxide solution pH >10.5 
TNES elution buffer 20 mM Tris-Cl (pH 7.5), 150 mM NaCl, 0.5% 




Adobe Creative Suite 4 Adobe Systems, San Jose 
Skyline (v.4.1.0.18169) MacCoss Lab Software 
STRING (v.10) ELIXIR’s Core Data 
MaxQuant and Andromeda (v.1.5.2.8) Max-Planck-Gesellschaft, Munich 
Microsoft Office 2007 Microsoft Corporation, Redmont 
OpenMS (v.1.11.0) Eberhard-Karls Universität, Tübingen  
Proteome Discoverer (v.1.10) Thermo Fischer Scientific, Schwerte 
Pymol (v.1.8) Schrödinger, New York 
Xcalibur (v.2.2) Thermo Fischer Scientific, Schwerte  





SPSS Statistics software (v.17.0) SPSS Inc.,Chicago 
Cytoscape (v.3.7.0) Cytoscape Consortium 
 
 
2.1.11 Laboratory Consumables 
Black polypropylene 96-well microtiter plate Greiner Bio-One, Frichenhausen  
Bottle-top filters 0.20 µm Sarstedt, Nümbrecht 
Coffee filter paper Melitta, Minden 
Combitips Eppendorf, Hamburg 
Conical centrifuge tubes (15 ml, 50 ml) Sarstedt, Nümbrecht 
Corex glass tubes Kendro, USA 
Custom made glass dishes MPI-BPC, Goettingen 
Dialysis tube clips 
Spectrum Laboratories, Rancho 
Domingues 
Disposable cuvettes Sarstedt, Nümbrecht 
Filtropur S 0.20 µm Sarstedt, Nümbrecht 
Gel cutting device (in-house designed) MPI-BPC, Goettingen 
Kontes® Glass Dounce homogenizer VWR International, Radnor 
LC sample vials Waters, Eschborn 
Microcentrifuge tubes (0.5 ml, 1.5 ml, 2 ml, 5 ml) Eppendorf, Hamburg 
Parafilm sealing film Bemis Company Inc., Neenah 
pH paper Roth, Karlsruhe 
Pipettes Gilson, Limburg-Offheim 
Pipetus® Pipetting aid Hirschmann Laborgeräte, Eberstadt 
Spectra/Por Dialysis membrane 
(MWCO 6-8000) 
Spectrum Laboratories, Rancho 
Domingues 
Syringe (1 ml, 5 ml, 20 ml, 50 ml) B. Braun Melsungen AG, Melsungen 
TLC plate Sigma-Aldrich, Steinheim 
 
 
2.1.12 Laboratory Equipment and Instruments 
Amersham Biosciences EPS 301 Power Supply GE Healthcare, Freiburg 
Autoclave, Varioklav Steam Sterilizer H+P  Thermo Fischer Scientific, Schwerte  
BBD 6220 CO2 incubator Heraeus, Hanau 
Bioreactor 5 L with ez-Control Applikon, Schiedam 
Cryofuge 6000i Swing Bucket Rotor Heraeus, Hanau 
EASY-nLC II System  Thermo Fischer Scientific, Dreieich  
Eppendorf 5415R Refrigerated Microcentrifuge Eppendorf, Hamburg 
Eppendorf BioPhotometer Eppendorf, Hamburg 
Gel Doc 2000 System Bio-Rad, Munich 
Heating Bath IKA®-Werke, Staufen 
Heraeus BK-600 Cooled Incubator Heraeus, Hanau 
Heraeus®  Megafuge® Swing Bucket Rotor 2704 Heraeus, Hanau 
Heraeus®  Megafuge® 1.0 R Centrifuge Heraeus, Hanau 
Heraeus® HERAsafe® KS Safety Cabinet Heraeus, Hanau 





Heraeus™ Fresco™ Microcentrifuge Heraeus, Hanau 
Heraeus™ Pico™ Microcentrifuge Heraeus, Hanau 
HPLC, 1100 Series  Agilent, USA  
Infors HT Shaking Incubator Infors HT, Einsbach 
LTQ Orbitrap Velos Mass Spectrometer Thermo Fischer Scientific, Dreieich  
LTQ Orbitrap XL Mass Spectrometer Thermo Fischer Scientific, Dreieich  
Magnetic Stirrer IKA®-Werke, Staufen 
Microfluidics HC-5000 950 ml/min Lab Fluidizer Microfluidics, Worcestershire 
MPC227 Dual Purpose Conductivity/pH/T Meter Metler-Toledo, Giesen 
NanoDrop 1000 Spectrophotometer Thermo Scientific, Wilmington  
Novex® NuPAGE® SDS-PAGE Gel System Invitrogen, USA 
Perfection V700 PRO scanner Epson, Nagano 
Pharmacia SMART System/uPeak Micro-
Purification System 
GE Healthcare, Freiburg  
Polyacrylamide Gel Electrophoresis System MPI-BPC, Goettingen 
Power Pac 200 Electrophoresis Power Supply Bio-Rad, Munich 
Q Exactive™ Hybrid Quadrupole-Orbitrap Mass 
Spectrometer  
Thermo Fischer Scientific, Dreieich 
Savant SpeedVac Concentrators  Thermo Scientific, Braunschweig 
SONOREX Super Ultrasonic Bath BANDELIN Electronic, Berlin 
Sorval SA600 rotor Kendro, USA  
Sorvall Evolution RC Superspeed Centrifuge Kendro, USA 
Sorvall Hb-6 rotor Kendro, USA  
Sorvall SS-34 rotor Kendro, USA  
Sub-Cell® GT Agarose Gel Electrophoresis 
System 
Bio-Rad, Munich 
Thermomixer Comfort Eppendorf, Hamburg 
Ultrospec 3000 UV/Visible Spectrophotometer  GE Healthcare, Freiburg 
UV cross-linking equipment with four 8-W 
germicidal lamps (G8T5)  
MPI-BPC, Goettingen, Sankyo 
Denki, Japan  
UV Transilluminator 2000 Bio-Rad, Munich 
Vortex Gene 2 Thermo Fischer Scientific, Schwerte 
VXR basic Vibrax® IKA®-Werke, Staufen 
Weighing balance Sartorius, Goettingen 
 
 







2.2.1 Standard Molecular Biology Methods 
2.2.1.1 Preparation of Competent Cells 
The chemically competent cells of E.coli (DH5α and Rosetta II) were prepared 
according to the standard method (CaCl2-method) (Sambrook et al., 1989). DH5α 
and Rosetta II strains were used for in vivo plasmid amplification and protein 
expression respectively. 
For the preparation of pre-culture, 5 ml of LB (lysogeny broth) medium was 
inoculated with E.coli strains and incubated at 37 °C overnight with constant 
shaking. This pre-culture was used to inoculate 250 ml of LB medium. The 
culture was then incubated at 37 °C with continuous shaking at 180 rpm till the 
OD600 of 0.4 was attained. The cells were left on ice for 10 min followed by 
harvesting by centrifugation at 3000 rpm for 15 min at 4 °C. The cell pellet was 
resuspended in 50 ml of cold 50 mM CaCl2 and incubated on ice for 30 min. The 
cells were then centrifuged again at 3000 rpm for 10 min at 4 °C. The 
supernatant was discarded and the cells were resuspended in 3 ml of cold 50mM 
CaCl2 containing 10% w/v sterile glycerol, aliquoted in 50 ul, frozen in liquid 
nitrogen and stored at -80 °C. 
2.2.1.2 Transformation of DH5α Cells 
Transformation of DH5α cells was carried out by the heat shock method 
(Sambrook et al., 1989). 350-400 ng of the plasmid DNA was incubated with 50µl 
of competent cells on ice for 30 min. The cells were given heat shock at 42 °C for 
90 sec and immediately chilled on ice for 1 min. Then 1 ml of LB-medium was 
added and the cells were incubated at 37 °C for 1 h with constant shaking. The 
cells were centrifuged at 8000 rpm for 2 min. Approximately 850 µl of supernatant 
was discarded and the cell pellet was resuspended in the rest of the supernatant. 
The cells were then platted on the selection media containing 100 µg/ml of 





ampicillin and incubated overnight at 37 °C for the isolation of transformed 
bacterial colonies. Single transformed bacterial colonies were selected for the 
inoculation of LB medium containing 100 µg/ml of ampicillin and incubated at 
37°C for overnight. Plasmid DNA was isolated from the transformed strain by 
using Invitrogen PureLink® HiPure Filter Plasmid Maxiprep Kit according to the 
manufacturer’s instructions. 
2.2.1.3 Determination of Nucleic Acid Concentration 
Concentrations of the nucleic acids were determined by measuring the 
absorbance of aqueous solutions at a wavelength of 260 nm against a reference 
on NanoDrop spectrophotometer. The equations used for the calculation of the 
concentrations are as follows (Sambrook et al., 1989) 
1 OD260 = 50 µg/ml double stranded DNA 
1 OD260 = 33 µg/ml single stranded DNA 
1 OD260 = 40 µg/ml single stranded RNA 
2.2.1.4 Restriction Digestion of Plasmid DNA 
Restriction digestion of different plasmid DNAs was performed in order to 
generate the template DNAs for in vitro transcription. For the generation of 
template DNA, 200 µg of PM5 plasmid DNA was digested with 100 U of BamHI-
HF enzyme, 200 µg of MINX plasmid DNA was digested with 200 U of XbaI 
enzyme, 200 µg of U6 plasmid DNA was digested with 200 U of BamHI enzyme 
using 140 µl of 10 X CutSmart® buffer making volume upto 1400 µl with RNase-
free water, whereas 200 µg of U4 plasmid DNA was digested with 200 U of StyI 
enzyme using 140 µl of 10 X NEBuffer 3.1 making volume upto 1400 µl with 
RNase-free water. The restriction digestion reaction mix was incubated at 37 °C 
for overnight. Approximately 5 µl of reaction mix was separated before adding 
enzyme, as control. The linearized DNA was recovered by phenol chloroform 
isoamyl alcohol extraction (PCI). The linearization of the plasmid DNA was 
confirmed by agarose gel electrophoresis. 





2.2.1.5 Phenol Chloroform Isoamyl Alcohol (PCI) Extraction 
In order to separate the nucleic acids from proteins, phenol chloroform isoamyl 
alcohol extraction was performed. Phenol-chloroform-isoamyl alcohol was added 
in the sample in 1:1 ratio along with 1 µl of 10 µg/µl of glycogen and shaken 
vigorously for 15 min and then centrifuged for 5 min at 13000 rpm. The upper 
aqueous phase was collected in the separate eppendorf tube. Then chloroform 
was added in the aqueous phase in 1:1 ratio and shaken vigorously for 15 min 
and centrifuged at 13000 rpm for 5 min. The upper aqueous phase was collected 
separately and nucleic acid was recovered by ethanol precipitation. 
2.2.1.6 Ethanol Precipitation 
The sample was ethanol precipitated by adding 1/10 volume of 3 M NaOAc pH 
5.3 and 2.5-3 volumes of 100% (v/v) ethanol for 2 h to overnight at -25 °C. The 
sample was then centrifuged at 4 °C for 30 min at 13000 rpm. The supernatant 
was discarded and the pellet was washed to remove remaining salts with 2 
volumes of 80% (v/v) ethanol. Sample was then centrifuged again at 4 °C for 
30min at 13000 rpm. The pellet was air dried after removing the supernatent. 
2.2.1.7 Agarose Gel Electrophoresis 
Agarose gel electrophoresis was performed to analyze and visualize the DNA 
according to the standard method (Sambrook et al., 1989). Gels were prepared 
by dissolving 1% w/v agarose in 1 X TBE buffer by heating. For visualization of 
DNA, ethidium bromide was added to the gel up to 0.5 µg/ml concentration while 
cooling. The DNA samples were diluted with 6 X DNA gel loading dye and were 
run horizontally by using 1 X TBE buffer at 120 V for 1-1.5 h along with DNA 
ladder. DNA was visualized on a Bio-Rad Gel Documentation System. 
2.2.1.8 In Vitro Transcription 
Different pre-mRNAs and snRNAs were synthesized by in vitro transcription 
using SP6 or T7 RNA polymerases and linearized plasmid DNAs as templates. 
The in vitro transcription reaction was prepared as follows 














5 X Transcription buffer 1 X 20 μl 20 μl 
0.1 M ATP 7.5 mM 7.5 μl 7.5 μl 
0.1 M UTP 7.5 mM 7.5 μl 7.5 μl 
0.1 M CTP 7.5 mM 7.5 μl 7.5 μl 
0.01 M GTP 1.3 mM 13 μl 13 μl 
152 mM m7GpppG cap 5 mM 3.28 μl ― 
1 M MgCl2 20 mM 2 μl 2 μl 
1 M DTT 10 mM 1 μl 1 μl 
10 mg/ml BSA 0.1 mg/ml 1 μl 1 μl 
40 U/μl RNAsin 100 U 2.5 μl 2.5 μl 
SP6/T7 RNA 
polymerase 
200 U 10 μl 10 μl 
DNA template  10 μg 10 μg 
Make up to final volume 
with autoclaved 
deionized water 
Total 100 μl 100 μl 
 
The reaction mix was incubated at 40 °C in case of SP6 RNA polymerase or at 
37 °C for T7 RNA polymerase for 3-4 h. The template DNA was digested with 
10U of RQ1 RNase Free DNase at 37 °C for 30 min. In order to purify the RNA 
from free nucleotides and fragments of RNA, the reaction mix was mixed with 
equal amount of RNA sample loading buffer and loaded on the 5% or 8% 
denaturing polyacrylamide gel. The RNA band was visualized by UV-shadowing 
using flour coated thin layer chromatography (TLC) plate. The RNA band was 
excised from the gel. RNA was eluted from the gel band by incubating in TNES 
elution buffer for overnight with shaking at room temperature. The eluted RNA 
was then purified by PCI extraction followed by ethanol precipitation. The 
precipitated RNA was dissolved in RNase free water. 





In order to study the interaction between Brat-NHL protein and hb RNA, the hb 
RNA was in vitro transcribed by Dr. Inga Loedige (from Dr. Gunter Meister’s lab 
of RNA Biology, Biochemistry Center Regensburg, University of Regensburg, 
Germany) according to the protocol described by Loedige et al., 2014. Briefly, a 
transcription reaction mix was prepared containing 2 µg/ml DNA template, 
0.1mg/ml T7 polymerase, 30 mM Tris pH 8, 25 mM MgCl2, 0.01% Triton-X100, 
1mM DTT, 10 mM each NTP, 2 U/mL pyrophosphatase (New England Biolabs) 
and 2 mM spermidin. The reaction mix was incubated at 37 °C for 4 h. The RNA 
was purified on 15% denaturing polyacrylamide gel. 
2.2.1.9 Denaturing Polyacrylamide Gel Electrophoresis for RNA 
Denaturing polyacrylamide gel electrophoresis was carried out in the presence of 
8 M urea for the separation of RNA fragments. The concentration of 
polyacrylamide 5% and 8% were used according to the size of the RNA to be 
isolated. The gel was polymerized by adding ammonium persulfate and TEMED. 
The RNA samples were mixed with RNA sample loading buffer and were loaded 
onto 0.5 mm thick polyacrylamide gel. The gel was run vertically in 1 X TBE at 
20W till the dye reaches the bottom of the gel. The RNA bands were visualized 
by UV-shadowing. 
2.2.1.10 Silver Staining of PAGE Gels 
Silver staining of the PAGE gels was done according to the modified protocol 
described by Merril et al., 1983. The PAGE gel was fixed in 40% (v/v) methanol, 
10% (v/v) acetic acid solution for at least 30 min to overnight. The gel was 
washed twice with 10% (v/v) ethanol, 5% (v/v) acetic acid solution each for 15min 
and then rinsed briefly with deionized water. The gel was stained with 12 mM 
silver nitrate solution for 30 min and then briefly rinsed twice with deionized 
water. The gel was developed with 0.28 M Na2CO3 and 0.0185% (v/v) 
formaldehyde solution until the desired staining intensity was reached. The 
developing reaction was stopped by using 5% (v/v) acetic acid solution. The gel 
was then scanned. 





2.2.2 Standard Protein Biochemical Methods 
2.2.2.1 Determination of Protein Concentration 
Concentrations of the protein samples were determined by Bradford colorimetric 
assay (Bradford, 1976). The standard curve for 0-20 µg was prepared from BSA 
standard stock solution (0.2 mg/ml). The protein sample was diluted with 
autoclaved deionized water upto 800 µl so the final concentration of the sample 
lies within the concentration range of the standards. Then 200 µl of Bradford 
solution was added so the final volume of the sample became 1 ml. The 
absorbance was measured at 595 nm and the protein concentration of the 
sample was calculated from the BSA standard curve. 
Concentrations of the purified proteins were measured at 280 nm by NanoDrop 
spectrophotometer. The concentrations were calculated by using theoretically 
determined extinction coefficients generated on the basis of protein sequences 
(Gasteiger et al., 2005). 
2.2.2.2 Denaturing Polyacrylamide Gel Electrophoresis for Proteins 
Proteins were separated by using the Novex® NuPAGE® SDS-PAGE Gel System 
according to manufacturer’s protocol under reducing conditions. The protein 
samples were mixed with 10 X Reducing Agent and 4 X Sample Buffer and 
heated at 70 °C for 10 min. The samples were loaded onto the pre-cast 4-12% 
Bis-Tris Gel with the thickness of 1.0 mm along with the protein ladder. The gel 
was run for 50 min at constant 200 V using MOPS as a running buffer with an 
Antioxidant in the inner chamber. 
2.2.2.3 Colloidal Coomassie Staining 
To visualize the separated proteins on the polyacrylamide gels, the gels were 
stained by using colloidal coomassie staining (Neuhoff et al., 1988). The gel was 
completely immersed and incubated with colloidal coomassie staining solution for 
overnight with gentle shaking. The gel was destained to remove the background 





staining by rinsing it several times with water. The gel was scanned by Epson 
scanner. 
 
2.2.3 Cell Culturing and Nuclear Extract Preparation 
2.2.3.1 HeLa S3 Cell Culturing  
HeLa S3 cells were grown in a fermenter according to the protocol described by 
Hartmuth et al., 2012. A cryostock of 108 cells was used to prepare a starting 
culture of 100 ml in a spinner flask. The cells were grown in High Glucose 
Dulbecco’s Modified Eagle’s Medium (DMEM) lacking Arginine, Lysine and 
Glutamine. The Light Arginine (Arg0) and Light Lysine (Lys0) were added into the 
medium upto the final concentration of 50 mg/ml. The medium was also 
supplemented with 10% Dialyzed Fetal Bovine Serum, 1 X 
Penicillin/Streptomycin and 1 X Glutamine. The cells were grown at 37 °C in 5% 
CO2 and 95% relative humidity. The cell culture was expanded over 4 L in the 
spinner flasks and grown upto six passages before inoculating the 5 L Bioreactor. 
The cells were grown in the fermenter under standard conditions (2–5 x 106 
cells/ml, with barbutation of synthetic air, keeping dissolved oxygen level to 20% 
by using feedback monitoring system). 
2.2.3.2 HeLa Nuclear Extract Preparation 
The cells from the fermenter were used to prepare the HeLa nuclear extracts. 
The cells were harvested freshly before the preparation of HeLa nuclear extract 
by centrifugation at 2000 rpm for 5 min in a Cryofuge 6000i, swing bucket rotor. 
The cells were washed twice with ice cold PBS and resuspended in 1.25-fold 
packed cell volume (PCV) of MC buffer containing 1/500 volume of 0.25 M DTE 
and EDTA-free protease inhibitor cocktail according to manufacturer’s 
instructions. The cells were incubated on ice for 5 min and dounced 18 times to 
lyse in a glass douncer kept on ice. Nuclei were pelleted by centrifugation for 
5min at 18000 x g at 4 °C in Sorvall SS34 rotor. The nuclei pellet was then 
resuspended in 1.3 fold the weight of nuclei of Roeder C buffer supplemented 





with 1/500 volume of 0.25 M DTE and 1/200 volume of 0.1 M PMSF and dounced 
20 times in a glass douncer on ice. The extract was then stirred for 40 min at 4°C. 
The nuclear debris was pelleted by centrifugation at 16000 rpm for 30 min at 4 °C 
in Sorvall SS34 rotor. The nuclear membrane was removed from the top of the 
supernatant. The supernatant was aliquoted and flash frozen in liquid nitrogen 
and stored at -80 °C. 
2.2.3.3 HeLa Nuclear Extract Dialysis 
The HeLa nuclear extract was thawed on ice. To remove traces of ethanol in 
which it was previously stored, the dialysis tube was washed multiple times with 
autoclaved deionized water. The nuclear extract was filled in the dialysis tube by 
clipping its one end. After filling the nuclear extract, the dialysis tube was clipped 
on the other end as well. The nuclear extract was dialyzed three times against 40 
volumes of Roeder D buffer for 2 h each with constant stirring at 4 °C. The 
dialyzed nuclear extract was centrifuged at 9000 x g for 2 min at 4 °C in Sorvall 
Hb-6 rotor. The supernatant was aliquoted and frozen in liquid nitrogen and 
stored at -80 °C. 
 
2.2.4 Expression, Isolation and Purification of Proteins and RNA-
Protein Complexes 
2.2.4.1 MS2-MBP Fusion Protein Overexpression and Purification 
In order to affinity purify the complex assembled on MS2-tagged pre-mRNA, 
MS2-MBP fusion protein was overexpressed and purified from chemically 
competent Rosetta II cells. For the expression of MS2-MBP fusion protein, 50 µl 
of the Rosetta II competent cells were chemically transformed with 350 ng of the 
MS2-MBP fusion protein plasmid DNA and inoculated in 100 ml of LB medium 
containing 100 µg/ml ampicillin and 34 µg/ml chloramphenicol and incubated for 
overnight at 37 °C with constant shaking at 180 rpm as pre-culture. Then 4 L of 
LB medium with 100 µg/ml ampicillin and 34 µg/ml chloramphenicol was 
inoculated with pre-culture. The bacterial culture was then incubated at 37 °C 





with constant shaking at 180 rpm till the OD600 reached upto 0.6-0.7. To induce 
the expression of the MS2-MBP fusion protein, IPTG was added to the final 
concentration of 0.75 mM. The culture was incubated at 37 °C with constant 
shaking at 180 rpm till the OD600 reached upto 2-2.5. Before induction 
approximately 1 ml of the bacterial cell culture was separated as control. The 
cells were harvested by centrifugation at 5000 rpm for 30 min at 4 °C. The 
supernatant was discarded and the cells were washed twice with PBS by 
centrifugation. The cells were resuspended in lysis buffer and lysed two times by 
microfluidizer at 80 psi. The lysate was centrifuged at 16000 rpm for 20 min at 
4°C. The supernatant was incubated for 1 h at 4 °C in a rotating glass bottle with 
10 ml of amylose beads equilibrated with water and lysis buffer. The incubated 
beads along with supernatant was loaded onto the 20 ml gravity flow column and 
let the column drain off. The beads were washed with 300 ml of lysis buffer, then 
with 200 ml of amylose matrix wash buffer and finally with 200 ml of sodium-
potassium buffer. The MS2-MBP fusion protein was eluted with 50 ml of sodium-
potassium buffer containing 15 mM maltose. In order to remove salts and excess 
maltose, the protein eluate was desalted by using HiPrep 26/10 desalting 
cartridge pre-equilibrated with sodium-potassium buffer. The eluate was then 
loaded onto a Heparin Sepharose HiTrap column equilibrated with sodium-
potassium buffer. The protein was then eluted by using heparin elution buffer. 
The protein concentration was determined by NanoDrop spectrophotometer. The 
protein was aliquoted and frozen in liquid nitrogen and stored at -80 °C. 
2.2.4.2 CWC2 Protein Overexpression and Purification 
The CWC2 protein was expressed and purified by Monika Raabe (from 
Bioanalytical Mass Spectrometry Group, Department of Cellular Biochemistry, 
Max Planck Institute for Biophysical Chemistry, Goettingen, Germany) and Dr. 
Jana Schmitzová (from Dr. Vladimir Pena’s Lab of Macromolecular 
Crystallography, Department of Cellular Biochemistry, Max Planck Institute for 
Biophysical Chemistry, Goettingen, Germany) respectively according to the 
protocol published by Schmitzová et al., 2012. The Rosetta II competent cells 
were transformed with pETM11-yCWC2 plasmid DNA for the expression of 





CWC2 protein with N-terminal hexahistidine tag. The pre-culture was prepared by 
inoculating the transformed colonies to the 2xYT medium supplemented with 
34µg/ml chloramphenicol and 50 µg/ml kanamycin and incubating at 30 °C with 
constant shaking overnight. The pre-culture was used to inoculate 6 L of 2xYT 
medium with 34 µg/ml chloramphenicol and 50 µg/ml kanamycin and incubated 
at 30 °C with constant shaking at 180 rpm till the OD600 reached upto 0.6. For the 
induction of CWC2 protein expression, IPTG was added to the final concentration 
of 0.6 mM. The culture was grown at 17 °C for 20 h with constant shaking till the 
OD600 reached upto 1.0-1.2. The cells were harvested by centrifugation at 
4000rpm for 20 min at 4 °C. The cell pellet was washed with PBS and frozen in 
liquid nitrogen and stored at -80 °C. Later, the cell pellet was resuspended in lysis 
buffer (50 mM HEPES-NaOH pH 7.5, 600 mM NaCl, 4 mM β-mercaptoethanol, 
15 mM imidazole, 15% (w/v) glycerol) containing EDTA-free protease inhibitor 
cocktail according to manufacturer’s instructions by vortexing. The cells were 
lysed six times by a microfluidizer at 80 psi. The lysate was centrifuged at 
10,000rpm for 40 min in Sorvall SS34 rotor. All purification steps were carried out 
at 4°C. The supernatant containing protein was incubated with Ni-NTA agarose 
beads (Macherey-Nagel) for 3 h. The protein was eluted from the beads by 
elution buffer (50 mM HEPES-NaOH pH 7.5, 600 mM NaCl, 2 mM β-
mercaptoethanol, 250 mM imidazole, 10% (w/v) glycerol). Since the eluate from 
the Ni-NTA column has high salt concentration so it was diluted to the final 
concentration of 50 mM NaCl. The eluate was then applied to the HiTrap Heparin 
HP column (GE Healthcare). The protein eluted from the heparin beads by 
elution buffer (50 mM HEPES-NaOH pH 7.5, 1 M NaCl, 4 mM β-
mercaptoethanol, 10 mM imidazole, 7% (w/v) glycerol) was concentrated using 
Centricon concentrators and was further purified by size exclusion 
chromatography (GE Healthcare). The protein was eluted from Superdex 75 
16/600 column (GE Healthcare) by elution buffer (30 mM HEPES-NaOH pH 7.5, 
200 mM NaCl, 2 mM β-mercaptoethanol, 5% (w/v) glycerol). The purified protein 
was analyzed by SDS-PAGE. The fractions with high purity were pooled together 
and concentrated. The protein concentration was determined by Bradford assay. 





The protein sample was then aliquoted, flash frozen in liquid nitrogen and stored 
at -80 °C. 
2.2.4.3 Brat-NHL Protein Overexpression and Purification 
The Drosophila BRAT-NHL protein provided by Dr. Inga Loedige (from Dr. Gunter 
Meister’s lab of RNA Biology, Biochemistry Center Regensburg, University of 
Regensburg, Germany) was prepared according to the protocol described by 
Loedige et al., 2014. Briefly, the Brat-NHL protein was expressed as 
hexahistidine-ubiquitin fusion by using pHUE vector system (Catanzariti et al., 
2004; Baker et al., 2005) in E.coli BL21. The culture was grown at 37 °C to an 
OD600 of 0.6. The protein expression was induced by adding 1 mM IPTG and 
incubated at 23 °C for overnight. The cells were lysed by incubation in His A 
buffer (50 mM Tris-Cl pH 8, 1 M NaCl, 5% (w/v) glycerol, 10 mM imidazol) 
containing 1 mg/ml lysozyme, 1 mM AEBSF, and 5 U/ml Benzonase followed by 
sonication. The lysate was centrifuged at 48,000 x g for 40 min at 4 °C. The 
supernatant was applied to HiTrap IMAC FF column charged with Ni2+. The 
protein was eluted by His B buffer (50 mM Tris-Cl pH 8, 1 M NaCl, 200 mM 
imidazol). Then the hexahistidine-ubiquitin moiety was cleaved off by incubating 
the eluate overnight at 4 °C with the Usp2cc enzyme in the presence of 1 mM 
DTT. The protein was then loaded on a HiPrep Superdex 75 26/60 column 
equilibrated by buffer containing 20 mM Tris-Cl pH 8, 150 mM NaCl and 1 mM 
DTT. The fractions containing highly pure protein were pooled together. All 
purification steps were carried out at 4 °C. The protein concentration was 
determined spectrophotometrically at 280 nm. The protein sample was aliquoted 
and flash-frozen in liquid nitrogen and stored at -80 °C. 
2.2.4.4 In Vitro RNA–Protein Complex Assembly from HeLa Nuclear Extract 
and Purification 
The RNA-protein complex (H/E complex) from the HeLa nuclear extract was 
assembled and purified according to the protocol mentioned by Qamar et al., 
2015. Briefly, 1 nmol of in vitro transcribed (labeled/non-labeled) MS2-tagged 
(PM5/MINX) pre-mRNA was incubated with 15-fold excess of MS2-MBP fusion 





protein for 30 min on ice. Then the pre-mRNA bound to MS2-MBP protein was 
incubated with 10 ml of HeLa nuclear extract for 30 min on ice. In order to affinity 
purify the complex, the gravity flow disposable chromatographic column was 
packed with 1 ml of amylose beads and washed three times with 2 ml of gradient 
buffer without glycerol. The sample was then loaded onto the column and allowed 
to flow through under gravity. The column was then washed three to five times 
with 2 ml of gradient buffer without glycerol. The assembled complex was eluted 
with 2 ml of 15 mM maltose buffer by gravity flow. The protein concentration was 
determined by Bradford assay. 
 
2.2.5 UV-Induced Cross-linking in RNA-Protein Complexes 
2.2.5.1 UV-Cross-linking of Brat-NHL protein with hb RNA 
The Brat-NHL-hb RNA complex was assembled by incubating 1 nmol of in vitro 
transcribed hb RNA with 1 nmol of recombinant Brat-NHL protein (provided by 
Inga Loedige from Dr. Gunter Meister’s lab of RNA Biology, Biochemistry Center 
Regensburg, University of Regensburg, Germany) making volume upto 100 µl 
with the buffer (20 mM Tris-Cl pH 8, 150 mM NaCl) for 1 h on ice. For UV-cross-
linking, the assembled complex was taken in a microtiter plate placed on 
aluminum block on ice at a distance of 1 cm from the lamps and UV-irradiated at 
254 nm for 10 min. The sample was then ethanol precipitated for overnight. The 
pellet was dissolved in 50 µl of 4 M Urea in 50 mM Tris-Cl pH 7.9 and diluted to 
1M Urea by adding 150 µl of 50 mM Tris-Cl pH 7.9. The RNA was hydrolyzed 
using 1 µl of RNase A (1 µg/µl) and T1 (1 U/µl) at 52 °C for 1 h followed by 1 µl of 
Benzonase (25 U/µl) in the presence of 1 mM MgCl2 at 37 °C for 1 h with 
continuous shaking at 500 rpm. The protein/peptide was digested using trypsin in 
enzyme to protein ratio of 1:20 (w/w) at 37 °C for 16 h with shaking at 500 rpm. 
The sample was then desalted by C18 reversed phase chromatography and 
enriched by TiO2 solid phase extraction as described by Kramer et al., 2011 
(details in materials and methods heading 2.2.5.3). The control (non-UV-
irradiated) sample was also processed in parallel to the UV-irradiated sample. 





For mass spectrometric analysis, the samples were dried in the SpeedVac and 
reconstituted in 12 µl of 5% (v/v) acetonitrile, 0.1% (v/v) formic acid. The samples 
were analyzed by LTQ Orbitrap Velos mass spectrometer (Thermo Scientific). 
2.2.5.2 UV-Cross-linking of CWC2 protein with U4 and U6 snRNAs 
The UV-cross-linking analysis of CWC2 protein with U4 and U6 snRNAs was 
done according to the protocol published by Schmitzová et al., 2012. The CWC2-
U4 snRNA and CWC2-U6 snRNA complexes were reconstituted by incubating 
100 µg of CWC2 for 30 min on ice with 3 µg of U4 and U6 snRNAs separately 
making volume upto 100 µl with the buffer (20 mM HEPES pH 7.5, 100 mM NaCl, 
1 mM DTT). The sample was UV-irradiated at 254 nm for 10 min in a microtiter 
plate kept on an aluminum block on ice at a distance of 1 cm from the light 
source. The sample was ethanol precipitated for overnight. The pellet was 
dissolved in 50 µl of 4 M Urea in 50 mM Tris-Cl pH 7.9 and adjusted to final 
concentration of 1 M Urea by adding 150 µl of 50 mM Tris-Cl pH 7.9. The 
hydrolysis of RNA was carried out by 1 µl of RNase A (1 µg/µl) and T1 (1 U/µl) at 
52 °C for 1 h followed by 1 µl of Benzonase (25 U/µl) in the presence of 1 mM 
MgCl2 at 37 °C for 1 h with shaking at 500 rpm. The protein was digested using 
trypsin in enzyme to protein ratio of 1:50 (w/w) at 37 °C for 16 h with continuous 
shaking at 500 rpm. The desalting and enrichment of the sample were carried out 
by C18 reversed phase chromatography and TiO2 solid phase extraction 
respectively according to the protocol described by Kramer et al., 2011 (detail in 
materials and methods heading 2.2.5.3). The control (non-UV-irradiated) samples 
were also processed in parallel to the UV-irradiated samples. For mass 
spectrometric analysis, the samples were dried in the SpeedVac and 
reconstituted in 12 µl of 5% (v/v) acetonitrile, 0.1% (v/v) formic acid. The samples 
were analyzed by Q-Exactive mass spectrometer (Thermo Scientific). 
2.2.5.3 UV-Cross-linking of RNA-Protein Complex from HeLa Nuclear 
Extract Assembled on PM5/MINX pre-mRNAs 
The purified RNA-protein complex (H/E complex) from HeLa nuclear extract was 
UV-cross-linked according to the protocol described by Qamar et al., 2015. The 





sample was taken in a volume of 1 ml (protein concentration 0.3 mg/ml) in pre-
cooled custom-made glass dishes, with a planar surface and an inner diameter of 
3.5 cm, so the depth of the sample solution was approximately 1 mm. The dishes 
were kept on an aluminum block on ice at a distance of 1 cm from the light 
source. The sample was UV-irradiated at 254 nm for 10 min. The sample was 
pooled in the Corex glass tube and ethanol precipitated for overnight. The pellet 
was dissolved in 100 µl of 1% (w/v) SDS in size exclusion (SE) running buffer by 
shaking and diluted to final concentration of 0.1% (w/v) SDS with size exclusion 
(SE) running buffer. The protein was digested with trypsin in 1:50 (w/w) enzyme 
to protein ratio at 37 °C for 16 h with continuous shaking at 500 rpm. The sample 
was then again ethanol precipitated. The pellet was re-dissolved in 5 µl of 1% 
(w/v) SDS in size exclusion (SE) running buffer and diluted upto 0.1% (w/v) SDS 
with SE running buffer. The sample was injected into the SMART system 
equipped with Superdex 75 PC 3.2/30 column running in SE running buffer with a 
flow rate of 40 μl/min at room temperature. The fractions containing RNA were 
pooled together and ethanol precipitated overnight. The pellet was dissolved in 
4M Urea, in 50 mM Tris-Cl pH 7.9 and adjusted to final concentration of 1 M Urea 
by adding 150 µl of 50 mM Tris-Cl pH 7.9. Digestion of RNA was carried out by 
1µl of RNase A (1 µg/µl) and T1 (1 U/µl) at 52 °C for 1 h followed by 1 µl of 
Benzonase (25 U/µl) in the presence of 1 mM MgCl2 at 37 °C for 1 h with shaking 
at 500 rpm. The protein was digested by using trypsin in 1:20 (w/w) enzyme to 
protein ratio at 37 °C for 16 h with continuous shaking at 500 rpm. The sample 
was desalted and enriched by C18 reversed phase chromatography and TiO2 
solid phase extraction respectively according to the protocol described by Kramer 
et al., 2011. For the C18 reversed phase chromatography the columns were 
prepared in-house by fitting 2 mm2 piece of coffee filter paper at the end of 10 µl 
pipette tip as frit material. The columns were packed with the C18 material 
suspended in 100% (v/v) methanol with the help of 1 ml combitip to give a bed 
height of 3 mm. The columns were fitted in 2 ml microcentrifuge tubes by making 
holes in the lid and washed by applying 60 µl of 95% (v/v) acetonotrile, 0.1% (v/v) 
formic acid, then 80% (v/v) acetonitrile, 0.1% (v/v) formic acid followed by 50% 
(v/v) acetonitrile, 0.1% (v/v) formic acid and finally by 0.1% (v/v) formic acid with 





centrifugation at 5000 rpm for 5 min after each step. Meanwhile, 10 µl of 100% 
(v/v) acetonitrile and 2 µl of 10% (v/v) formic acid were added into the sample to 
make an end concentration to 5% (v/v) acetonitrile and 0.1% (v/v) formic acid 
respectively. The sample was vortexed and centrifuged for 2 min at 13,000 rpm 
at room temperature to remove precipitates. The sample was then applied onto 
the column in portions of 60 µl by centrifugation at 5000 rpm for 5 min after each 
step. The column was then washed twice with 60 µl of 0.1% (v/v) formic acid and 
the sample was eluted, once with 60 μl of 20% (v/v) acetonitrile, 0.1% (v/v) formic 
acid, twice with 50% (v/v) acetonitrile, 0.1% (v/v) formic and once with 80% (v/v) 
acetonitrile, 0.1% (v/v) formic acid by centrifugation at 5000 rpm for 5 min. The 
eluate was then dried in the SpeedVac for 45 min. In order to remove the non-
cross-linked peptides TiO2 solid phase extraction was performed. The TiO2 
columns were prepared with the TiO2 suspension in the same manner as for C18 
reversed phase chromatography. The columns were washed twice with 60 μl of 
buffer B by centrifugation at 3000 rpm for 5 min. Meanwhile, the sample was 
dissolved in 100 μl of buffer A by vortexing and ultrasonification for 1 min and 
loaded onto the column in the portion of 60 μl by centrifugation at 3000 rpm for 
5min. The column was then washed three times with buffer A and four times with 
buffer B, each time with centrifugation at 3000 rpm for 5 min. The sample was 
eluted thrice with 40 μl of buffer C by centrifugation at 3000 rpm for 5 min. The 
control (non-UV-irradiated) sample was also processed in parallel to the UV-
irradiated sample. For mass spectrometric analysis, the samples were dried in 
the SpeedVac and reconstituted in 12 µl of 5% (v/v) acetonitrile, 0.1% (v/v) formic 
acid. The samples were analyzed by LTQ Orbitrap Velos mass spectrometer 
(Thermo Scientific). 
 





2.2.6 Quantitative Analysis of RNA-Protein Cross-links 
2.2.6.1 Quantitative Analysis of CWC2-U4 snRNA and U6 snRNA Cross-
links 
For the quantitative analysis of CWC2-U4 snRNA and U6 snRNA cross-links, the 
experiment was carried out in the set of three forward and reverse biological 
replicates. In the forward experiment, 3 µg of U6 snRNA transcribed by using 
non-labeled UTP and 3 µg of U4 snRNA transcribed by using isotopically-labeled 
(13C) UTP were pooled together in 1:1 ratio and were incubated with 200 µg of 
CWC2 making volume upto 200 µl with the buffer (20 mM HEPES pH 7.5, 
100mM NaCl, 1 mM DTT) for 30 min on ice. For the reverse experiment 3 µg of 
U6 snRNA transcribed by using isotopically labeled (13C) UTP and 3 µg of U4 
snRNA transcribed by using non-labeled UTP were pooled together in 1:1 ratio 
and were incubated with 200 µg of CWC2 making volume up to 200 µl with the 
buffer (20 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT) for 30 min on ice. The 
samples were UV-irradiated and processed in the same manner as described in 
section 2.2.5.2 of materials and methods. Finally, the samples were analyzed by 
Q-Exactive mass spectrometer (Thermo Scientific). 
 
2.2.7 Mass Spectrometry Methods 
2.2.7.1 In-Gel Digestion of Proteins 
In-gel hydrolysis of proteins was performed according to the modified protocol of 
Shevchenko et al., 2007. Unless otherwise stated, all the incubation steps were 
carried out at 26 °C with continuous shaking at 1050 rpm for 15 min. The 
solutions were removed after each incubation step. Each SDS-PAGE gel lane 
was cut into 22 equal slices with the help of in-house designed gel cutting device 
(Schmidt & Urlaub, 2009). Each gel slice was cut into small pieces, washed with 
150 µl of water and dehydrated with 150 µl of acetonitrile. The gel pieces were 
then dried by SpeedVac. The proteins were reduced by adding 100 µl of 100 mM 
DTT prepared in 50 mM ammonium bicarbonate pH 8 and incubating at 56 °C for 





50 min at 1050 rpm. The gel pieces were then dehydrated with 150 µl of 
acetonitrile and the reduced cysteines were alkylated with 100 µl of 60 mM 
Iodoacetamide (IAA) prepared in 50 mM ammonium bicarbonate pH 8 for 20 min 
at 26 °C and 1050 rpm. The gel pieces were washed with 150 µl of 50 mM 
ammonium bicarbonate pH 8, dehydrated and dried again as described before. 
The dried gel pieces were rehydrated with 20 µl of trypsin digestion buffer (15 µl 
of 0.1 µg/µl modified trypsin making volume upto 100 µl with 25 mM ammonium 
bicarbonate pH 8), for 30 min on ice. The gel pieces were overlaid with 25 mM 
ammonium bicarbonate pH 8, if needed. Then they were incubated at 37 °C for 
overnight with constant shaking at 1050 rpm in thermomixer. 
2.2.7.2 Extraction of Peptides 
The peptides from in-gel digestion were extracted according to the protocol 
described by Shevchenko et al., 2007. All incubation steps were carried out at 
37°C for 15 min with a constant shaking at 1050 rpm by thermomixer. The gel 
pieces were processed by series of extraction steps comprised of incubation with 
50 µl of water and 50 µl of acetonitrile then with 50 µl of 5% (v/v) formic acid 
followed by twice with 50 µl of acetonitrile. The supernatants from each step were 
collected and pooled together in new microcentrifuge tubes. The extracted 
peptides were dried in SpeedVac and stored at -20 °C until subjected to LC-ESI-
MS/MS analysis. For MS analysis the samples were dissolved in 20 µl of 5% (v/v) 
acetonitrile and 1% (v/v) formic acid by extensive vortexing and sonication for 
2min each. The samples were then analyzed by LTQ Orbitrap XL mass 
spectrometer (Thermo Scientific). 
2.2.7.3 LC-ESI-MS/MS 
The mass spectrometric analysis was carried out by administering the samples to 
nanoflow-liquid chromatography (nano-LC) system coupled to electrospray 
ionisation mass spectrometer (ESI-MS). During the course of Ph.D. studies three 
mass spectrometers were used. The samples from in-gel digestion were 
analyzed on LTQ Orbitrap XL mass spectrometer (Thermo Scientific) coupled to 
Agilent nano-LC system (Agilent Technologies) whereas the RNA-protein cross-





linking samples were analyzed on LTQ Orbitrap Velos (Thermo Scientific) and Q-
Exactive (Thermo Scientific) mass spectrometers coupled to Agilent nano-LC 
system (Agilent Technologies) and EASY-nLC II system (Thermo Scientific) 
respectively. The details regarding LC separation and MS analysis are given as 
follows. 
(A) Nanoflow-Liquid Chromatography Separation (Nano-LC) 
(i) Nano-LC Separation (Agilent nano-LC system) 
The sample was applied onto trapping column (C18 AQ 120 Å material with 
particle size of 5 µm, 20 mm length, 0.150 mm inner diameter) at a flow rate of 
10μl/min (60 min gradient) and 15 μl/min (118 min gradient) in 3% buffer B (buffer 
A: 0.1% (v/v) formic acid; buffer B: 95% (v/v) acetonitrile, 0.1% (v/v) formic acid) 
followed by elution and separation on an analytical column (C18 AQ 120 Å 
material with particle size of 5 µm, 150 mm length, 0.075 mm inner diameter) at a 
flow rate of 130 nl/min (60 min gradient) and 150 nl/min (118 min gradient) using 
a linear gradient of 4-37% buffer B (buffer A: 0.1% (v/v) formic acid; buffer B: 
95% (v/v) acetonitrile, 0.1% (v/v) formic acid) over 37 min (60 min gradient) and 
102 min (118 min gradient). The column was then washed with 90-95% buffer B 
and re-equilibrated with 3% buffer B. Both the columns were packed in-house by 
Uwe Pleßmann (Bioanalytical Mass Spectrometry Group, Department of Cellular 
Biochemistry, Max Planck Institute for Biophysical Chemistry, Goettingen, 
Germany). 
(ii) Nano-LC Separation (Thermo EASY-nLC II system) 
The sample was injected into a trapping column (C18 AQ 120 Å material with 
particle size of 3 µm, 40 mm length, 0.1 mm inner diameter) in-line with the 
analytical column (C18 AQ 120 Å material with particle size of 3 µm, 10 cm 
length, 50 µm inner diameter), both packed in-house by Uwe Pleßmann 
(Bioanalytical Mass Spectrometry Group, Department of Cellular Biochemistry, 
Max Planck Institute for Biophysical Chemistry, Goettingen, Germany). The 
sample was loaded onto trapping column at a flow rate of 15 μl/min in 3% buffer 





B (buffer A: 0.1% (v/v) formic acid; buffer B: 95% (v/v) acetonitrile, 0.1% (v/v) 
formic acid) followed by elution and separation on an analytical column at a flow 
rate of 320 nl/min using a linear gradient of 4-36% buffer B (buffer A: 0.1% (v/v) 
formic acid; buffer B: 95% (v/v) acetonitrile, 0.1% (v/v) formic acid) over 42 min 
(50 min gradient) and 97 min (105 min gradient). The column was then washed 
with 95% buffer B and equilibrated automatically by the instrument. 
(B) ESI-MS/MS Analysis 
(i) LTQ Orbitrap XL Mass Spectrometer 
The instrument was operated in data dependent acquisition mode with Top 8 
method. The MS scans were recorded in the m/z range 350-1600 at a resolution 
setting of 30,000 FWHM at m/z 400 and automatic gain control (AGC) at 106. 
Fragmentation was generated by CID activation for the precursor ions having the 
charge state 2 and above. The MS/MS scans were recorded at normalized 
collision energy of 35 and a dynamic exclusion of 60 sec with a repeat count of 1. 
(ii) LTQ Orbitrap Velos Mass Spectrometer 
The instrument was operated in data dependent acquisition mode with Top 10 
method. The MS survey scans were recorded in the m/z range 350-1600 at a 
resolution setting of 30,000 FWHM. The automatic gain control was set to 106. 
Fragmentation was generated by HCD activation for the precursor ions having 
the charge state 2, 3 and 4. The MS/MS scans were recorded at normalized 
collision energy of 35 and a dynamic exclusion of 20 sec at a resolution setting of 
7500 FWHM and isolation width of 2 Th. 
(iii) Q-Exactive Mass Spectrometer 
The instrument was operated in data dependent acquisition mode with Top 12 
method. The MS survey scans were recorded in the m/z range 350-1600 at a 
resolution setting of 70,000 FWHM. The automatic gain control was set to 106. 
Fragmentation was generated by HCD activation for the precursor ions having 
the charge state 2, 3 and 4. The MS/MS scans were recorded at normalized 





collision energy of 28 and a dynamic exclusion of 15 sec at a resolution setting of 
17,500 FWHM with a fixed first mass of m/z 100. 
 
2.2.8 Data Analysis 
2.2.8.1 Proteome Analysis by MaxQuant 
The raw data obtained after MS analysis was further analyzed by using 
MaxQuant software version 1.5.2.8 incorporated with Andromeda (Cox & Mann, 
2008; Cox et al., 2011). The searches were made against UniProt human protein 
database (23rd December 2011). Following parameters were brought under 
consideration for data analysis: MS/MS tolerance was set to 0.5 Da, false 
discovery rate (FDR) at both peptide and protein level to 1%. Minimum peptide 
length of 5 amino acids was used along with minimum ratio count of 2. Cysteine 
carbamidomethylation was used as fixed modification whereas the oxidation of 
methionine, N-terminal protein acetylation and phosphorylation of serine, 
threonine and tyrosine were used as variable modifications. The tryptic specificity 
with no proline restriction, allowed upto 2 missed cleavages, was set. The results 
obtained were used for further data analysis and interpretation. 
2.2.8.2 RNA-protein Cross-linking Analysis by OpenMS 
The RNA-protein cross-linking data was analyzed by using RNPxl tool of 
TOPPAS workflow engine in an OpenMS software environment using OMSSA as 
search engine (Kohlbacher et al., 2007; Sturm et al., 2008) according to the 
details provided by Kramer et al., 2014. Briefly, the raw data files were converted 
into .mzML format with the help of msconvert command line tool of ProteoWizard 
set of Library and Tools (Chambers et al., 2012) or by using Proteome Discoverer 
software version 1.10 (Colaert et al., 2011). The data was then subjected to 
series of filter pipelines and then searched for the probable cross-linked peptides 
by using RNPxl pipeline. The results obtained were visualized by TOPPView and 
manually validated. The identified cross-links were then mapped on the crystal 





structure, if available from RCSB PDB (http:// www.rcsb.org) using PyMOL 
software version 1.8 (Schrödinger, LLC). 
For the quantitative analysis, the extracted ion chromatograms (XICs) of MS 
spectra were generated by using Xcalibur software (Thermo Scientific) and 
Skyline software (MacCoss Lab).The ratios were calculated from the peak area of 
the extracted ions. The results obtained were used for further statistical analysis 
by using SPSS Statistics software (v.17.0) and data interpretation. 
The other online tools used for the calculation of monoisotopic masses of peptide 
and RNA oligonucleotides etc. were as follows 
• Peptide Mass Calculator version 3.2 (University of Leuven, Belgium) 
(http://rna.rega.kuleuven.ac.be/masspec/pepcalc) 
• Mongo Oligo Mass Calculator version 2.06 (University of Leuven, Belgium) 
(http://rna.rega.kuleuven.ac.be/masspec/mongo) 
• Protein Prospector version 5.14.4 (University of California, US) 
(http://prospector.ucsf.edu/prospector/mshome) 
2.2.8.3 Quantitative Analysis by Skyline 
For relative quantitative analysis using skyline software, the extracted ion 
chromatograms were generated for the spectral library and Savitzky-Golay 
smoothing was applied (Appendix Figure 6.33-6.47). In each window the most 
intense peak was selected for marking the peak boundaries (dotted black lines). 
IDs were from the built spectral library showing the retention times of spectra of 
the identified cross-links. Red, blue, brown and purple colour peaks were from 
doubly charged light labeled, doubly charged heavy labeled, triply charged light 
labeled and triply charged heavy labeled forms of cross-links respectively. In the 
present study, the presence of first two isotopic peaks was set mandatory for 
quantification. Therefore, the area for the first two isotopic peaks (M and M+1) 
were used for the quantitative analysis (Appendix Table 6.7 & Table 6.8). 





2.2.8.4 Statistical Analysis 
The compiled quantitative data from excel file was transferred to the SPSS data 
editor and log10 transformation was applied for normalization. The data normality 
was confirmed by using Kolmogorov-Smirnov and Shapiro-Wilk tests. The 
comparative studies were carried out statistically by using one-way ANOVA. For 
determining any significant differences, Duncan’s multiple comparison test was 
applied at 5% level of significance.  
2.2.8.5 Interactome Analysis 
For protein-protein interaction network analysis, the data obtained from OpenMS 
and MaxQuant were analyzed by STRING database. The STRING database 
(Jensen et al., 2009) was queried for known protein-protein structural and 
functional interactions. The comma-delimited files (.csv) were imported in 
cytoscape (version 3.7.0). The network was analyzed by using NetworkAnalyzer 
plug-in (Assenov et al., 2008) and cytoHubba plug-in (Chin et al., 2014). 
 






In the cellular context, the RNA-binding proteins (RBPs) interact with the RNA 
molecules to constitute ribonucleoprotein (RNP) complexes that play a crucial 
role in the transcriptional and post transcriptional gene regulation. The application 
of RNA-protein cross-linking by UV-irradiation at a wavelength of 254 nm 
followed by mass spectrometry has proved to be promising technique in 
predicting the arrangement of RNA and protein molecules in these RNP 
complexes. During the course of study, the RNA-protein interaction sites within 
various in vitro reconstituted RNP complexes were determined up to the peptide 
or even the amino acid level. The RNP complexes containing single protein were 
processed by the conventional cross-linking method; however, for the analysis of 
complex samples comprised of several proteins like the interactome from HeLa 
nuclear extract assembled on pre-mRNA, the method was developed and 
optimized. The RNA-protein cross-links identified from the complexes assembled 
on different pre-mRNAs were also quantitatively analyzed by labeling RNAs, 
peptides and proteins providing the information regarding the ability/affinity of 
various RBPs to interact with particular RNA assembled under similar 
conditions/treatments. The MS data obtained was evaluated and validated 
manually. The manual interpretation of the MS/MS spectra led to the identification 
of the cross-linking site up to the amino acid resolution as well as the detection of 
fragment ions, generated during the fragmentation of nucleic acid present in a 









3.1 Identification of Cross-links from Brat-NHL-hb RNA 
Complex 
During the early embryonic development in Drosophila, brain tumor protein (Brat) 
along with Pumilio (Pum) and Nanos (Nos) forms a complex for the translational 
repression of the hb mRNA (Wharton & Struhl, 1991; Murata & Wharton, 1995; 
Sonoda & Wharton, 2001). It has been thought that Pum binds to the hb RNA 
directly and then recruits Brat and Nos by protein-protein interactions but here it 
has been reported in collaboration with Inga Loedige (from Dr. Gunter Meister’s 
lab of RNA Biology, Biochemistry Center, University of Regensburg, Germany) 
that Brat directly binds to the hb RNA. 
Brat is a member of conserved family of TRIM-NHL proteins, which are identified 
by the presence of N-terminal tripartite motif (TRIM) and a C-terminal NCL-1, 
HT2A, LIN-41 (NHL) domain (Sardiello et al., 2008). The NHL domain of TRIM-
NHL proteins has been reported as RBD (Kwon et al., 2013). It is arranged in six-
bladed β propeller structure (Figure 3.1 A & B), similar to the WD40 fold 
(Edwards et al., 2003) and has a positively charged top surface showing the 
potential to bind negatively charged molecules like nucleic acids. It has been 
observed that for in vivo translational repression of the hb mRNA approximately 
100 nucleotides long fragment of hb 3′ UTR containing two Nanos response 
elements (NREs) (termed as hb RNA hereafter) is necessary (Wharton & Struh, 
1991) (Figure 3.1 C). 
In order to find the RNA-binding activity of Brat, the Brat-NHL-hb RNA complex 
was in vitro assembled by incubating the in vitro transcribed hb RNA along with 
recombinantly expressed purified NHL domain of Brat (~ 32 kDa, ranging 756-
1037 amino acid) provided by the collaborator (Inga Loedige). The sample was 
UV-cross-linked, and the cross-links were enriched according to the standard 
protocol as described in sections 2.2.5.1 and 2.2.5.3 of materials and methods 
respectively. The samples were analyzed on LTQ Orbitrap Velos mass 
spectrometer and the data analysis was performed by OpenMS as mentioned in 





section 2.2.8.2 of materials and methods. The candidate spectra of the cross-








Figure 3.1: The top electropositive surface of the Drosophila Brat-NHL domain interacts with hb 
RNA (Figure adapted from Loedige et al., 2014 and modified). (A)The sequence alignment based 
on the crystal structure of Brat (PDB ID: 1Q7F). The secondary structure has been illustrated 
above the sequence alignment (Edwards et al., 2003). The amino acids constituting the β strands 
has been shown in bold and highlighted in yellow (βa), pink (βb), brown (βc) and green (βd) 
colours (Loedige et al., 2014). (B)The top view of Brat-NHL domain’s crystal structure at the 
resolution of 1.95 Å (PDB ID: 1Q7F, chain A) (Edwards et al., 2003).It has six bladed β propeller 
structure. Each blade is comprised of βa, βb, βc and βd strands which are anti-parallel β strands 
that are interlinked through flexible loop regions. The strands of blade V have been coloured 
according to the sequence alignment shown in Fig. 3.1 A. The loops connecting βa with βb and 
βc with βd form the bottom surface whereas the ones connecting βb with βc and βd with βa 
constitute the top surface (Loedige et al., 2014). (C) Sequence of ~100 nucleotide long hb RNA 
fragment (nucleotide 2834-2935) containing two NREs shown in bold and underlined. Each NRE 
is composed of one BoxA (blue) and one BoxB (green) motif (Loedige et al., 2014). 
 
So far, six peptides of Brat-NHL protein have been identified to be cross-linked to 
the nucleotides of hb RNA (Table 3.1). For all these cross-linked peptides the 
cross-linking site has been cut down to the amino acid resolution indicating the 
exact amino acids in contact with the hb RNA or are lying in close proximity to it. 
It has been observed that five out of six cross-linked peptides, span the top 
surface of the NHL domain (Figure 3.2 A). Four cross-linked amino acids (Y829, 












while the two (K865 and F866) are located on a positively charged patch at the 
circumference (Figure 3.2 B). 
Bringing the cross-linking data into consideration, the collaborators have 
performed the studies by making point mutations in Brat-NHL domain and 
checked the RNA-binding activity by electrophoretic mobility shift assay (EMSA). 
It has been found that the mutations of the top surface residues Y829 (cross-linked 
amino acid) and R875 (amino acid of a cross-linked peptide 865KFGATILQHPR875) 
resulted in the impaired or completely abrogated binding of Brat-NHL domain to 
hb RNA respectively. The mutation of K809 (cross-linked amino acid), lying at the 
bottom surface had no effect on its binding activity (Loedige et al., 2014). 
In addition to EMSA, the collaborators have also investigated the effect of point 
mutations on Brat-mediated translational repression by using luciferase reporter 
assay. The mutations of C890, F916 (cross-linked amino acids) and R875, K891 
(amino acids of the cross-linked peptides 865KFGATILQHPR875 and 885IIVVECK891 
respectively) resulted in the impaired Brat-mediated repression whereas unlike 
the effect of mutation of Y829 (cross-linked amino acid) in EMSA, there was no 
effect on repression. The repression by Brat was unaffected by the mutations of 
top surface C820 (cross-linked amino acid) and the bottom surface K809 (cross-
linked amino acid) and K925 (amino acid of a cross-linked peptide 
913HLEFPNGVVVNDK925) residues (Loedige et al., 2014). 
Overall, the mutations of amino acids Y829, C890 and F916 which are found to be 
cross-linked and amino acids R875, K891 belonging to cross-linked peptides 
865KFGATILQHPR875 and 885IIVVECK891 respectively has led to either 
compromised Brat-mediated translational repression or impaired binding of Brat-
NHL domain to hb RNA. On the other hand, the mutations of top surface cross-
linked amino acid C820 and the bottom surface cross-linked amino acid K809 and 
the amino acid K925 of a cross-linked peptide 913HLEFPNGVVVNDK925 showed 
no effect in either of the two assays. This clearly demonstrates that the positively 
charged top surface of Brat-NHL domain directly interacts with the hb RNA. 
 





Table 3.1: Cross-links identified from Brat-NHL-hb RNA complex. 
 



























bottom/II 804IQIFDKEGR812 K809 U-H2O A.6.3 



















Surface/Blade: Location of the peptide within the protein structure; Peptide: Sequence of the 
cross-linked peptide along with its position within the protein sequence; Amino acid: One letter 
symbol of the cross-linked amino acid along with its position within the protein sequence. The 
amino acids highlighted in grey show the probable amino acids found to be cross-linked as the 
exact cross-linking site cannot be specified further; RNA: Nucleotides found to be cross-linked to 
the peptide. Nucleotides in bold are provided with corresponding MS/MS spectra (Appendix, 
Figure A.6.1-A.6.6); Figure: Figure numbers of MS/MS spectra of the corresponding cross-linked 
peptides provided in Appendix. 
 
 











Figure 3.2: Cross-links identified from in vitro assembled Brat-NHL-hb RNA complex (Figure 
adapted from Loedige et al., 2014 and modified). (A) The identified cross-linked peptides have 
been highlighted in purple in a structure based sequence alignment (Edwards et al., 2003). Five 
out of six peptides are located on the top surface of the NHL domain. The amino acid residues 
found to be cross-linked to RNA adducts have been shown in bold and red (Loedige et al., 2014). 
(B) Crystal structure of Brat-NHL domain (PDB ID: 1Q7F, chain A) (Edwards et al., 2003) viewed 
from the top. The cross-linked peptides and amino acids have been displayed in purple and red 
colours respectively (Loedige et al., 2014). 
 
It has also been established that BoxA motif of NRE recruits Brat. In a very recent 
publication by Loedige et al., 2015, the Brat-NHL domain in complex with fifteen 
nucleotide short RNA containing the consensus UUGUUG motif at the 5′ end 
followed by an oligo stretch of nine Us (Figure 3.3 A) was crystalized at resolution 
of 2.3 Å (PDB ID: 4ZLR) (Figure 3.3 B). In a crystal structure, the RNA was found 
to be interacting to three pockets, each located at the interface of two neighboring 
blades (between blades II and III, IV and V, VI and I) across positively charged 
top surface of the Brat-NHL domain. All identified RNA-protein cross-links were 
mapped on the crystal structure. The cross-linked amino acids Y829 and C820 were 
located in the first binding pocket along with U1 and U2 whereas C890 and F916 
were lying in the second binding pocket along with G3 of RNA motif (Figure 3.3 
B). It has been observed that amino acids Y829 and F916 were situated in closer 
proximity to U1 and G3-U4 respectively (Figure 3.3 C & D) than C820 and C890 in 
their respective binding pockets. The amino acids K891 and R875 from the cross-
linked peptides, used for the mutation analysis were also mapped on the crystal 
structure. Both these amino acids were found to be located closer to G3 and U4 
of RNA respectively (Figure 3.3 D & E). Similarly, a second Brat-NHL domain 










cross-linked amino acids with oligo-U stretch as with consensus RNA motif at 5′ 






























Figure 3.3: Mapping of cross-linked peptides on the crystal structure of Brat-NHL domain with 
small stretch of RNA. (A) Sequence of NREs of hb RNA containing BoxA and BoxB sites 
indicated in blue and green letters respectively. The Brat and Pum binding sites have been 
accentuated in light red and brown colours respectively. The Brat consensus sequence UUGUUG 
has been highlighted in light red followed by an oligo stretch of nine Us also crystallized with Brat-
NHL domain as shown in Fig. 3.3 B (Figure adapted from Loedige et al., 2015and modified). (B) 
Crystal structure of both Brat-NHL monomers bound to the consensus motif RNA shown in Fig. 
3.3 A (PDB ID: 4ZLR) (Loedige et al., 2015). The cross-linked peptides and amino acids have 
been shown in purple and red colours respectively. The amino acids (K891 and R875) used for 
mutation analysis from the cross-linked peptides other than the cross-linked amino acids have 
been indicated in orange colour. The RNA has been shown in blue (Us) and green (Gs) colours. 
(C) The zoomed in crystal structure showing the cross-linked peptide in sticks (purple) with cross-
linked amino acid Y829 (red) lying in close proximity to nucleotide U1 (blue). (D) The zoomed in 
structure presenting the cross-linked peptide in sticks (purple) with F916 (red) lying closer to G3-U4 
(green-blue) and K891 (orange) near to G3 (green). (E) The zoomed in view of the cross-linked 

















3.2 Identification of Cross-links from CWC2-U4 and U6 
snRNAs Complexes 
Splicing is an essential step in eukaryotic pre-mRNA processing. In yeast, this 
process is catalysed by the spliceosomes and nineteen complex (NTC) 
consisting of small nuclear ribonucleoproteins and Prp19 along with number of 
associated splicing factors respectively. Among these splicing factors, CWC2 has 
been reported to be capable of binding RNA (Schmitzová et al., 2012). It has 
been shown that CWC2 contacts the U6 snRNA during splicing in yeast extracts. 
Furthermore, it can also interact with U1, U4 and U5 snRNAs, in vitro (McGrail et 
al., 2009). Although few identified interaction sites have already been published 
by Schmitzová et al., 2012 by UV-cross-linking, but here additional interaction 
sites of CWC2 have been reported in addition to the previously reported ones 
which will later help in quantitative analysis of the CWC2-U4 and U6 snRNA 
complexes. 
The crystal structure of CWC2 at a resolution of 2.4 Å shows that it is comprised 
of CCCH-type zinc finger (ZnF), a RNA recognition motif (RRM) domain and a 
Torus domain. The N-terminal part of the RRM domain is connected to a C-
terminal appendage of Torus domain by a positively charged connector element 
showing the tendency to interact with RNA (Figure 3.4). Here the U4 and U6 
snRNAs have been used for the interaction studies of CWC2 with snRNAs and 
will provide a better comparison to the previously published data by Schmitzová 
et al., 2012. 
In order to have detailed insight into CWC2 binding activity with U4 and U6 
snRNAs, the CWC2 protein (~39 kDa) was incubated with in vitro transcribed U4 
(162 nt) and U6 (121 nt) snRNAs separately. The complex was UV-cross-linked, 
followed by enrichment of cross-links according to the protocol, described in 
sections 2.2.5.2 and 2.2.5.3 of materials and methods respectively. The samples 
were analyzed on a Q-Exactive mass spectrometer. The data obtained was then 
analyzed by OpenMS as mentioned in section 2.2.8.2 of materials and methods. 
The candidate spectra of the cross-linked peptides were then manually validated. 





During the current studies, eighteen peptides of CWC2 protein have been found 
to be cross-linked with U4/U6 snRNAs. Except for one cross-linked peptide, the 
cross-linking site has been curtailed to the amino acid level, showing the 
probable cross-linked amino acid interacting with U6/U4 snRNAs (Table 3.2). It 
has been observed that three cross-linked amino acids (K10, W37 and C111) are 
lying in the Torus domain, three (K116, Y120 and S129) in the connector element 
and eight (Y138, K152, F162, R172, Y188, L222, K224 and C181) in the RRM domain. One 
cross-linked peptide 87CEYLHHIPDEEDIGK101 occupies the ZnF domain (Figure 
3.5 A & B). On comparison it has been noticed that seven of the identified cross-
linked peptides are the same as reported by Schmitzová et al., 2012 and eleven 














Figure 3.4: Structure of CWC2 
protein (Figure adapted from 
Schmitzová et al., 2012 and 
modified). (A) Schematic 
illustration of domains in CWC2 
protein along with amino acid 
range. The torus domain has been 
shown in blue, ZnF domain in 
maroon, connector element in 
yellow, RRM in green and C-
terminal domain (CTD) in grey. (B) 
The crystal structure of CWC2 
protein at a resolution of 2.4 Å 
(PDB ID: 3TP2, chain A) 
(Schmitzová et al., 2012). The 
domains have been coloured 
according to domains shown in 
Fig. 3.7 A. 
B 
 
PDB ID: 3TP2 
 





Table 3.2: Cross-links identified from CWC2-U4 snRNA and CWC2-U6 snRNA complexes. 
 






8SAKVQVK14 K10 U-H2O A.6.7 







































































Domain: Location of the peptide within the protein structure; Peptide: Sequence of the cross-
linked peptide along with its position within the protein sequence. The peptides in yellow have 
also been reported by Schmitzová et al., 2012; Amino acid: One letter symbol of the cross-linked 
amino acid along with its position within the protein sequence. The amino acids in yellow have 
also been reported by Schmitzová et al., 2012; RNA: Nucleotides found to be cross-linked to the 
peptide. The mass increment of 152 Da (C4H8S2O2) is due to the involvement of DTT in cysteine-
uracil cross-links (Zaman et al., 2015). Nucleotides in bold are provided with corresponding 
MS/MS spectra (Appendix, Figure A.6.7-A.6.24); Figure: Figure numbers of MS/MS spectra of the 
corresponding cross-linked peptides provided in Appendix. 




























L222 U-H2O A.6.19 














































The RRM, ZnF and Torus domains have been shown to have tendencies to 
interact with RNA previously (Schmitzová et al., 2012). The RRM domain has two 
well conserved RNP1 and RNP2 motifs. Among seven identified cross-linked 
peptides, two peptides 180NCGFVK185 and 136TLYVGGIDGALNSK149 have been 
found to be lying in these RNP1 and RNP2 motifs respectively (Figure 3.5 C). It 
has been reported by Schmitzová et al., 2012 that the double mutants Y138/Y120 
and Y138/C181 depicted impaired binding of CWC2 protein with U6 snRNA 
whereas Y138/K152 showed the insignificance of K152 for RNA binding by EMSA. 
The C-terminal domain of CWC2 have been reported to be interacting with the 
WD40 domain of Prp19 protein (Ohi & Gould, 2002; Vander Kooi et al., 2010) 
during splicing and is showing no detectable RNA-binding activity by EMSA 
(Schmitzová et al., 2012). During the interaction analysis of CWC2 with U4 and 
U6 snRNAs by UV-cross-linking, three peptides of the C-terminal domain 
225WANEDPDPAAQK236, 276TFPEASVDNVK286 and 315ENISSKPSVGK325 with 

















































Figure 3.5: Identified cross-
linked peptides of CWC2-U4 
snRNA and CWC2-U6 snRNA 
complexes. (A) The identified 
cross-linked peptides have 
been highlighted in purple in a 
sequence of CWC2 protein 
(Schmitzová et al., 2012). The 
cross-linked amino acid 
residues have been indicated 
in red. (B) The crystal 
structure of CWC2 protein at 
a resolution of 2.4 Å (PDB ID: 
3TP2, chain A) (Schmitzová 
et al., 2012). The identified 
cross-linked peptides and 
amino acid residues have 
been illustrated in purple and 
red colours respectively. (C) 
Comparison of consensus 
RNP1 and RNP2 sequences 
(Maris et al., 2005) (Figure 
adapted from Schmitzová et 
al., 2012). The amino acids 
shown in red colour are 
important for RNA binding. X 
depicts any amino acid. 





3.3 Quantitative Analysis of CWC2-U4 snRNA and U6 
snRNA Cross-links 
The CWC2 protein has been reported to bind with RNAs non-specifically in vitro 
(McGrail et al., 2009). The previous studies have shown that CWC2 interacts with 
RNAs through RRM, torus, connector element and ZnF domains (Schmitzová et 
al., 2012). In order to determine whether the CWC2 as a whole protein and its 
domains individually possess a preference for any RNA to interact or bind 
indiscriminately, the comparative studies have been carried out by relative 
quantification approach. For relative comparison of different conditions, relative 
quantification through label based approach proves to be extremely useful 
(Nikolov et al., 2012). 
For relative quantitative analysis of CWC2-U4 snRNA and U6 snRNA cross-links, 
the U6 and U4 snRNAs, transcribed by using non-labeled (light (12C)) and 
isotopically labeled (heavy (13C)) UTP respectively were pooled in 1:1 ratio and 
were incubated with CWC2 protein. In another set of identical experiment, the 
labels were swapped for RNA transcription. The former set of experiment was 
referred as “forward” and the later one as “reverse” respectively. The complexes 
were UV irradiated and the cross-links were enriched according to the protocol 
described in sections 2.2.6.1 and 2.2.5.3 of materials and methods respectively. 
The samples were run on Q-Exactive mass spectrometer (Figure 3.6). The data 
obtained was then analysed by OpenMS. The candidate spectra of the cross-
linked peptides were then manually validated (Figure 3.7 A & B). 
The relative quantification was first carried out by generating extracted ion 
chromatograms (XICs) of the identified cross-linked peptides precursors m/z at 
their respective retention time in Xcalibur software (Thermo Scientific) as 
mentioned in section 2.2.8.2 of materials and methods. In case the cross-linked 
peptides have been identified in one condition and if the intensity of the cross-
linked peptide is not sufficient to trigger the MS/MS fragmentation in another, the 
XIC was generated by using expected precursor m/z at its particular retention 
time. The ratios were calculated from the peak area of the extracted ion 









Figure 3.6: Workflow for relative quantification of U4/U6 snRNA-CWC2 cross-links. The differentially labeled U4 and U6 snRNAs are pooled in 1:1 ratio and 
incubated with CWC2 protein. The sample is UV-irradiated and hydrolyzed by RNases and endoproteinases. The non-cross-linked RNA fragments are 
removed by desalting and the cross-links are further enriched by TiO2 chromatography. The isolated cross-links are analyzed by LC-ESI-MS/MS. The shown 
workflow is of forward experiment and for the reverse experiment only labels are swapped for transcription of snRNAs. 











Figure 3.7: MS/MS spectrum of peptide NCGFVK cross-linked to U+152. (A) MS/MS spectrum of 
peptide cross-linked to [U+152] having light uracil. The mass shift of b-series from b2 ion and of y-
series from y5 ion shows that Cysteine is a cross-linked amino acid. (B) MS/MS spectrum of 
peptide cross-linked to [U+152] having heavy uracil. The mass shift of b-series from b2 ion and of 






















37WSQGFAGNTR46 W37 U A.6.25 














115EKFADYR121 K116 U-H2O A.6.11 




























L222 U-H2O A.6.19 
K224 U-H2O A.6.20 
Continued...... 
 






























Domain: Location of the peptide within the protein structure; Peptide: Sequence of the cross-
linked peptide along with its position within the protein sequence. Amino acid: One letter symbol 
of the cross-linked amino acid along with its position within the protein sequence. RNA: Non-
labeled/labeled uracil along with other nucleotides found to be cross-linked to the peptide. The 
cross-linked peptides along with the isotopically labeled (heavy (13C)) uracil, identified at the MS2 
level are indicated by highlighting the nucleotides in yellow. The mass increment of 152 Da 
(C4H8S2O2) is due to the involvement of DTT in cysteine-uracil cross-links (Zaman et al., 2015). 
Nucleotides in bold are provided with corresponding MS/MS spectra (Appendix, Figure A.6.7-
A.6.32); Figure: Figure numbers of MS/MS spectra of the corresponding cross-linked peptides 
provided in Appendix. 
 
Total sixteen peptides have found to be cross-linked to U4/U6 snRNAs in forward 
and reverse replicates (Table 3.3). The m/z of the identified cross-links with light 
and heavy labeled uracil have been theoretically calculated for the charge states 
of +2 and +3. The area under the curve (AUC) have been estimated for all the 
cross-linked peptides by generating the XICs. The area of each cross-linked 
peptide along with its miss-cleavage state and all of the charge states (+2 and 
+3) and RNA moiety combinations have been added and used for further 
calculations. For statistical analysis log transformation has been applied to 
normalize the peak areas of the cross-links and for normality confirmation 





Kolmogorov-Smirnov and Shapiro-Wilk tests have been applied (mentioned in 




Figure 3.8: Normalization graphs. (A) The Q-Q plot of observed logarithmic (log10) peak area vs. 
expected normal value. (B) The histogram of observed logarithmic (log10) peak area values 
plotted against their frequencies confirm normality. 
 
Keeping the selection stringent for relative quantification, three cross-linked 
peptides, 106TEVLDCFGR114 of torus domain, 136TLYVGGIDGALNSK149 of RNP2 
motif of RRM domain and 180NCGFVK185 of RNP1 motif of RRM domain have 
been selected for further studies. These cross-linked peptides have been 
identified in most of the forward and reverse replicates and used for calculating 
heavy to light (H/L) and light to heavy (L/H) ratios respectively. Few cross-links 
peak area values have been found to be missing in their light-heavy pair so their 
ratios cannot be calculated and are omitted from comparative studies (Appendix 
Table 6.6). 
The relative quantitation was also carried out by generating the extracted ion 
chromatograms using Skyline software (as described in section 2.2.8.3 of 
materials and methods). The spectral library of above mentioned three cross-
linked peptides along with different oligonucleotide combinations (Appendix Table 
6.7) was built. The identified oligonucleotide combinations were added as 
A B 





modifications. The Savitzky-Golay smoothing was applied to the extracted ion 
chromatograms (XICs). The most intense peak among the light and heavy pair 
was selected for marking the peak boundaries manually after carefully inspecting 
the isotopic pattern (Figure 3.9 A & B, Appendix Figures 6.33-6.47). The ratios 
were then calculated from the peak areas of the extracted ion chromatograms 
which were further used for the statistical analysis and data interpretation 
(Appendix Table 6.7). 
It has been reported that the CWC2 protein binds more efficiently to U4 snRNA 
than U6 snRNA in vitro (McGrail et al., 2009). The current comparative study of 
cross-linking tendency of CWC2 protein to U4 and U6 snRNA by taking individual 
ratio (ratio of each peptide cross-linked to per RNA moiety) into consideration has 
shown that the CWC2 is more inclined towards U4 snRNA than U6 snRNA for 
cross-linking (Appendix Table 6.6 & Table 6.8). However, the combined effect of 
the three cross-linked peptides (106TEVLDCFGR114, 136TLYVGGIDGALNSK149 
and 180NCGFVK185) along with all the combinations of RNA moiety shows that 
both U4 and U6 snRNAs cross-link with almost similar efficiency with CWC2 
protein in all the individual forward and reverse replicates. The statistical analysis 
by one-way ANOVA (Duncan’s test) at p=0.05 (mention in section 2.2.8.4 of 
materials and methods) proves that there is no significant difference in the cross-
















Figure 3.9: Example of Extracted ion chromatogram and isotopic distribution of a cross-link 
showing the mass difference due to labeling. (A) The extracted ion chromatograms (XICs) of both 
light-heavy pair of a peptide NCGFVK cross-linked to UA+152 with the charge state of +2. The 
XIC in red and blue are from doubly charged light labeled and doubly charged heavy labeled 
forms of the cross-link respectively. (B) The isotopic distribution of NCGFVK + [UA+152] cross-
link, with non-labeled (light (12C)) UTP at m/z 736.7079 and with isotopically labeled (heavy (13C)) 
UTP at m/z 741.2232 with the charge state of +2. The difference between the two monoisotopic 













Figure 3.10: Bar diagrams of Mean of log2 ratios of CWC2-U4/U6 snRNA cross-links. (A) The 
means are calculated from the logarithmic (log2) ratios of peak area from Xcalibur of all the three 
cross-linked peptides of each of the forward and reverse replicates. (B) The means are calculated 
from the logarithmic (log2) ratios of peak area from Skyline of all the three cross-linked peptides of 
each of the forward and reverse replicates. The statistical analysis shows that there is no 
significant difference in the cross-linking efficiency of CWC2 protein to U4 and U6 snRNAs among 
the replicates of forward experiment as well as of the reverse experiment. 
 
In order to further investigate if any domain/motif of CWC2 protein preferentially 
cross-links to U4 or U6 snRNA, the relative quantification was carried out by 
using the ratios of the cross-linked peptides of Torus domain and RNP1 and 
RNP2 motifs in both forward and reverse experiments. The analysis has revealed 
that all the domains/motifs of CWC2 protein cross-link to U4 and U6 snRNAs 
almost indiscriminately (Figure 3.11). 
 
 
Figure 3.11: Bar diagram of Mean of log2 ratios of individual cross-linked domain/motif to U4/U6 
snRNA. (A) The means are calculated from the logarithmic (log2) ratios of peak area from Xcalibur 
of all the three forward and reverse replicates of each domain/motif cross-link. (B) The means are 
calculated from the logarithmic (log2) ratios of peak area from Skyline of all the three forward and 















3.4 Identification of Cross-links from MS2-MBP Protein 
The ribonucleoprotein complexes play a significant role in all fundamental cellular 
processes. There are several methods to purify these complexes. For the current 
studies, the H/E complex from HeLa nuclear extract was purified by MS2-MBP 
affinity purification method (Zhou & Reed, 2003). The method is based on the 
affinity of the bacteriophage MS2 coat protein for its target MS2 RNA stem-loops. 
For the isolation of in vitro assembled RNP complex, the bait RNA (PM5 pre-
mRNA/MINX pre-mRNA) was tagged with three MS2 RNA stem-loops. The MS2-
MBP fusion protein was bound to these MS2 hairpin loops. The RNA-MS2-MBP 
complex was then used to assemble the H/E complex by incubating with HeLa 
nuclear extract. The assembled complex was isolated by affinity purification using 
amylose beads and maltose in elution buffer as described in section 2.2.4.4 of 
materials and methods. The evident binding of MS2-MBP fusion protein to the 
MS2 RNA stem-loops of target RNA (Figure 3.12) explicitly require the detailed 
account of probable interaction sites of this protein with RNA. 
In order to find the interactions of MS2-MBP fusion protein, the data obtained by 
the MS analysis of the UV-cross-linked RNP complex from HeLa nuclear extract 
on LTQ Orbitrap Velos mass spectrometer (as described in section 2.2.5.3 of 
materials and methods) was analyzed by OpenMS as mentioned in section 
2.2.8.2 of materials and methods using the database containing MS2-MBP 
sequence. The candidate spectra of the cross-linked peptides identified were 










Figure 3.12: MS2-MBP fusion protein and MS2 RNA stem-loop. (A) 
Coomassie stained ~55 kDa bands of purified MS2-MBP fusion protein 
from different sample batch preparations. (B) The sequence and 
structure of MS2 hairpin loop with Uracil at position -5 in wild type 
(Figure adapted from Hornet al., 2004 and modified) which was 
substituted with cytosine in in vitro transcribed MS2-tagged pre-mRNAs. 
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Twelve peptides of maltose binding protein and two of MS2 coat protein have 
been found to be cross-linked to the nucleotides (Figure 3.13 A, Table 3.4). 
Overall, out of fourteen peptides, the probable cross-linked amino acid residues 
have been screened for seven peptides only. For seven of the cross-linked 
peptides of MBP protein, the exact cross-linked amino acid could not be identified 
however the cross-linking regions have been narrowed down upto few amino 
acids as shown in Table 3.4. 
















A.6.48 28FEKDTGIK35 U-H2O 
 UA-H2O 







N 68FGGYAQSGLLAEITPDKAFQDK89 K84 U-H2O A.6.51 
C 121DLLPNPPKTWEEIPALDK138 124P-T129 U-H2O A.6.52 
C 129TWEEIPALDKELK141 138K/E139 U-H2O A.6.53 
N 275ELAKEFLENYLLTDEGLEAVNK296 275E-L285 U-H2O A.6.54 







3 307SYEEELAKDPR317 314K/D315 U-H2O A.6.57 









 438KYTIKVEVPK447 K442 U-H2O A.6.60 
443VEVPKGAWR451 K447 U-H2O A.6.61 
Protein: Protein name along with its UniProt ID; Domain/Segment: Location of the peptide within 
the protein structure; Peptide: Sequence of the cross-linked peptide along with its position within 
the protein sequence; Amino acid: One letter symbol of the cross-linked amino acid along with its 
position within the protein sequence. The amino acids highlighted in grey show the probable 
amino acids that are found to be cross-linked as the exact cross-linking site cannot be specified 
further; RNA: Nucleotides found to be cross-linked to the peptide. Nucleotides in bold are 
provided with corresponding MS/MS spectra (Appendix, Figure A.6.48-A.6.61); Figure: Figure 
numbers of MS/MS spectra of the corresponding cross-linked peptides provided in Appendix. 





Maltose binding protein has previously been known to play role in several 
biological processes like carbohydrate transport and cellular response to DNA 
damage stimulus etc. but its direct interaction with nucleic acid has not been 
reported until now. In the current study, twelve peptides of MBP have been found 
to be cross-linked to uracil. In most of these peptides, lysine has been found to 
be a cross-linked amino acid residue. These cross-linked peptides have been 
mapped on the 1.8 Å crystal structure of monomeric maltose binding protein 
(Figure 3.13 B). The protein has two distinct globular N (residues 1-109 and 264-
309) and C (114-258 and 316-370) domains, joined by three segments 1 
(residues 110-113), 2 (residues 259-263) and 3 (residues 310-315). There is a 
deep groove between the two domains containing the oligosaccharide-binding 
site. Each domain is comprised of central β-pleated sheet, flanked on both sides 
by α-helices (Quiocho et al., 1997). Most of the cross-linked peptides are found to 
be lying in the region of α-helices. Out of twelve cross-linked peptides, seven 
have been occupying N domain, four occupying C domain and one occupying the 













Figure 3.13: Identified 
cross-linked peptides of 
MS2-MBP fusion protein. 
(A) The identified cross-
linked peptides have been 
highlighted in purple in a 
sequence of MS2-MBP 
fusion protein (Sharff et al., 
1992; Grahn et al., 1999). 
The cross-linked amino acid 
residues and regions have 
been indicated in red. The 
MBP sequence has been 
shown in bold and blue 
colour whereas the MS2 
coat protein sequence has 
been presented in bold and 
brown colour. (B) Crystal 
structure of MBP viewed 
from the top (PDB ID: 
1OMP) (Sharff et al., 1992). 
The identified cross-linked 
peptides and amino acid 
residues/regions have been 
illustrated in purple and red 
colours respectively. 
PDB ID: 1OMP 





Much has been reported about the interaction of RNA bacteriophage coat protein 
MS2 with specific stem-loop structure of viral RNA. In the current studies, two 
peptides of MS2 protein have been found to be cross-linked to uracil. It has also 
been observed that lysine is a cross-linked amino acid in the peptides which is in 
concordance to the observation of Budowsky et al., 1976 in which lysine residues 
in coat protein were found to be cross-linked to the genomic nucleic acid upon 
UV-irradiation. The cross-linked peptides have been mapped on 2.86 Å crystal 
structure of MS2 coat protein with a stretch of RNA (Figure 3.14). The structure is 
comprised of three chains each containing 129 amino acids. The structure has 
been shown in three coat protein dimers. Each monomer is composed of five 
stranded β-sheet and two α-helical segments. The cross-linked lysine residues 
K442 and K447 of peptides 438KYTIKVEVPK447 and 443VEVPKGAWR451 
respectively are found to be lying in β-sheet in closer proximity to cytosine at 
position −5 of nucleotides in RNA in the crystal structure. This has also been 
reported by Grahn et al., 1999 that K442 is among the probable amino acids that 
formed cross-links with nucleotides and the substitution of wild type uracil by 
cytosine at position −5 resulted in stronger binding of RNA hairpin to MS2 coat 
protein so it can be anticipated that in the present study, K442 is the probable 
amino acid and uracil (in case of contamination)/cytosine (in case of bait RNA) at 
position −5 is the probable nucleotide taking part in cross-linking. The study of the 
crystal structure of MS2 coat protein revealed the partial mapping of the cross-
linked peptide 443VEVPKGAWR451, reason being the difference arising in the MS2 
coat protein sequence of MS2-MBP fusion protein from the original sequence of 
the available MS2 coat protein alone with the deletion of 67VATQTVGGVELPVA80 
region. 
In short the studies showed that the MS2 coat protein interacts with the specific 
stem-loop structure of the RNA. In addition to this the current study also revealed 
that the MBP part of the MS2-MBP fusion protein may undergo cross-linking with 
RNA. Mostly the lysine residue of the MS2-MBP protein get cross-linked to uracil 
with the loss of water molecule. 
 






Figure 3.14: Crystal structure of MS2 coat protein along with the MS2 stem-loop RNAs (PDB ID: 
1ZDK) (Grahn et al., 1999). Cross-linked peptides have been highlighted in purple whereas the 
cross-linked amino acids have been indicated in red colour. The RNA has been illustrated in 
orange colour with the probable nucleotide (Cytosine in this case) shown in blue at position -5 of 















(PDB ID: 1ZDK) 





3.5 Identification of Uracil Fragments and Adducts 
Cross-linking in combination with mass spectrometry (MS) has proven to be a 
powerful approach for the structural investigation of RNA-protein cross-links. It 
not only provides the information about the part of the biomolecule undergone 
cross-linking but also helps in the identification of specific site of cross-linking. 
The UV induced cross-linking utilizes the natural sensitivity of nucleobases and 
amino acid residues to generate a zero-length cross-link directly between the 
adjacent molecules without any intervening linker (Meisenheimer & Koch, 1997). 
The subsequent mass spectrometric analysis of the peptide-oligonucleotide 
heteroconjugates is used to determine the exact cross-linking site. 
By taking the fact into consideration that the cross-links are additive in nature, the 
peptide-oligonucleotide cross-links are identified by database search (Kramer et 
al., 2014). The MS2 spectra of the cross-links are usually dominated by the 
peptide signals but one can also observe the characteristic marker ions produced 
by the CID fragmentation of the cross-linked nucleotides. In addition to these, the 
nucleotide fragments can be observed as adducts cross-linked to an amino acid 
residue resulting in the shifting of ion series. 
Several studies have been conducted on the nucleobases and nucleosides along 
their isotopically labeled analogues and modified species by CID fragmentation. 
The fragmentation occurs by the opening of the base ring and the loss of low 
molecular weight neutral components. The common losses detected during 
fragmentation are of ammonia (NH3), carbon monoxide (CO), cyanic acid NHCO, 
hydrogen cyanide (HCN) and water (H2O) (Nelson & McCloskey, 1994; Liu et al., 
2008). However, different nucleosides and their modified species show significant 
differences in their fragmentation. 
During the cross-linking studies, conducted by using labeled/non-labeled PM5 
pre-mRNA/MINX pre-mRNA complexed with HeLa nuclear extract proteins (as 
described in section 2.2.4.4 & 2.2.5.3 of materials and methods), the MS2 
spectra obtained, has the sequence information of the cross-linked peptides 
along with the signals of fragment ions of the cross-linked nucleotides. Uracil 





nucleotide is found to be the most frequently cross-linked nucleotide with the 
peptide moieties. Several uracil nucleotide fragments that have been reported 
before (Table 3.5 & 3.6) were also been observed in the MS2 spectra (Newton et 
al., 1986; Nelson & McCloskey, 1994; Liu et al., 2008). However, there have 
been few unidentified signals in the MS2 spectra. Since the peptide and 
oligonucleotides have different fractional mass depending upon their different 
molecular composition therefore on the basis of fractional mass these 
unidentified signals are assumed to be generated by the fragmentation of 
oligonucleotides (Pourshahian & Limbach, 2008) i.e. uracil nucleotide in the 
current case. 
In order to estimate the elemental composition of the generated fragments, the 
ion signals from unlabeled and different isotopically labeled uracil nucleotide i.e. 
13C, 13C15N labeled and site specific deuterated uracil nucleotides (Figure 3.15) 
have been compared for the same peptide-oligonucleotide cross-link. 
Table 3.5: List of Uracil nucleotide (fragment) adducts with their assigned abbreviations 
and calculated masses.  
*The RNA (fragment) adducts and marker ions highlighted in yellow have been identified during 
the current studies. 
 





C3O # 51.9949 
Uracil-H2O U'0 94.0167 
Uracil U' 112.0273 
Uridin-H2O U0-p 226.0590 
Uridin Up 244.0695 
Uridinmonophosphate-H2O U0 306.0253 
Uridinmonophosphate U 324.0359 
Uridin-H2O-H2O-CH2O U0-p-0-CH2O 178.0378 
Uridin-H2O-C3O U0-p-# 174.0640 
Uridin-H2O-H2O U0-p-0 208.0484 
Table 3.6: List of Uracil nucleotide marker ions with their symbols and calculated m/z. 
 
RNA marker ions Symbol Calculated m/z 
Uracil U' 113.0351 
Uridine-H2O U0-p 227.0667 
Uridinmonophosphate-H2O U0 307.0331 
Uridinmonophosphate U 325.0437 
Uridin-H2O-H2O-CH2O U0-p-0-CH2O 179.0456 
Uridin-H2O-C3O U0-p-# 175.0718 
 





























































































Monoisotopic Mass: 329.06725 Da  
Figure 3.15: Uracil nucleotides. (A) Unlabeled uracil nucleotide. (B) 13C9 labeled uracil nucleotide. 
(C) 13C915N2 labeled uracil nucleotide. (D) 5-D1, ribose-3‘, 4‘, 5‘, 5‘-D4 labeled uracil nucleotide. 
 
The peptide 375DYAFVHFEDR384 derived from heterogeneous nuclear 
ribonucleoprotein R protein was found to be cross-linked to uracil nucleotide. In 
MS2 spectrum, the ion signal at m/z 179.0447 (Figure 3.16 A) with relatively high 
intensity is assumed to be generated by the fragmentation of the cross-linked 
uracil nucleotide. This ion signals have been compared with its corresponding ion 
signals in other spectra of the same cross-linked peptide with the isotopically 
labeled uracil nucleotides (13C9, 13C915N2 and 5-D1, ribose-3‘, 4‘, 5‘, 5‘-D4 labeled 
uracil nucleotide). The difference in mass helps in predicting the elemental 
A B 
C D 





composition of the uracil nucleotide fragment. Since in 13C-labeled uracil 
nucleotide all carbon atoms are labeled so the difference of the ion signal at m/z 
187.0712 in spectrum B (Figure 3.16 B) with the corresponding ion signal at m/z 
179.0447 in spectrum A (Figure 3.16 A) shows the presence of eight carbon 
atoms in the fragment. Similarly, in case of 13C15N-labeled uracil nucleotide, the 
difference of ion signal at m/z 189.0654 in spectrum C (Figure 3.16 C) with the 
corresponding ion signal at m/z 187.0712 in spectrum B (Figure 3.16 B) depicts 
the presence of two nitrogen atoms in the fragment. When the site specific 
deuterated uracil nucleotide was used, the difference of ion signal at m/z 
182.0636 in spectrum D (Figure 3.16 D) with its corresponding ion signal at m/z 
179.0447 in spectrum A (Figure 3.16 A) indicates the loss of two deuterium 
atoms and the presence remaining 3 deuterium atoms in the uracil nucleotide 
fragment of interest.  
Upon CID fragmentation of nucleotides, the loss of phosphate group and neutral 
loss of water are commonly observed. So by keeping all these points into 
consideration the elemental composition of the uracil nucleotide fragment of 
interest can be assumed i.e. C8H6N2O3 generated via combined loss of two water 
(H2O) molecules, one phosphate group (HPO3) and formaldehyde (CH2O) 
molecule. This result is in concordance with the previous studies conducted on 
the pseudouridine fragmentation in which the loss of two water molecules and 
CH2O from the sugar moiety give rise to a product ion at m/z 179 (Dudley et al., 
2000). The structure of uracil nucleotide fragment of interest can be predicted as 

































Figure 3.16: The MS2 spectra of the peptide 375DYAFVHFEDR384 cross-linked to U. (A) The MS2 
spectrum of before mentioned cross-link with unlabeled uracil nucleotide. The spectrum has ion 
signals at m/z 179.0447 of uracil nucleotide fragment of interest and m/z 227.0657 (U-H3PO4) 
showing that the unlabeled U is cross-linked with the peptide. (B) The MS2 spectrum of before 
mentioned cross-link with 13C9 labeled uracil nucleotide. The spectrum has ion signals at m/z 
187.0712 of uracil nucleotide fragment of interest, m/z 236.0955 (U-H3PO4) and of tyrosine 
immonium ion with the U adducts (#: C3O, U0: U-H2O, U’: Uracil marker ion) showing that the 13C-
labeled U is cross-linked to Y. (C) The MS2 spectrum of before mentioned cross-link with 13C915N2 
labeled uracil nucleotide. The spectrum has ion signals at m/z 189.0654 of uracil nucleotide 
fragment of interest, m/z 238.0896 (U-H3PO4) and of tyrosine immonium ion with the U adducts 
C 
D 





(#: C3O, U0-p: U-H3PO4) showing that the 13C15N-labeled U is cross-linked to Y. (D) The MS2 
spectrum of before mentioned cross-link with 5-D1, ribose-3‘, 4‘, 5‘, 5‘-D4labeled uracil nucleotide. 
The spectrum has ion signals at m/z 182.0636 of uracil nucleotide fragment of interest, m/z 
232.0969 (U-H3PO4) and of tyrosine immonium ion with the U adducts (#: C3O, U0: U-H2O) 



















Monoisotopic Mass: 178.037842 Da






























































Monoisotopic Mass: 186.064681 Da
















































































Monoisotopic Mass: 188.05875 Da




































Monoisotopic Mass: 181.056672 Da










P Molecular Formula:  C8H3D3N2O3
 
 
Figure 3.17: The predicted structural formulae of the Uracil nucleotide fragment (m/z 179.0447). 
(A) The predicted structural formula of the unlabeled uracil nucleotide fragment generated by the 
loss of two H2O, one HPO3 and one CH2O molecules. (B) The predicted structural formula of the 
13C-labeled uracil nucleotide fragment generated by the loss of two H2O, one HPO3 and one 
CH2O molecules. (C) The predicted structural formula of the 13C15N-labeled uracil nucleotide 
fragment generated by the loss of two H2O, one HPO3 and one CH2O molecules. (D) The 
predicted structural formula of the D-labeled uracil nucleotide fragment generated by the loss of 
two H2O, one HPO3 and one CH2O molecules. 
C 
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Similarly, the peptide 215YQVIGK220 of mitochondrial endonuclease G is found to 
be cross-linked to uracil nucleotide with the loss of H2O molecule. Its MS2 
spectrum shows the ion signal with relatively high intensity at m/z 175.0714 
(Figure 4 A), which is expected to be produced as a result of fragmentation of 
cross-linked uracil nucleotide. In order to deduce the elemental composition of 
this uracil nucleotide fragment of interest, the ion signal at m/z 175.0714 (Figure 
3.18 A) is compared with its corresponding ion signals in other spectra of the 
same cross-linked peptide with the isotopically labeled uracil nucleotides. The 
MS2 spectrum B (Figure 3.18 B) of cross-linked peptide 15YQVIGK220 with 13C-
labeled uracil nucleotide with the loss of H2O shows the ion signal of the uracil 
nucleotide fragment of interest at m/z 181.0916 which is different from the 
corresponding ion signal in spectrum A by six carbon atoms. Likewise, ion signal 
at m/z 183.0851 in the MS2 spectrum C (Figure 3.18 C) of cross-linked peptide 
15YQVIGK220 with 13C15N-labeled uracil nucleotide with the loss of H2O in 
comparison with the ion signal at m/z 181.0916 in spectrum B (Figure 3.18 B) 
indicates the presence of two nitrogen atoms. Finally, the elemental composition 
of the uracil nucleotide fragment of interest, deduced by the above mentioned 
observations is C6H10N2O4, generated by the loss of one HPO3 and C3O 
molecules. On the basis of this molecular formula, the probable structure of uracil 
nucleotide fragment of interest can be predicted, fitting to the exact monoisotopic 



































Figure 3.18: The MS2 spectra of the peptide 215YQVIGK220 cross-linked to U-H2O. (A) The MS2 
spectrum of the mentioned cross-link with unlabeled uracil nucleotide with the loss of water. The 
spectrum has ion signal at m/z 175.0714 of uracil nucleotide fragment of interest and a shift in b-
series from b2 ion by U adduct (U’0: Uracil marker ion-H2O and predicted uracil nucleotide adduct 
of 208 Da) showing that the unlabeled U is cross-linked with the Y/Q of a peptide. (B) The MS2 
spectrum of before mentioned cross-link with 13C9 labeled uracil nucleotide. The spectrum has ion 
signals at m/z 181.0916 of uracil nucleotide fragment of interest and of tyrosine immonium ion 
with the U adduct (U0-p: U-H3PO4) and a shift of b-series from b2 ion by U adduct (U’0: Uracil 
marker ion-H2O and predicted uracil nucleotide adduct of 217 Da) showing that the 13C-labeled U 
is cross-linked to Y. (C) The MS2 spectrum of before mentioned cross-link with 13C915N2 labeled 
uracil nucleotide. The spectrum has ion signals at m/z 183.0851 of uracil nucleotide fragment of 
interest and a shift of b-series from b2 ion by U adduct (predicted uracil nucleotide adduct of 219 































Monoisotopic Mass: 324.035866 Da















Monoisotopic Mass:  174.064057 Da









































Monoisotopic Mass: 333.066059 Da














































































Monoisotopic Mass: 335.060129 Da





























Monoisotopic Mass:  182.078256 Da










Figure 3.19: The predicted structural formulae of the Uracil nucleotide fragment (m/z 175.0714). 
(A) The predicted structural formula of the unlabeled uracil nucleotide fragment generated by the 
loss of one H2O, one HPO3 and one C3O molecules. (B) The predicted structural formula of the 
13C-labeled uracil nucleotide fragment generated by the loss of one H2O, one HPO3 and one C3O 
molecules. (C) The predicted structural formula of the 13C15N-labeled uracil nucleotide fragment 
generated by the loss of one H2O, one HPO3 and one C3O molecules.  
 
The MS/MS spectrum of the cross-linked peptide 215YQVIGK220 with U-H2O 
shows a shift in b ion series with the mass of 208 Da, 217 Da and 219 Da when 
the peptide is cross-linked with unlabeled, 13C-labeled and 13C15N-labeled uracil 
nucleotides with the loss of water respectively. The difference in the mass shift of 
b ion series with the corresponding ion series in other spectra of the same cross-
linked peptide with the isotopically labeled uracil nucleotides (Figure 3.18) helps 
in predicting the elemental composition of the expected uracil nucleotide adduct. 
By comparing the mass shifts, it has been concluded that the elemental 
composition of the predicted uracil nucleotide fragment observed as an adduct in 
b ion series is C9H8N2O4. This fragment is assumed to be generated by the loss 
of two H2O and one HPO3 molecules from the intact uracil nucleotide. Based on 
the molecular formula, the probable structure of the uracil nucleotide fragment 
C 





observed as an adduct can be predicted which fits to its monoisotopic mass of 
208.0484 Da (Figure 3.20). Similar fragment of 208 Da was also observed by the 




















Monoisotopic Mass: 324.035866 Da















































Monoisotopic Mass: 333.066059 Da

















































































Monoisotopic Mass: 335.060129 Da



































Monoisotopic Mass:  219.07267 Da









Figure 3.20: The predicted structural formulae of the Uracil nucleotide fragment observed as a U 
adduct in Figure 3.18 resulting in the shift of b ion series by the mass of 208 Da. (A) The 
predicted structural formula of the unlabeled uracil nucleotide fragment generated by the loss of 
two H2O and one HPO3 molecules. (B) The predicted structural formula of the 13C-labeled uracil 
nucleotide fragment generated by the loss of two H2O and one HPO3 molecules. (C) The 
predicted structural formula of the 13C15N-labeled uracil nucleotide fragment generated by the loss 


















3.6 Identification of RNP Complexes Isolated from HeLa 
Nuclear Extract and their Cross-linking Analysis 
The life cycle of mRNA is predominantly regulated by the interaction of RNA 
binding protein with the RNAs (Keene, 2007; Glisovic et al., 2008). The 
complexity of this regulation has increased with that of the organisms. In the 
mammalian cells, more than 1300 RNA binding proteins interact with 
miscellaneous RNA with varying specificity and affinity through their diverse 
range of RNA binding domains (RBDs) and motifs (Castello et al., 2012; 
Munschauer, 2015). These include polypyrimidine tract-binding protein 1 
(PTBP1), Y-box-binding protein 1 (YBX1) and serine-rich (SR) proteins etc. Till 
now more than 50 RBDs have been reported (Anantharaman et al., 2002; 
Glisovic et al., 2008; Munschauer, 2015; Castello et al., 2016). The RBPs interact 
with RNAs by using one or multiple RBDs. The most widely studied RBDs are 
RNA recognition motif (RRM), K homology (KH) domain, zink finger (ZnF) domain 
and cold shock domain (CSD) etc. For the better understanding of these 
interactions, high-throughput in vitro (Van Nostrand et al., 2016) and in vivo (Ray 
et al., 2013) techniques have been established. These techniques can be either 
protein-centric (Ingolia et al., 2009; Darnell, 2010) or RNA-centric (Hartmuth et 
al., 2002; Castello et al., 2012) followed by mass spectrometry or RNA 
sequencing respectively. However, all these methods involve few technical 
challenges for example the isolation of non-specific RNA-protein interactions, the 
low abundance of target biomolecules and low yield of RNP complexes etc. 
To overcome the limitations occurring during interaction analysis of the large 
RNP complexes, the optimization was carried out in the existing protocols 
described by Deckert et al., 2006 for isolation of RNP complex and by Urlaub et 
al., 2002 and Luo et al., 2008 for purification and enrichment of cross-links. For 
the current studies, RNA-centric approach has been adopted. The (PM5/MINX) 
pre-mRNA tagged with three MS2-binding RNA stem-loops was transcribed by 
using non-labeled/labeled UTP (Figure 3.21). To assemble the RNP complex the 
tagged pre-mRNA was pre-incubated with MS2-MBP fusion protein and later with 
the HeLa nuclear extract on ice to prevent any protein degradation and RNA 





processing. After several washes to remove the non-specific interacting proteins, 
the RNP complex was affinity purified by using amylose beads and maltose in 
elution buffer without glycerol (as described in detail in materials and method 
section 2.2.4.4) (Jurica et al., 2002; Deckert et al., 2006; Bessonov et al., 2008). 
 
 
Figure 3.21: The structure of MS2-tagged (PM5 & MINX) pre-mRNA. The PM5 pre-mRNA 
comprised of 478 bp and has single exon whereas MINX pre-mRNA has 323bp and two exons 
(Deckert et al., 2006; Bessonov et al., 2008). 
 
The purified RNP complex was UV-irradiated at 254 nm to generate a zero length 
cross-linking between the nucleotide of RNA molecule and the amino acid of a 
protein lying in close proximity to each other. In parallel, the non-UV-irradiated 
sample was also processed as control. In order to perform the interactome 
analysis, the proteins of the RNP complex were separated by using pre-cast 4-
12% Bis-Tris Gel. The gel was subsequently stained with coomassie blue 
followed by cutting out 22 slices from each lane (as mentioned in section 2.2.7.1 
of materials and methods) (Figure 3.22). The proteins were hydrolyzed within the 
gel by using trypsin and the peptides were extracted to perform the mass 
spectrometric analysis for the identification of the proteins (as described in 
materials and methods section 2.2.7). The results obtained after data searches 





were used to construct an interactome by using Cytoscape (version 3.7.0) and 
NetworkAnalyser plug-in (described in section 2.2.8.5 of material and methods) 




Protein-Protein interaction network was also constructed for the identified cross-
linked proteins (described in section 2.2.8.5 of materials and methods) in order to 
have a clear overview of the isolated RNP complex and to find out the structural 
as well as functional relationships between the proteins. Network construction 
was based on known interactions deduced on experimental inference, literature 
survey and databases. Every protein was presented as an individual node. Edges 
represented the interactions between the proteins. The interactome analysis of 
the cross-linked proteins showed that the cross-linked RNP complex was mainly 
H/E complex that under suitable conditions can lead to spliceosomal A, B, and C 
complexes (Wahl et al., 2008). 
Network analysis for RNP complexes assembled on two pre-mRNAs MINX and 
PM5 were carried out separately. Interactome for RNP complex assembled by 
using MINX pre-mRNA revealed 52 nodes and 227 edges with good 
connectedness (3 weakly connected components and 23 strongly connected 
components) (Figure 3.24). Average degree (number of edges connected to 
Figure 3.22: Coomassie stained 4-12% 
Bis-Tris Gel. The proteins of the UV-cross-
linked RNP complex were separated on 
the gel and the coomassie stained. Each 
lane was then cut into 23 slices. M: Protein 
marker; Lane1: UV-cross-linked RNP 
complex assembled on PM5 pre-mRNA; 
Lane 2: UV-cross-linked RNP complex 
assembled on MINX pre-mRNA. 





nodes) was 8.73. The network diameter was 9, whereas average path length was 
found to be 2.74. Among other parameters the graph density was calculated to 
be 0.086. Connected component attribute revealed that there were 23 strongly 
connected components. The Average clustering coefficient was 0.288. 
With 44 nodes and 163 edges, the attribute values for interaction revealed by 
RNP proteins assembled on PM5 pre-mRNA network analysis also showed good 
connectedness (Figure 3.23). Average degree was calculated to be 7.244 with 
network diameter of 7. Graph density was calculated to be 0.082. Connected 
components overview showed 26 strongly connected components. Average 
clustering coefficient was found to be 0.197. 
 
Figure 3.23: Interactome of RNP complex (after cross-linking, purification and enrichment) from 
HeLa nuclear extract assembled on PM5 pre-mRNA. Interactome network was constructed based 
on the information from the experiments. The structural and functional relationships are shown as 
edges that are connecting individual proteins (nodes). Nodes were labeled according to the gene 
names as reported by STRING database (Jensen et al., 2009). 
 






Figure 3.24: Interactome of RNP complex (after cross-linking, purification and enrichment) from 
HeLa nuclear extract assembled on MINX pre-mRNA. Interactome network was constructed 
based on the information from the experiments. The structural and functional relationships are 
shown as edges that are connecting individual proteins (nodes). Nodes were labeled according to 
the gene names as reported by STRING database (Jensen et al., 2009). 
 
After ethanol precipitation of the UV-cross-linked RNP complex, the pellets were 
dissolved in 1% (w/v) SDS in size exclusion buffer (as mentioned in section 
2.2.5.3 of materials and methods). Such high percentage of SDS, inhibit the 
activity of the enzymes which were used later in the protocol. So different 
percentages of SDS by w/v (1%, 0.1% and 0.05%) were tested for the efficient 
activity of trypsin. The HeLa nuclear extract proteins were ethanol precipitated 
and the pellets were diluted in the above mentioned SDS concentrations in SE 
running buffer and later digested with trypsin. The peptides were identified by 
mass spectrometry. The increasing number of identified peptides was found to be 
in the order of 0.05%>0.1%>1% (w/v) SDS. Keeping the dilution volume under 
consideration, the pulled-down H/E complex pellet dissolved in 1% (w/v) SDS in 
size exclusion buffer was diluted to 0.1% (w/v) SDS with SE running buffer. The 





proteins were digested with trypsin and the samples were again ethanol 
precipitated. The pellets were re-dissolved in 1% (w/v) SDS and diluted up to 
0.1% (w/v) SDS with size exclusion (SE) running buffer. The intact non-cross-
linked pre-mRNA and the pre-mRNA with cross-linked peptides were separated 
from the non-cross-linked peptides by size exclusion (SE) chromatography (as 
mentioned in section 2.2.5.3 of materials and methods). The elution profile of the 
size exclusion chromatography of both control a UV-irradiated samples did not 
display any noticeable difference due to the low cross-linking yield and relatively 
low resolution of the column. The fractions that contain RNA were pooled 
together and then administered to ethanol precipitation. The fractions were also 
analyzed by running them on the Bis-Tris gel followed by silver staining (as 
mentioned in section 2.2.1.10 of materials and methods). The silver stained gel of 
control sample showed sharp silver stained bands of PM5 pre-mRNA (lanes 
containing fractions 4-6) and peptides (lanes containing fractions 10-16) where as 
that of UV-irradiated sample displayed a smear of PM5 pre-mRNA along with the 
cross-linked peptides (lane containing fraction 4). A smear was also observed in 
the lane containing fraction 8 presumably due to the cross-linked peptides with 














Figure 3.25: Silver stained gels with their respective size exclusion chromatograms (Figure 
adopted from Qamar et al., 2015). (a) Silver stained gel of control sample fractions; (c) Silver 
stained gel of cross-linked sample fractions; (b) Size exclusion chromatogram of control sample 
fractions; (d) Size exclusion chromatogram of cross-linked sample fractions. In comparison of the 
4th fraction of control and cross-linking samples, a smear due to cross-linking of RNA is clearly 
visible in silver stained gel of cross-linking sample. 
 





The fractions containing RNA were pooled together and ethanol precipitated. For 
the unambiguous identification of the cross-linked peptide by mass spectrometry, 
the corresponding cross-linked nucleotide moiety was generated as small as 
possible. The pellets were dissolved in urea and the RNA was digested by using 
combination of nucleases. First by RNase A and T1 and then by benzonase so 
the RNA oligonucleotide should not be more than four nucleotides. The samples 
were then subjected to C18 reversed-phase chromatography to desalt the 
sample and to remove the non-cross-linked RNA from the cross-linked peptide-
oligonucleotide heteroconjugates. Making use of the phosphate backbone of the 
peptide-oligonucleotide heteroconjugate, the cross-links were enriched from 
residual non-cross-linked peptides by TiO2 solid phase extraction as mentioned in 
section 2.2.5.3 of materials and methods. The cross-links were analyzed by mass 
spectrometry (Figure 1.4). The data obtained was then analyzed by using 
OpenMS. The cross-linked peptide hits were identified by comparing with the 
control and after removing the true peptide hits as mentioned in section 2.2.8.2 of 
materials and methods. The candidate spectra of the cross-linked peptides were 
then manually validated. 
During the current studies, more than 3000 candidate cross-linked peptide hits 
generated by PM5 pre-mRNA and MINX pre-mRNA each, have been manually 
validated in order to filter out the false positive results from the true cross-linked 
peptide hits. More than 290 cross-links belonging to 123 peptides along with 
respective oligonucleotide moieties have been identified. In 87 of the cross-linked 
peptides the cross-linking site has been cut down to amino acid resolution. These 
cross-linked peptides belonged to 54 different proteins. The positions of these 
cross-linked peptides within their respective proteins revealed that most of them 
belong to the RBDs like RRMs and KH domains etc. (Table 3.7, Figure 3.26). 
This adds more authenticity to the results obtained from the present study. In 
addition to this the cross-linked peptides who have not been assigned to any 
RBDs can also be considered as a strong candidate for the discovery of novel 
RNA-binding motifs. 
 







Figure 3.26: The graphical representation of distribution of the cross-linking sites within RNA-
binding proteins along with their domains. The structures have been derived from 
UniProt/PROSITE (human) database. The ribosomal proteins are not included within the figure. 
The annotation of the symbols representing the domains/sites/protein are given on the lower right 
side of the figure.  























































phosphatase 2A 56 kDa 
regulatory subunit alpha 





































































































































































































































































































































































































































































- 593M(Ox)CLFAGFQR601 C594 U 
- 256GYFEYIEENK265 Y257 U 
Nucleolin/Origin recognition 
complex subunit 1/DNA-

































































































RRM1 371VFGNEIKLEKPK382 K377 U-H2O 
RRM2 458SISLYYTGEK467 Y462 U 













316INEIRQM(Ox)SGAQIK328 - U-H2O 





















































RRM3 411HQNVQLPR418 H411 U 
RRM4 
445NFQNIFPPSATLHLSNIPPSVSEEDLK471 - U-H2O 
Probable ATP-dependent 




































































































- 112YGPPSR117 Y112 U 
Continued...... 





















RRM 18VDNLTYR24 Y23 U 





















































































U1 small nuclear 























U1 small nuclear 









- 192LGGGLGGTR200 L196 ACU 
- 219YDERPGPSPLPHR231 Y219 U 












































Matrin-3 P43243 RRM2 525NYILM(Ox)R530 Y526 U 
Continued...... 





























































































40S ribosomal protein S2  P15880 - 










60S ribosomal protein L6  Q02878 - 238EKYEITEQR246 E238-K239 U-H2O 





Protein: Protein name; UniProt ID; UniProt ID of the identified protein; Motif/Domain: Location of the peptide within the protein structure; Peptide: Sequence of 
the cross-linked peptide along with its position within the protein sequence, the ones which were identified by using PM5 pre-mRNA their first position number 
was highlighted in grey and the ones which were identified by using MINX pre-mRNA their sequence was highlighted in yellow; Amino acid: One letter symbol 
of the cross-linked amino acid along with its position within the protein sequence. The amino acids highlighted in grey show the probable amino acids found to 
be cross-linked as the exact cross-linking site cannot be specified further; RNA: Nucleotides found to be cross-linked to the peptide.  
 






Soon after the emergence of pre-mRNA from its transcription site, it undergoes 
splicing, editing and polyadenylation, mediated by RBPs (RNA binding proteins) 
and trans-acting RNAs, present as RNPs. RNA in concert with the protein 
partners performs functions of considerable subtlety. Binding of proteins with 
RNA in fact determines the fate of the RNA from its synthesis to decay (Castello 
et al., 2012; Beckmann et al., 2016).  
Studies on RNA binders have corroborated the presence of protein domains with 
dual functionality, RNA binding activity and enzymatic properties (Walden et al., 
2006), foldings of unexplored function (Jia et al., 2008) and unbound protein 
sectors with ill-defined tertiary structure (Phan et al., 2011). Advanced scientific 
approaches have led to the exploration of entire repertoire of RBPs (Cléry & 
Allain, 2013). There are multiple copies of RNA binding domains possessing 
varied structural configurations to broaden the functional repertoire of RNA 
binding proteins, this in turn helps to accommodate enormous diversified 
substrates (Lunde et al., 2007).  
The work presented in the current study focused on two main objectives: 
1.  (a) Qualitative analysis of protein-RNA cross-links involving Brat-NHL-hb 
RNA complex and CWC2-U6/U4 snRNAs complex using conventional 
cross-linking method.  
(b) Qualitative analysis of protein-RNA cross-links derived from highly 
complex RNP assemblies isolated from HeLa nuclear extract by using the 
modified and optimized protocol. 
2. Quantitative studies of CWC2-U6/U4 snRNAs cross-links. 
In this chapter the implication of qualitative approach for the analysis of Brat-
NHL-hb RNA cross-links and CWC2-U6/U4 snRNAs cross-links has been 
discussed in conjunction with the strategy adopted for the quantitative studies of 
CWC2-U6/U4 snRNAs cross-links by using isotope labeled RNAs.  





Structural investigation through optimized method used in this study helped to 
elucidate interaction sites within large RNP complexes using UV induced cross-
linking approach. 
This investigation may help in determining the significance of mass spectrometric 
methods for identification and characterization of protein-RNA interactions in RNP 
complexes as well as in the prospective quantitative analysis of protein-RNA 
cross-links 
During the course of this research several RNP complexes studied have been 





















4.1 Cross-links from Brat-NHL-hb RNA Complex 
Various TRIM-NHL proteins like Drosophila Brat protein, C. elegans NHL-2 and 
LIN-41 proteins and mammalian TRIM71 etc. have been found in different RNP 
complexes (Duchaine et al., 2006; Hammell et al., 2009; Rybak et al., 2009; 
Wulczyn et al., 2010; Chang et al., 2012; Loedige et al., 2013). The interactions 
within these RNPs are either dependent on RNA (Hammell et al., 2009; Chang et 
al., 2012; Li et al., 2012) or the relevant NHL domain of the protein (Neumüller et 
al., 2008; Schwamborn et al., 2009; Chang et al., 2012; Loedige et al., 2013). 
Defining domain of the TRIM-NHL is a set of the NHL repeats. The NHL domain 
of TRIM-NHL proteins has been reported as RBD (Kwon et al., 2013). 
Previously it has been believed that the Pum protein directly interacts with the hb 
RNA and then along with Nos recruits the Brat via protein-protein interactions. 
During our studies it has been shown that the Brat protein directly binds to the hb 
RNA. The NHL domain of brain tumor protein (Brat), member of conserved family 
of TRIM-NHL proteins, has been identified as RBD. In order to find the RNA-
binding activity of Brat, the BRAT-NHL-hb RNA complex was in vitro assembled 
by incubating the in vitro transcribed hb RNA along with recombinantly expressed 
purified NHL domain of Brat.  
Using conventional UV-cross-linking method followed by mass spectrometry 
(MS), positively charged top surface of the NHL domain has been identified to 
contact RNA (Table 3.1 & Figure 3.2). The mutations of the cross-linked and 
selected amino acids residues located within the cross-linked peptides on this 
surface abrogated Brat-NHL binding to the hb mRNA in vitro and impaired 
translational repression by Brat in vivo (Loedige et al., 2014).  
Cross-linking site when cut down to the amino acid resolution, the exact amino 
acids in contact with the hb RNA or lying in close proximity to it are indicated. 
Five out of six identified cross-linked peptides are located on the top surface of 
the NHL domain. Within these peptides, seven amino acid residues were 
identified to be cross-linked, indicating their direct contact with or very close 
proximity to RNA. Among these, four residues were located on the top surface, 





whereas two others lied in a positively charged stretch at the circumference 
(Table 3.1 & Figure 3.2). 
Recently, it has been established that the Brat protein is recruited by the BoxA 
motif of NRE of hb RNA (Figure 3.3) (Loedige et al., 2015). The NHL domain of 
Brat is a six-bladed β propeller structure, similar to WD40 fold (Slack & Ruvkun, 
1998; Stirnimann et al., 2010; Edwards et al., 2003) and has a positively charged 
top surface showing the potential to bind negatively charged molecules like 
nucleic acids (Loedige et al., 2014). Numerous aromatic and positively charged 
residues that have the tendency to interact with the RNA, project from this top 
surface. This surface has been reported to be affected by the mutations which 
lead to the Brat mutant phenotype or abrogate Brat function (Arama et al., 2000; 


















4.2 Cross-links from CWC2-U4 and U6 snRNAs 
Complexes 
 
4.2.1 Identification of Cross-links from CWC2-U4 and U6 snRNAs 
Complexes 
Removal of non-coding introns from pre-mRNA and ligation of flanking coding 
regions called exons, are the essential events of splicing process for eukaryotic 
gene expression (Hayduk et al., 2012). Accurate and original protein coding 
capacity of the gene is conditional with the fact that how precisely and accurately 
the introns are removed to retain the originality of the gene (McGrail et al., 2009).  
Process of splicing is catalysed by spliceosomes that are comprised of numerous 
protein splicing factors as well as five small nuclear RNAs namely U1, U2, U4, U5 
and U6. A set of orderly interactions engenders the assembly of snRNPs onto 
pre-mRNA. The NineTeen Complex (NTC) which serves an important assistance 
for the spliceosomal snRNPs, has been considered as an essential component of 
active spliceosomes from yeast to humans (Villa & Guthrie, 2005). The release of 
U1 and U4 and the incorporation of NTC is indicative of the change of inactive 
state of spliceosome to active state (Hogg et al., 2010). Among the splicing 
factors, CWC2 is exclusively significant NTC associated protein that carries RRM 
(RNA recognition motif) and CCCH-type Zinc finger (ZnF) motifs for binding RNA 
(Ohi & Gould, 2002) in addition to Torus domain with motifs that has been 
reported to be capable of binding RNA.  
Data generated by using UV-cross-linking approach along with mass 
spectrometry for the CWC2-U4/U6 snRNAs complex, revealed total eighteen 
peptides of CWC2 protein cross-linked to U4/U6 snRNAs (Table 3.2 & Figure 
3.5). Seven of the identified cross-linked peptides have already been reported by 
Schmitzová et al., 2012 and eleven are the novel peptides that are found to be 
cross-linked with U4/U6 snRNAs during the current studies. Previously the C-





terminal domain of CWC2 protein has not been known for any RNA-binding 
activity but in the present studies, three peptides of the C-terminal domain i.e. 
225WANEDPDPAAQK236, 276TFPEASVDNVK286 and 315ENISSKPSVGK325 with 
amino acid residues W225, F277 and K320 have been tracked down to be cross-
linked with U4/U6 snRNAs. With the exception of one cross-linked peptide 
87CEYLHHIPDEEDIGK101, the cross-linking site has been reduced to the amino 
acid level in rest of the identified cross-linked peptides (Table 3.2). 
In the future, the mutation analysis of the identified cross-linked amino acid 
residues, if performed, can help in adding to the information regarding the 
association of CWC2 with any of the U4/U6 snRNAs of the spliceosome. 
 
4.2.2 Quantification of Cross-links from CWC2-U4 and U6 
snRNAs Complexes 
A relative quantification approach by using isotopically labeled RNAs was 
adopted during the present study to figure out whether the CWC2 as a single 
protein, and its domains in their individual entity, possess interaction affinity for 
any RNA or an impartial binding takes place. Relative quantification approach in 
this regard is quite amenable (Nikolov, et al., 2012). In vitro studies on CWC2 
have revealed nonspecific binding of RNAs with CWC2 (McGrail et al., 2009). 
RRM, Torus, ZnF domains and connector elements are the key factors involved 
during CWC2 interaction with RNAs (Schmitzová et al., 2012). 
Two sets of reciprocative experiments (Figure 3.6) elucidated sixteen peptides 
cross-linked to U4/U6 snRNAs in forward and reverse replicates (Table 3.3). 
Xcalibur software (mentioned in section 2.2.8.2 of materials and methods) has 
been used for relative quantitation of tracked down peptides. Three cross-linked 
peptides i.e. 106TEVLDCFGR114 of torus domain, 136TLYVGGIDGALNSK149 of 
RNP2 motif of RRM domain and 180NCGFVK185 of RNP1 motif of RRM domain, 
identified in all forward and reverse replicates were selected for further 
quantitative analysis. Under the defined parameters, log10 of peak areas 





calculated from XICs of individual cross-linked peptides of CWC2, along with all 
combinations of RNA moiety and charge states show that CWC2 is more inclined 
towards U4 snRNA for cross-linking as compared to U6 snRNA (Appendix Table 
6.6). This was inconcordance to previous studies by McGrail et al., 2009. 
However, the ratios calculated for previously mentioned three cross-linked 
peptides pointed to the similar cross-linking tendency of CWC2 toward both U4 
and U6 snRNAs in both sets of experiments (Figure 3.10).  
In an attempt to adopt a semi-automated approach, Skyline software tool was 
used for quantitative analysis. The log2 ratio of peak areas of the three individual 
cross-linked peptides, 106TEVLDCFGR114 of torus domain, 
136TLYVGGIDGALNSK149 of RNP2 motif of RRM domain and 180NCGFVK185 of 
RNP1 motif of RRM domain along with separate RNA moiety combinations but 
combined charge state of each RNA moiety, showed that CWC2 cross-links more 
efficiently with U4 snRNA as compared to U6 snRNA (Appendix Table 6.7 & 6.8).  
In an effort to explore the preference of any domain of CWC2 protein for U4 or 
U6 snRNAs, the relative quantification studies performed on log2 ratios of cross-
linked peptides of RNP1 and RNP2 motifs and Torus domains for both sets of 
forward and reverse experiments, by using Xcalibur and Skyline software 
revealed that there was no evidence of any cross-link preference by any of the 













4.3 Cross-links from HeLa Nuclear Extract 
 
4.3.1 Identification of Cross-links from MS2-MBP Protein 
Isolation of functional ribonucleoproteins in vitro is obtained through the 
combination of approaches like gel filtration with affinity chromatography 
employing bacteriophage MS2 coat protein. Spliceosome obtained so is used to 
determine the protein components of the spliceosome by mass spectrometry 
(Zhou & Reed, 2003). During the course of current studies, the RNP complex 
assembled by using HeLa nuclear extract was purified by MS2-MBP affinity 
purification method (Zhou & Reed, 2003). Data obtained by the MS analysis of 
the UV-cross-linked RNP complexes on LTQ Orbitrap Velos mass spectrometer 
was analysed by OpenMS. The affinity of the bacteriophage MS2 coat protein for 
its target MS2 RNA stem loops formed the basis of this method. The binding of 
MS2-MBP fusion protein to the MS2 RNA stem loops of target RNA has opened 
possibility to study the probable interaction sites of the aforementioned protein 
with RNA. 
Direct interaction of MBP with nucleic acids has not been reported till now. Two 
peptides of MS2 coat protein and twelve peptides of MBP were found to be 
involved in cross-linking with oligonucleotides (Table 3.4 & Figure 3.13). Cross-
linked amino acid residues for only seven peptides were screened out of fourteen 
cross-linked peptides. For the first time, the present studies have demonstrated 
that twelve peptides of MBP cross-link to uracil, whereby the lysine has been 
designated as the cross-linked amino acid residue.  
Crystal structure of monomeric MBP (Figure 3.13) shows two distinct globular N 
and C domains, joined by three segments. Each domain is composed of central 
β-pleated sheet, flanked on both sides by α-helices (Quiocho et al., 1997). Most 
of the cross-linked peptides are found to be lying in the region of α-helices. Out of 
twelve cross-linked peptides, seven have been occupying N domain, four 





occupying C domain and one occupying the third segment joining the two 
domains.  
In the current studies, two peptides of MS2 protein were found to be cross-linked 
to uracil. The results are concomitant to those reported by Budowsky et al., 1976, 
according to which lysine residues in coat protein were found to cross-link to the 
genomic nucleic acid upon UV-irradiation. 
Crystal structure of MS2 coat protein is composed of three coat protein dimers 
with a stretch of RNA (Figure 3.14). Each monomer is composed of five stranded 
β-sheet and two α-helical segments. The cross-linked lysine residues K442 and 
K447 of peptides 438KYTIKVEVPK447 and 443VEVPKGAWR451 respectively are 
found to be lying in β-sheet in closer proximity to cytosine at position −5 of 
nucleotides in RNA in the crystal structure. Grahn et al., 1999 reported that K442 
is among the probable amino acids that formed cross-links with nucleotides and 
the substitution of wild type uracil by cytosine at position −5 resulted in stronger 
binding of RNA hairpin to MS2 coat protein so from the present study, it can be 
anticipated that K442 is the probable amino acid and uracil (in case of 
contamination)/cytosine (in case of bait RNA) at position −5 is the probable 
nucleotide taking part in cross-linking.  
 
4.3.2 Identification of Uracil Fragments and Adducts 
To determine the specific and definite cross-linking sites, mass spectrometric 
analysis of peptide oligonucleotide heteroconjugates is carried out. Cross-linking 
in combination to mass spectrometry provides an ideal paradigm to elucidate 
uncharacterized and unidentified RNA-protein cross-links (Kühn-Holsken et al., 
2005). UV-induced cross-linking assists in generating direct zero-length cross 
links without intervening linker. 
Keeping in view that the cross-links are additive in nature, the peptide-
oligonucleotide cross-links were identified by using OpenMS. In addition to the 
peptide signals, the signals of characteristic marker ions produced by 





fragmentation of the cross-linked nucleotides can also be observed in the MS2 
spectra. Furthermore, the nucleotide fragments can be observed as adducts 
cross-linked to an amino acid residue resulting in the shifting of ion series within 
the spectra. The identification of these fragments and adducts may add to the 
authenticity of cross-linking data generated by the mass spectrometric analysis of 
the cross-links. 
During the cross-linking analysis of RNP complex assembled by incubating 
labeled/non-labeled (PM5/MINX) pre-mRNA with HeLa nuclear extract proteins 
followed by the mass spectrometric and data analysis, revealed that the uracil 
nucleotide is the most frequently cross-linked nucleotide with the peptide 
moieties. In the previous studies numerous uracil nucleotide fragments have 
been reported (Table 3.5 & 3.6). However, in the current studies, there have been 
few signals in the MS2 spectra, which are assumed to be generated by the 
fragmentation of uracil. For this, the target signals generated by using isotopically 
labeled uracil (13C, 13C15N and 5-D1, ribose-3‘, 4‘, 5‘, 5‘-D4 labeled uracil) were 
compared to estimate the elemental composition. 
The peptide 375DYAFVHFEDR384 derived from heterogeneous nuclear 
ribonucleoprotein R protein was found to be cross-linked to uracil nucleotide. 
Upon CID fragmentation of nucleotides, the loss of phosphate group and neutral 
loss of water are usually observed. By keeping all these points in view the 
elemental composition of the uracil nucleotide fragment of interest can be 
predicted i.e. C8H6N2O3 generated via combined loss of two water (H2O) 
molecules, one phosphate group (HPO3) and formaldehyde (CH2O) molecule 
(Figure 3.17). This result is in accordance with the previous studies conducted on 
the pseudouridine fragmentation in which the loss of two water molecules and 
CH2O from the sugar moiety give rise to a product ion at m/z 179. 
The peptide 215YQVIGK220 of mitochondrial endonuclease G is found to be cross-
linked to uracil nucleotide with the loss of H2O molecule. Its MS2 spectrum shows 
relatively high intensity ion signal at m/z 175.0714, which is expected to be 
generated by the fragmentation of cross-linked uracil nucleotide. The 





comparative analysis among the MS2 spectra of the same cross-linked peptide 
with labeled and non-labeled uracil shows that the elemental composition of the 
target ion signal is C6H10N2O4 (Figure 3.18 & 3.19). 
The MS2 spectrum of the cross-linked peptide 215YQVIGK220 with U-H2O shows a 
shift in b ion series with the mass of 208 Da. When the MS2 spectra of the same 
cross-linked peptide along with differentially labeled and non-labeled uracil have 
been compared, the elemental composition of the target adduct was deduced to 
be C9H8N2O4 which was probably generated due to the loss of two H2O and one 
HPO3 molecules from the intact uracil nucleotide (Figure 3.18 & 3.20). In 1969, 
Rice & Dudek have also reported a similar fragment of 208 Da generated by the 
fragmentation of pseudouridine however in the current studies it has been 
observed by the fragmentation of uracil. 
 
4.3.3 Identification of RNPs Isolated from HeLa Nuclear Extract 
and their Cross-linking Analysis 
Biological and mechanistic functions of RNA-proteins complexes are crucial to 
many biological processes (Kramer et al., 2014). UV-induced cross-linking 
approach coupled with mass spectrometry analysis have paved way for the 
identification of proteins in direct contact with RNA (Castello et al., 2012; Klass et 
al., 2013). Progress and advancements in resolving different elements of RNA-
protein complexes will contribute to the identification of different RBPs as well as 
will help in predicting the binding time of a set of given RBPs to an individual RNA 
(Klass et al., 2013). Such approaches will ultimately provide more precise 
information of the function of RNA-protein complexes, including how does the 
assemblage of the complexes take place and how they modulate cellular 
function. 
Previous studies have established the specificity of combining UV-induced cross-
linking and mass spectrometry in structural investigations of moderately complex 
RNA-protein complexes (Urlaub et al., 1997; Kühn-Hölsken et al., 2010; Kramer 





et al., 2011; Mozaffari-Jovin et al., 2012) and also through mutagenesis studies of 
identified cross-linked amino acids in single RNPs (Ghalei et al., 2010; Müller et 
al., 2011). 
In the present studies, the emphasis has been laid in establishing a method for 
the interaction analysis of highly complex RNP complexes, as in the current case 
the RNP complex isolated from the HeLa nuclear extract. For this the already 
existing protocols used for the analysis of small and less complex samples have 
been modified and optimized. For the isolation of the RNP complex, RNA-centric 
methodology has been adopted by using pre-mRNAs tagged with MS2-binding 
RNA stem loops (Deckert et al., 2006). The isolated complex has been cross-
linked by UV-irradiation at 254 nm for 10 min. In order to improve the 
identification by mass spectrometry, the cross-linked peptides have been 
enriched from the non-cross-linked RNA and peptides by using size exclusion 
chromatography, C18 reversed-phase chromatography and TiO2 solid phase 
extraction (Urlaub et al., 1995; Urlaub et al., 2002; Luo et al., 2008). Later on the 
enriched peptide-RNA oligonucleotide heteroconjugates have been analyzed by 
mass spectrometry. 
Our results emphasize on the use of the established method to identify direct 
interaction sites within proteins-RNA complexes, and this has considerably 
broadened the scope of preceding studies in which mass spectrometry had been 
able to identify the entire proteins rather than the specific cross-linking sites 
(Baltz et al., 2012; Castello et al., 2012; Klass et al., 2013; Mitchell et al., 2013). 
The comparative study involving the cross-linking sites and their relative 3D 
structures signifies the structural relevance of cross-linking approach as well as 
providing an opportunity for predicting the novel RNA-binding sites. 
There are considerable differences between previously reported methods and our 
adopted approach. The interactions that are described by computationally 
predicted RNA-binding sites, may not be recognized in a particular RNA-protein 
complex.  





The current experimental approach helps in improving computational speculation 
of RNA-binding motifs in proteins that contain multiple RNA interaction sites 
(Schmitzová et al., 2012) as well as the proteins that constitute the composite 
RNA interaction site via inter protein interactions (Urlaub et al., 2001). The cross-
linked proteins isolated from HeLa nuclear extract during this study are found to 
belong to mainly H/E complex (Wahl et al., 2008). The number of cross-links 
identified i.e. more than 290 belonging to 123 peptides along with respective RNA 
oligonucleotide combinations belonging to more than 54 proteins mostly located 
in the RBDs, has provided the new perspectives in studying the RNP complexes 





















4.4 Conclusion and Future Perspectives 
While much of the work has been done during the past decade to establish the 
methodologies for the identification and investigation of the interactions in RNA-
protein complexes, there exist considerable challenges that are still needed to be 
addressed to identify cross-linked peptides, cross-linking sites and cross-linked 
RNA oligonucleotide moieties with RNA binding proteins. 
Generating the accurate predictions about protein complexes that interact with 
RNA is an important step in understanding the biological functions and 
mechanisms. One of the main objectives of current study was to combine the 
results of different approaches for identification of the cross-linked regions within 
RNP complexes and explore the caveats and considerations required regarding 
adoption of method to identify cross-linked regions up to peptide or amino acid 
level. This was required to build a clear picture of the RNA-protein complex 
functionality, considering the assemblage of these complexes and their role in the 
modulation of cellular functions.  
Vast heterogeneity exists in the RNA protein interactions within RNP complexes. 
Novel approaches to identify and validate intermolecular cross-links in RNPs may 
not only help in predicting the exact protein entity (peptide/amino acid) in already 
described RBDs/RRMs/RBMs involved in interacting with RNA but will also help 
in predicting the regions or domains that interact with RNA and have not been 
reported before. Relative quantitative analysis of RNA-protein cross-links has 
been carried out during the course of the study that helped to quantitatively 
analyse the interactions of the protein as well as of its domains with the cross-
linked RNA. Manual interpretation of the MS/MS spectra has contributed 
promising improvement in data analysis strategy.  
The studies conducted during the research work have contributed in the 
identification and characterization of protein-RNA interactions within the 
aforementioned complexes and also provided the quantitative insight into the 
protein-RNA interactions. The methods adapted will assist in the qualitative as 
well as quantitative interaction analysis of both in vivo and in vitro assembled 





large RNP complexes. Fully automated system for quantitative data analysis of 
RNA-protein cross-links is required to handle the large cross-linking data sets. 
The results will also contribute in improving the data analysis approach for 
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ANNOTATION OF MS/MS SPECTRA 
The MS/MS spectra of cross-linked heteroconjugates were annotated according 
to the established nomenclature for peptide fragments described previously 
(Roepstorff & Fohlman, 1984; Biemann, 1990). In addition, neutral loss of water 
from both peptide and RNA fragments was annotated with a superscript “0”, the 
immonium ion with “IM” and the mass increment of 151.9966 Da due to DTT 
(C4H8S2O2) (Zaman et al., 2015) with “152”. Annotations of RNA adducts and 
RNA marker ions are given in the tables 6.1 and 6.2 respectively together with 
calculated masses and m/z values. 
 
Table 6.1: List of RNA (fragment) adducts with their assigned abbreviations and calculated 
masses.  
 





C3O # 51.9949 
Uracil-H2O U'0 94.0167 
Uracil U' 112.0273 
Uridin-H2O U0-p 226.0590 
Uridin Up 244.0695 
Uridinmonophosphate-H2O U0 306.0253 
Uridinmonophosphate U 324.0359 
 
Table 6.2: List of RNA marker ions with their symbols and calculated m/z. 
 
RNA marker ions Symbol Calculated m/z 
Adenin A' 136.0623 
Adenosinmonophosphate-H2O A0 330.0603 
Adenosinmonophosphate A 348.0709 
Cytosin C' 112.0511 
Cytidinmonophosphate-H2O C0 306.0491 
Cytidinmonophosphate C 324.0597 
Guanin G' 152.0572 
Guanosinmonophosphate-H2O G0 346.0553 
Guanosinmonophosphate G 364.0658 
Uracil U' 113.0351 
Uridine-H2O U0-p 227.0667 
Uridinmonophosphate-H2O U0 307.0331 
Uridinmonophosphate U 325.0437 





Table 6.3: RNA-protein cross-links identified from Brat-NHL-hb RNA complex followed by corresponding MS/MS spectra. 
 







z m/z(calc) m/z(exp) 
Δm 
(ppm) 
top/II 824DSQLLYPNR832 Y829 U 1104.5563 324.0359 1428.5922 2 715.3039 715.3053 1.96 
top/II 815FQFGECGK822 C820 U 914.3956 324.0359 1238.4315 2 620.2236 620.2236 0 
bottom/II 804IQIFDKEGR812 K809 U-H2O 1104.5927 306.0253 1410.618 2 706.3168 706.3162 -0.85 
top/III 865KFGATILQHPR875 865K/F866 U-H2O 1266.7196 306.0253 1572.7449 3 525.2561 525.2550 -2.10 
top/IV 913HLEFPNGVVVNDK925 F916 U 1466.7517 324.0359 1790.7874 2 896.4015 896.3995 -2.23 
top/IV 885IIVVECK891 C890 U 802.4622 324.0359 1126.4981 2 564.2569 564.2564 -0.89 
Surface/Blade: Location of the peptide within the protein structure; Peptide: Sequence of the cross-linked peptide along with its position within the protein 
sequence; Amino acid: One letter symbol of the cross-linked amino acid along with its position within the protein sequence. The amino acids highlighted in 
grey show the probable amino acids found to be cross-linked as the exact cross-linking site cannot be specified further; RNA: Nucleotide found to be cross-
linked to the peptide; m(calc) Peptide: Theoretical mass of the cross-linked peptide; m(calc) RNA: Theoretical mass of the cross-linked RNA; m(calc) Cross-
link: Calculated mass of the RNA-protein cross-link; z: Charge state of the cross-link; m/z(calc): Calculated m/z of the cross-link by using formula m+z(mH)/z; 























































z m/z(calc) m/z(exp) 
Δm 
(ppm) 
Torus 8SAKVQVK14 K10 U-H2O 758.4650 306.0253 1064.4903 2 533.2530 533.2529 -0.19 
Torus 37WSQGFAGNTR46 W37 U 1122.5206 324.0359 1446.5565 2 724.2861 724.2900 5.38 
Torus 106TEVLDCFGR114 C111 U+152 1038.4804 476.0325 1514.5129 2 758.2643 758.2612 -4.09 
ZnF 87CEYLHHIPDEEDIGK101 - U+152 1796.8039 476.0325 2272.8364 3 758.6199 758.6200 0.13 
connector element 115EKFADYR121 K116 U-H2O 927.4450 306.0253 1233.4703 2 617.7430 617.7452 3.56 
connector element 117FADYR121 Y120 UA 670.3074 653.088 1323.3954 2 662.7055 662.7051 -0.61 
connector element 122EDM(Oxidation)GGIGSFR131 S129 U 1083.4654 324.0359 1407.5013 2 704.7585 704.7581 -0.57 
RRM/RNP2 136TLYVGGIDGALNSK149 Y138 U 1406.7405 324.0359 1730.7764 2 866.3960 866.3917 -4.96 
RRM 150HLKPAQIESR159 K152 U-H2O 1177.6567 306.0253 1483.6820 3 495.5685 495.5700 3.03 
RRM 162FVFSR166 F162 U-H2O 654.3489 306.0253 960.3742 2 481.1949 481.1945 -0.83 
RRM 167LGDIDRIR174 R172 UA 956.5402 653.088 1609.6282 3 537.5505 537.5502 -0.56 
RRM 188YQANAEFAK196 Y188 U 1040.4926 324.0359 1364.5285 2 683.2721 683.2708 -1.91 
RRM 217EGTGLLVK224 L222 U-H2O 815.4752 306.0253 1121.5005 2 561.7581 561.7579 -0.36 
RRM 217EGTGLLVKWANEDPDPAAQK236 K224 U-H2O 2138.0643 306.0253 2444.0896 3 815.7043 815.7024 -2.33 
RRM/RNP1 180NCGFVK185 C181 U+152 666.3159 476.0325 1142.3484 2 572.1820 572.1807 -2.27 
CTD 225WANEDPDPAAQK236 W225 U 1340.5996 324.0359 1664.6355 2 833.3256 833.3300 5.28 
CTD 276TFPEASVDNVK286 F277 U 1205.5927 324.0359 1529.6286 2 765.8221 765.8209 -1.56 
CTD 315ENISSKPSVGK325 K320 U-H2O 1144.6087 306.0253 1450.6340 2 726.3248 726.3245 -0.42 
Domain: Location of the peptide within the protein structure; Peptide: Sequence of the cross-linked peptide along with its position within the protein sequence; 
Amino acid: One letter symbol of the cross-linked amino acid along with its position within the protein sequence; RNA: Nucleotide found to be cross-linked to 
the peptide; m(calc) Peptide: Theoretical mass of the cross-linked peptide; m(calc) RNA: Theoretical mass of the cross-linked RNA; m(calc) Cross-link: 
Calculated mass of the RNA-protein cross-link; z: Charge state of the cross-link; m/z(calc): Calculated m/z of the cross-link by using formula m+z(mH)/z; 
m/z(exp): Observed m/z of the cross-link; Δm (ppm): Calculated mass error in ppm by using formula [m/z(exp) −m/z(calc)/m/z(calc)] × 106. 
 


























































































































































z m/z(calc) m/z(exp) 
Δm 
(ppm) 
Torus 37WSQGFAGNTR46 W37 U 1122.5206 333.0661 1455.5867 2 728.8012 728.8007 -0.69 
Torus 47FVSPFALQPQLHSGK61 F47 U-H2O 1654.8830 306.0253 1960.9083 3 654.6439 654.6422 -2.6 
Torus 106TEVLDCFGR114 C111 U+152 1038.4804 485.0627 1523.5431 2 762.7793 762.7789 -0.53 
ZnF 87CEYLHHIPDEEDIGK101 - U+152 1796.8039 485.0627 2281.8666 3 761.6300 761.6309 1.18 
RRM/RNP2 136TLYVGGIDGALNSK149 Y138 U 1406.7405 333.0661 1739.8066 2 870.9111 870.9103 -0.92 
RRM 188YQANAEFAK196 Y188 U 1040.4926 333.0661 1373.5587 2 687.7872 687.7857 -2.18 
RRM/RNP1 180NCGFVK185 C181 U+152 666.3159 485.0627 1151.3786 2 576.6971 576.6959 -2.08 
CTD 310KNISR314 K310 UA-H2O 616.3656 635.078 1251.4436 2 626.7296 626.7290 -0.96 
Domain: Location of the peptide within the protein structure; Peptide: Sequence of the cross-linked peptide along with its position within the protein sequence; 
Amino acid: One letter symbol of the cross-linked amino acid along with its position within the protein sequence; RNA: Nucleotide found to be cross-linked to 
the peptide; m(calc) Peptide: Theoretical mass of the cross-linked peptide; m(calc) RNA: Theoretical mass of the cross-linked RNA; m(calc) Cross-link: 
Calculated mass of the RNA-protein cross-link; z: Charge state of the cross-link; m/z(calc): Calculated m/z of the cross-link by using formula m+z(mH)/z; 
m/z(exp): Observed m/z of the cross-link; Δm (ppm): Calculated mass error in ppm by using formula [m/z(exp) −m/z(calc)/m/z(calc)] × 106. 
 

































































Replica_1 Replica_2 Replica_3 
F-L F-H R-L R-H F-L F-H R-L R-H F-L F-H R-L R-H 
Torus 8SAKVQVK14 7.2 - 7.3 - 6.6 - 7 - 7 - 7.2 - 
Torus 37WSQGFAGNTR46 - - - - - 6.6 - - - - - - 
Torus 47FVSPFALQPQLHSGK61 - - - - 5.7 - - - - - - - 
Torus 106TEVLDCFGR114 7.9 8.2 8.4 7.8 7.9 8.2 8.3 7.3 7.1 7.5 8 7.4 
ZnF 87CEYLHHIPDEEDIGK101 - 7.5 - - - 6.8 6.7 - - - - - 
connector element 122EDM(Oxidation)GGIGSFR131 - - 5.7 - - - 6.9 - - - 6.8 - 
connector element 115EKFADYR121 - - 7.2 - 7.3 - - - - - - - 
RRM/RNP2 136TLYVGGIDGALNSK149 8.5 8.5 8.7 8 8.7 8.8 9.1 8.2 8.4 8.5 8.8 8.1 
RRM 150HLKPAQIESR159 - - - - 8 - 8.2 - - - - - 
RRM 188YQANAEFAK196 - - 7.2 - 7.1 6.1 8 - 6 7.3 7.8 - 
RRM 217EGTGLLVK224 - - - - - - 7.2 - 6.7 - 7.4 - 
RRM 217EGTGLLVKWANEDPDPAAQK236 6.9 - 7.2 - 7 - 7 - - - - - 
RRM/RNP1 180NCGFVK185 8.6 8.7 9.1 8.7 8 8.8 8.8 8.1 8.2 8.5 8.8 8.4 
CTD 225WANEDPDPAAQK236 6.2 - 7 - 6.2 - 7.1 - - - 7.5 - 
CTD 310KNISR314 6.7 - 7.1 - 6.5 - - - - - - - 
CTD 315ENISSKPSVGK325 7.5 - 7.8 - 7.8 - 8.1 - 7.4 - 7.7 - 
Domain: Location of the peptide within the protein structure; Peptide: Sequence of the cross-linked peptide along with its position within the protein sequence; 
Replica: Three sets of replicates with forward and reverse labeled samples in each set; F-L: The log10 of peak areas of the U4/U6 snRNA-CWC2 cross-links 
in forward replicate with light label; F-H: The log10 of peak areas of the U4/U6 snRNA-CWC2 cross-links in forward replicate with heavy label; R-L: The log10 
of peak areas of the U4/U6 snRNA-CWC2 cross-links in reverse replicate with light label; R-H: The log10 of peak areas of the U4/U6 snRNA-CWC2 cross-
links in reverse replicate with heavy label. 
*The area of each cross-linked peptide along with its miss-cleavage state and all of the charge states (+2 and +3) and RNA moiety combinations have been 
added and then their log10 have been calculated. 
 
 





Table 6.7: The logarithmic (log2) ratio of peak areas (Appendix A.6.33-A.6.47) of the U4/U6 snRNA-CWC2 cross-links in quantitative mass 
spectrometric analysis, calculated by using Skyline. 
 
Domain Peptide RNA z 
Replica_1 Replica_2 Replica_3 
Median SD 
F R F R F R 
Torus 
106TEVLDCFGR114 U 2 0 0 1.48 0 0 0 0 0.60 
U+152 2 0.61 1.76 0.28 2.45 0.55 2.06 1.18 0.92 
RRM/RNP2 
136TLYVGGIDGALNSK149 U 2 -0.07 1.72 0.20 2.44 0.01 1.90 0.96 1.11 
UA 2 0.03 3.34 -0.10 3.53 -1.56 0 0.02 1.88 
3 -0.10 3.37 -0.07 3.83 0.43 0 - - 
UAA 2 0 0 0.86 0 0 0 0 1.12 
3 0.46 0 0.28 3.91 0 0 - - 
UG 2 1.26 3.01 0.32 2.85 0.32 2.35 1.80 1.27 
3 1.68 2.83 0.30 3.37 0.57 3.14 - - 
134NKTLYVGGIDGALNSK149 U-H2O 2 0 0 0 0 0 0 0 0 
3 0 0 0 0 0 0 - - 
RRM/RNP1 
180NCGFVK185 U 2 -0.37 0 0 0 0.90 2.42 0 1.03 
U+152 2 -0.13 0.97 0.08 1.60 0.55 1.22 0.76 0.67 
UA 2 1.07 0.34 0.46 3.13 1.14 1.89 1.10 1.04 
UA+152 2 -0.11 2.29 0 2.42 0.30 1.52 0.91 1.15 
UAA 2 0 0 0 0 0 0 0 0 
UAA+152 2 2.24 0 1.02 3 0 0 0 1.07 
3 0 0 1.62 0 0 0 - - 
UG 2 0 2.84 0 0 0.28 2.45 0.14 1.34 
UG+152 2 0 0 0.19 2.62 0.85 1.82 0.52 1.09 
Domain: Location of the peptide within the protein structure; Peptide: Sequence of the cross-linked peptide along with its position within the protein sequence; 
RNA: Nucleotide found to be cross-linked to the peptide; Replica: Three sets of replicates with forward and reverse labeled samples in each set; F: The log2 
ratio of peak areas of the U4/U6 snRNA-CWC2 cross-links in forward replicate; R: The log2 ratio of peak areas of the U4/U6 snRNA-CWC2 cross-links in 
reverse replicate; Median: Median of the log2 ratio of peak areas of the peptide in forward and reverse replicates with all charge states (+2 and +3) with each 
cross-linked oligonucleotide combination; SD: Standard deviation of the median calculated. 
 





Table 6.8: The logarithmic (log2) ratio of peak areas (Appendix A.6.33-A.6.47) of the U4/U6 snRNA-CWC2 cross-links in quantitative mass 
spectrometric analysis, calculated by using Skyline. (With Imputation) 
 
Domain Peptide RNA z 
Replica_1 Replica_2 Replica_3 
F R F R F R 
Torus 
106TEVLDCFGR114 U 2 20.17 21.12 1.48 26.87 24.12 22.58 
U+152 2 0.61 1.76 0.28 2.45 0.55 2.06 
RRM/RNP2 
136TLYVGGIDGALNSK149 U 2 -0.07 1.72 0.20 2.44 0.01 1.90 
UA 2 0.03 3.34 -0.10 3.53 -1.56 27 
3 -0.10 3.37 -0.07 3.83 0.43 27.27 
UAA 2 0 0 0.86 25.96 0 0 
3 0.46 25.41 0.28 3.91 0 23.73 
UG 2 1.26 3.01 0.32 2.85 0.32 2.35 
3 0.68 2.83 0.30 3.37 0.57 3.14 
134NKTLYVGGIDGALNSK149 U-H2O 2 -21.71 23.58 -24.83 25.31 0 19.34 
3 -22.58 24.45 -25.11 25.28 0 0 
RRM/RNP1 
180NCGFVK185 U 2 -0.37 22.37 21.31 24 0.90 2.42 
U+152 2 -0.13 0.97 0.08 1.60 0.55 1.22 
UA 2 1.07 0.34 0.46 3.13 1.14 1.89 
UA+152 2 -0.11 2.29 0 2.42 0.30 1.52 
UAA 2 0 17.40 23.87 23.97 0 0 
UAA+152 2 2.24 27.55 1.02 3 0 0 
3 24.73 26.62 1.62 24.48 0 0 
UG 2 0 2.82 0 26.82 0.28 2.45 
UG+152 2 26.51 26.50 0.19 2.62 0.85 1.82 
Domain: Location of the peptide within the protein structure; Peptide: Sequence of the cross-linked peptide along with its position within the protein sequence; 
RNA: Nucleotide found to be cross-linked to the peptide; Replica: Three sets of replicates with forward and reverse labeled samples in each set; F: The log2 
ratio of peak areas of the U4/U6 snRNA-CWC2 cross-links in forward replicate; R: The log2 ratio of peak areas of the U4/U6 snRNA-CWC2 cross-links in 
reverse replicate. 
* The missing values of peak area were imputed with “1” and then ratios were calculated. 
 





The extracted ion chromatograms (XICs) of the U4/U6 snRNA-CWC2 cross-links in quantitative mass spectrometric analysis by using Skyline. 
A.6.33: TEVLDCFGR+U 
 


























































































































27KFEKDTGIK35 K30 U-H2O 1064.5865 306.0253 1370.6118 3 457.8784 457.8761 -5.02 
31DTGIKVTVEHPDK43 K35 U-H2O 1437.7463 306.0253 1743.7716 3 582.2650 582.2641 -1.54 
36VTVEHPDKLEEK47 K43 UA-H2O 1422.7354 635.078 2057.8134 3 686.9456 686.9440 -2.33 
68FGGYAQSGLLAEITPDKAFQDK89 K84 U-H2O 2355.1746 306.0253 2661.1999 3 888.0744 888.0703 -4.62 
121DLLPNPPKTWEEIPALDK138 124P-T129 U-H2O 2075.0938 306.0253 2381.1191 3 794.7141 794.7142 0.12 
129TWEEIPALDKELK141 138K/E139 U-H2O 1570.8242 306.0253 1876.8495 3 626.6243 626.6250 1.12 
275ELAKEFLENYLLTDEGLEAVNK296 275E-L285 U-H2O 2537.2900 306.0253 2843.3153 3 948.7795 948.7779 -1.68 
279EFLENYLLTDEGLEAVNKDKPLGAVALK306 285L-K296 U-H2O 3088.6331 306.0253 3394.6584 3 1132.5606 1132.5640 3.00 
297DKPLGAVALK306 297D/K298 U-H2O 1010.6123 306.0253 1316.6376 2 659.3266 659.3304 5.76 
307SYEEELAKDPR317 314K/D315 U-H2O 1335.6306 306.0253 1641.6559 3 548.2264 548.2258 -1.09 
356QTVDEALKDAQTNSSSVPGR375 K363 U-H2O 2102.0239 306.0253 2408.0492 3 803.6908 803.6930 2.73 
364DAQTNSSSVPGRGSIEGR381 370S-R375 UCA 1816.8663 958.13 2774.9963 3 926.0065 926.0037 -3.02 
MS2 
(P03612) 
438KYTIKVEVPK447 K442 U-H2O 1203.7226 306.0253 1509.7479 3 504.2571 504.2557 -2.77 
443VEVPKGAWR451 K447 U-H2O 1040.5766 306.0253 1346.6019 2 674.3087 674.3092 0.74 
Protein (UniProt ID): Protein name along with its UniProt ID; Peptide: Sequence of the cross-linked peptide along with its position within the protein sequence; 
Amino acid: One letter symbol of the cross-linked amino acid along with its position within the protein sequence. The amino acids highlighted in grey show the 
probable amino acids found to be cross-linked as the exact cross-linking site cannot be specified further; RNA: Nucleotide found to be cross-linked to the 
peptide; m(calc) Peptide: Theoretical mass of the cross-linked peptide; m(calc) RNA: Theoretical mass of the cross-linked RNA; m(calc) Cross-link: 
Calculated mass of the RNA-protein cross-link; z: Charge state of the cross-link; m/z(calc): Calculated m/z of the cross-link by using formula m+z(mH)/z; 
m/z(exp): Observed m/z of the cross-link; Δm (ppm): Calculated mass error in ppm by using formula [m/z(exp) −m/z(calc)/m/z(calc)] × 106. 
 
 
































































































Table 6.10: Selective RNA-protein cross-linking hits, identified from RNP complex from HeLa nuclear extract and their calculations. 
 










z m/z(calc) m/z(exp) 
Δm 
(ppm) 
ATP-dependent RNA helicase 
DDX3X/DDX3Y/Probable ATP-





U 1351.6264 324.0359 1675.6623 2 838.8389 838.8421 3.81 
ELAV-like protein 1 
VAGHSLGYGFVNYVTAK - UU 1781.9100 630.0612 2411.9712 3 804.9982 804.9986 0.49 
DANLYISGLPR Y109 U 1217.6404 324.0359 1541.6763 2 771.8459 771.8444 -1.94 
GVAFIR F151 UU 661.3911 630.0612 1291.4523 2 646.7339 646.7335 -0.61 
Endonuclease G, mitochondrial YQVIGK Y215-Q216 U-H2O 706.4013 306.0253 1012.4266 2 507.2211 507.2232 4.14 
Far upstream element-binding 
protein 2 
M(Ox)ILIQDGSQNTNVDKPLR G273-S274 U 2057.0575 324.0359 2381.0934 3 794.7056 794.7044 -1.50 
CGLVIGR C436 U 716.4003 324.0359 1040.4362 2 521.2259 521.2253 -1.15 
Far upstream element-binding 
protein 3 
CGLVIGK C366 U 688.3941 324.0359 1012.4300 2 507.2228 507.2238 1.97 
H/ACA ribonucleoprotein complex 
subunit 4 
IMLPGVLR M316 AU-H2O 897.5469 635.0778 1532.6247 3 511.8827 511.8815 -2.34 
Heterogeneous nuclear 
ribonucleoprotein A0 
AVSREDSARPGAHAK - UGA 1550.7913 998.1358 2548.9271 4 638.2395 638.2401 0.94 
Heterogeneous nuclear 
ribonucleoprotein A1 
NQGGYGGSSSSSSYGSGR Y366 U 1693.6928 324.0359 2017.7287 2 1009.8721 1009.8710 -1.08 
Heterogeneous nuclear 
ribonucleoprotein A1/A1-like 2 
LFIGGLSFETTDESLR F23/F23 AU-H2O 1783.8991 635.0778 2418.9769 3 807.3334 807.3330 -0.49 
GFAFVTFDDHDSVDK - AU 1698.7525 653.0884 2351.8409 3 784.9548 784.9534 -1.78 
AVSREDSQRPGAHLTVK - U 1849.9758 324.0359 2174.0117 4 544.5107 544.5093 -2.57 
IEVIEIM(Ox)TDRGSGK R140/R140 U 1562.7973 324.0359 1886.8332 2 944.4244 944.4310 6.98 
IEVIEIMTDR M137/M137 U 1217.6325 324.0359 1541.6684 2 771.842 771.8428 1.03 
Heterogeneous nuclear 




U 732.4533 324.0359 1056.4892 2 529.2524 529.2517 -1.32 
Continued...... 
 




















IETIEVMEDR M158 U 1233.5910 324.0359 1557.6269 2 779.8212 779.8226 1.79 
AVSREDSVKPGAHLTVK - U 1792.9794 324.0359 2117.0153 4 530.2616 530.2609 -1.32 
Heterogeneous nuclear 
ribonucleoprotein A/B 
IFVGGLNPEATEEK F157 U 1502.7616 324.0359 1826.7975 2 914.4065 914.4047 -1.96 
EVYQQQQYGSGGR Y240 U 1498.6800 324.0359 1822.7159 2 912.3657 912.3638 -2.08 
GFGFILFK - AU 927.5217 653.0884 1580.6101 2 791.3128 791.314 1.51 
GFVFITFK 
F197 or F199 
or F202 
U 957.5323 324.0359 1281.5682 2 641.7919 641.7918 -0.15 
M(Ox)FVGGLSWDTSK W78 U 1342.6226 324.0359 1666.6585 2 834.3370 834.3350 -2.39 
Heterogeneous nuclear 
ribonucleoproteins A2/B1 
AVAREESGKPGAHVTVK R99 U 1734.9376 324.0359 2058.9735 4 515.7511 515.7504 -1.35 
EESGKPGAHVTVK G103-K104 U-H2O 1337.6938 306.0253 1643.7191 3 548.9142 548.9133 -1.63 
GFGFVTFDDHDPVDK - AU 1694.7576 653.0884 2347.8460 3 783.6231 783.6216 -1.91 
YHTINGHNAEVR Y174 U 1409.6799 324.0359 1733.7158 3 578.9131 578.9120 -1.90 
ALSRQEM(Ox)QEVQSSR - AU 1663.7947 653.0884 2316.8831 3 773.3022 773.3005 -2.19 
IDTIEIITDRQSGK R147 U 1587.8467 324.0359 1911.8826 3 638.302 638.3021 0.15 
Heterogeneous nuclear 
ribonucleoproteins C1/C2 
GFAFVQYVNER F52 or F54 UU 1328.6513 630.0612 1958.7125 2 980.3640 980.3620 -2.04 
Heterogeneous nuclear 
ribonucleoproteins C1/C2/C-like 1 
VFIGNLNTLVVK F19/F19 UU 1315.7863 630.0612 1945.8475 2 973.9315 973.9293 -2.25 
Heterogeneous nuclear 
ribonucleoprotein D0 
IFVGGLSPDTPEEK - U 1487.7507 324.0359 1811.7866 3 604.9367 604.9354 -2.14 
Heterogeneous nuclear 
ribonucleoprotein D0/D-like 
GFGFVLFK F142/F193 AU 913.5061 653.0884 1566.5945 3 523.2060 523.2049 -2.10 
Heterogeneous nuclear 
ribonucleoprotein K 
LLIHQSLAGGIIGVK G157 U 1517.9292 324.0359 1841.9651 3 614.9962 614.9948 -2.27 
DLAGSIIGK G400 U 872.4967 324.0359 1196.5326 2 599.2741 599.2725 -2.66 





Y386 U 3799.7979 324.0359 4123.8338 4 1031.9662 1031.9630 -3.10 
NPNGPYPYTLK Y574 U 1262.6295 324.0359 1586.6654 2 794.3405 794.3460 6.92 
Heterogeneous nuclear 
ribonucleoprotein L/L-like 
LNVCVSK - U 761.4105 324.0359 1085.4464 2 543.731 543.7314 0.73 
Continued...... 
 




















VGEVTYVELLM(Ox)DAEGK Y100 U 1767.8600 324.0359 2091.8959 3 698.3064 698.3055 -1.28 
Heterogeneous nuclear 
ribonucleoprotein Q 
VTEGLTDVILYHQPDDK Y276 U 1941.9683 324.0359 2266.0042 3 756.3425 756.3414 -1.45 
DYAFIHFDER - AU 1311.5883 653.0884 1964.6767 3 655.9000 655.8990 -1.52 
Heterogeneous nuclear 
ribonucleoprotein Q/R 
IKALLER K125 U-H2O 841.5385 306.0253 1147.5638 2 574.7897 574.7876 -3.65 
LFVGSIPK S249/S252 ACU 859.5167 958.1297 1817.6464 2 909.8310 909.8294 -1.75 
VLFVR F341/F344 U 632.4009 324.0359 956.4368 2 479.2262 479.2254 -1.66 
SAFLCGVM(Ox)K C96/C99 U 970.4615 324.0359 1294.4974 2 648.2565 648.2547 -2.77 
Heterogeneousnuclear 
ribonucleoprotein R 
DYAFVHFEDR - U 1297.5727 324.0359 1621.6086 3 541.5440 541.5432 -1.47 
STAYEDYYYHPPPR - U 1757.7685 324.0359 2081.8044 3 694.9426 694.9410 -2.30 
Heterogeneous nuclear 
ribonucleoprotein U 
M(Ox)CLFAGFQR C594 U 1087.4942 324.0359 1411.5301 2 706.7728 706.7718 -1.41 
GYFEYIEENK Y257 U 1290.5768 324.0359 1614.6127 2 808.3141 808.3140 -0.12 
Matrin-3 NYILM(Ox)R Y526 U 824.4214 324.0359 1148.4573 2 575.2364 575.2381 2.95 
Nucleolin 
VEGTEPTTAFNLFVGNLNFNK - AU 2311.1484 653.0884 2964.2368 3 989.0867 989.0855 -1.21 
FGYVDFESAEDLEK Y351 CU 1647.7303 629.0772 2276.8075 3 767.2710 767.2742 4.17 
NLPYKVTQDELK Y402 AU 1446.7718 653.0884 2099.8602 3 700.9612 700.9605 -0.99 
GIAYIEFK Y433 AU 939.5065 653.0884 1592.5949 3 531.8728 531.8720 -1.50 
GYAFIEFASFEDAK F527 U 1593.7350 324.0359 1917.7709 2 959.8932 959.8922 -1.04 
GFGFVDFNSEEDAK 
F612 or F614 
or F617 
U 1560.6732 324.0359 1884.7091 2 943.3623 943.3599 -2.54 
TLVLSNLSYSATEETLQEVFEK Y495 U 2500.2584 324.0359 2824.2943 3 942.4392 942.4390 -0.21 
VFGNEIKLEKPK K377 U-H2O 1400.8027 306.0253 1706.828 3 569.9504 569.9516 2.10 








UGG 606.3740 1014.129 1620.503 2 811.2593 811.2587 -0.73 





























U 649.3798 324.0359 973.4157 2 487.7156 487.7149 -1.43 
Poly(rC)-binding protein 
1/2/3 
INEIRQM(Ox)SGAQIK - U-H2O 1502.7874 306.0253 1808.8127 3 603.9454 603.9444 -1.65 








U 801.4595 324.0359 1125.4954 2 563.7555 563.7556 0.177 
Poly(U)-binding-splicing 
factor PUF60 
VYVGSIYYELGEDTIR Y138 U 1875.9254 324.0359 2199.9613 3 734.3282 734.3284 0.27 
Polypyrimidine tract-binding 
protein 1 
HQNVQLPR H411 U 990.5359 324.0359 1314.5718 2 658.2937 658.2924 -1.97 
NFQNIFPPSATLHLSNIPPSVSEEDLK - U-H2O 2993.5133 306.0253 3299.5386 3 1100.8540 1100.8506 -3.08 
Probable ATP-dependent 
RNA helicase DDX5 
LIDFLECGK C234 U 1036.5262 324.0359 1360.5621 2 681.2888 681.2887 -0.14 
Probable E3 ubiquitin-
protein ligase TRIML2 
RLFLEK - UU 804.4857 630.0612 1434.5469 2 718.2812 718.2799 -1.80 
Proteasome subunit beta 
type-3 
LNLYELK Y74 U 891.5065 324.0359 1215.5424 2 608.779 608.7781 -1.47 
Putative pre-mRNA-splicing 
factor ATP-dependent RNA 
helicase DHX15 
YM(Ox)TDGM(Ox)LLREAM(Ox)NDPLLER - ACU 2315.0595 958.1297 3273.1892 4 819.3051 819.3037 -1.70 
Putative RNA-binding 
protein 3 
GFGFITFTNPEHASVAM(Ox)R - U 1996.9464 324.0359 2320.9823 3 774.6686 774.6671 -1.93 
Continued...... 
 























U 778.4337 324.0359 1102.4696 2 552.2426 552.2431 0.90 
RNA-binding protein 39 IESIQLMM(Ox)DSETGR M
282 U 1624.7436 324.0359 1948.7795 3 650.6010 650.6003 -1.07 
RNA-binding protein 39/Probable 
RNA-binding protein 23 
LYVGSLHFNITEDM(Ox)LR - U 1922.9559 324.0359 2246.9918 3 750.0051 750.0032 -2.53 
RNA-binding protein 47/ 
APOBEC1 complementation 
factor/Mitotic spindle assembly 




AU 662.4115 653.0884 1315.4999 2 658.7577 658.7585 1.21 
RNA-binding protein FUS 
TGQPMINLYTDR - AU 1407.6816 653.0884 2060.7700 3 687.9311 687.9281 -4.36 
APKPDGPGGGPGGSHM(Ox)GGNYGDDR - U 2267.9613 324.0359 2591.9972 4 649.0071 649.0054 -2.61 
Serine/arginine-rich splicing 
factor 1 
IYVGNLPPDIR Y19 AU 1255.6924 653.0884 1908.7808 3 637.2681 637.2670 -1.72 
YGPPSR Y112 U 675.3340 324.0359 999.3699 2 500.6927 500.6918 -1.79 
Serine/arginine-rich splicing 
factor 2/8 
GFAFVR F59 U 695.3754 324.0359 1019.4113 2 510.7134 510.7134 0 
VDNLTYR Y23 U 879.4450 324.0359 1203.4809 2 602.7482 602.7488 0.99 
VGDVYIPR Y44 U 917.4970 324.0359 1241.5329 2 621.7742 621.7734 -1.28 
Serine/arginine-rich splicing 
factor 3 
SVWVAR W40 UU 716.3969 630.0612 1346.4581 2 674.2368 674.2363 -0.74 
VYVGNLGNNGNK Y13 U 1247.6258 324.0359 1571.6617 2 786.8386 786.8327 -7.49 
Serine/arginine-rich splicing 
factor 5 
VFIGRLNPAAR G9-R10 CU 1212.7090 629.0772 1841.7862 3 614.9365 614.9358 -1.13 
Serine/arginine-rich splicing 
factor 6 
NGYGFVEFEDSR - U 1418.6102 324.0359 1742.6461 2 872.3308 872.3293 -1.71 
Serine/arginine-rich splicing 
factor 9 
IYVGNLPTDVR - AU 1245.6717 653.0884 1898.7601 3 633.9278 633.9265 -2.05 
Continued...... 
 



















phosphatase 2A 56 kDa regulatory 





UU 661.4023 630.0612 1291.4635 2 646.7395 646.7409 2.16 
Signal recognition particle 9 kDa 
protein 
VTDDLVCLVYK C48 U 1266.6529 324.0359 1590.6888 2 796.3522 796.3525 0.37 
Small nuclear ribonucleoprotein E VQKVM(Ox)VQPINLIFR K12 U-H2O 1699.9806 306.0253 2006.0059 3 669.6764 669.6810 6.86 
Splicing factor 3B subunit 4 NQDATVYVGGLDEK Y16 U 1507.7154 324.0359 1831.7513 2 916.8834 916.8826 -0.87 
Splicing factor U2AF 65 kDa 
subunit 
NFAFLEFR F199 CU 1042.5235 629.0772 1671.6007 3 558.2080 558.2070 -1.79 
GAKEEHGGLIR K70 U-H2O 1165.6203 306.0253 1471.6456 3 491.5563 491.5535 -5.69 
LFIGGLPNYLNDDQVK L261-F262 U 1804.9359 324.0359 2128.9718 3 710.6651 710.6640 -1.54 
AFNLVKDSATGLSK D293-S294 UU 1449.7827 630.0612 2079.8439 3 694.2891 694.2908 2.44 
Transcriptional activator protein 
Pur-alpha/beta/Purine-rich 
element-binding protein gamma 
FYLDVK F74/F47/F73 AU 783.4166 653.0884 1436.505 3 479.8428 479.8420 -1.66 
U1 small nuclear ribonucleoprotein 
70 kDa 
RVLVDVER L175 U 984.5716 324.0359 1308.6075 3 437.2103 437.2100 -0.68 
LGGGLGGTR L196 UCA 786.4347 958.1297 1744.5644 3 582.5292 582.5285 -1.20 
YDERPGPSPLPHR Y219 U 1519.7531 324.0359 1843.789 3 615.6041 615.5987 -8.77 
Y-box-binding protein 1 
RPQYSNPPVQGEVM(Ox)EGADN-
QGAGEQGRPVR 
Y208-N210 U 3238.5173 324.0359 3562.5532 4 891.6461 891.6450 -1.23 
GAEAANVTGPGGVPVQGSKYAADR S136-Y138 U-H2O 2271.1243 306.0253 2577.1496 3 860.0576 860.0518 -6.74 
NYQQNYQNSESGEK Y158 UA 1687.7074 653.0884 2340.7958 3 781.2730 781.2691 -4.99 




U 939.4562 324.0359 1263.4921 2 632.7538 632.7525 -2.05 
EDVFVHQTAIK - ACU 1285.6666 958.1297 2243.7963 3 748.9399 748.9388 -1.46 





AU 712.3292 653.0884 1365.4176 2 683.7166 683.7149 -2.48 
Continued...... 
 















z m/z(calc) m/z(exp) 
Δm 
(ppm) 
40S ribosomal protein S2 TYSYLTPDLWK 
Y248 or 
Y250 
U 1385.6867 324.0359 1709.7226 2 855.8691 855.8680 -1.28 
60S ribosomal protein L5 HIM(Ox)GQNVADYMR Y207 U 1465.6441 324.0359 1789.6800 3 597.5678 597.5669 -1.50 
60S ribosomal protein L6 EKYEITEQR E238-K239 U-H2O 1194.5880 306.0253 1500.6133 3 501.2122 501.2118 -0.79 
60S ribosomal protein L34 AFLIEEQK I97 GU 976.5229 669.0833 1645.6062 2 823.8109 823.8096 -1.57 
Protein (UniProt ID): Protein name along with its UniProt ID; Peptide: Sequence of the cross-linked peptide along with its position within the protein sequence; 
Amino acid: One letter symbol of the cross-linked amino acid along with its position within the protein sequence. The amino acids highlighted in grey show the 
probable amino acids found to be cross-linked as the exact cross-linking site cannot be specified further; RNA: Nucleotide found to be cross-linked to the 
peptide; m(calc) Peptide: Theoretical mass of the cross-linked peptide; m(calc) RNA: Theoretical mass of the cross-linked RNA; m(calc) Cross-link: 
Calculated mass of the RNA-protein cross-link; z: Charge state of the cross-link; m/z(calc): Calculated m/z of the cross-link by using formula m+z(mH)/z; 
m/z(exp): Observed m/z of the cross-link; Δm (ppm): Calculated mass error in ppm by using formula [m/z(exp) −m/z(calc)/m/z(calc)] × 106. 
*MS2 spectra of the cross-linked peptide hits given in Table 6.10 can be provided in soft copy on the demand of the examiners. Refer to the supplementary 
material of the published paper entitled “Photo-cross-linking and high-resolution mass spectrometry for assignment of RNA-binding sites in RNA-binding 
proteins” by Kramer et al., 2014 containing several MS2 spectra. 
 
 






Figure 6.62: Interactome of isolated RNP complex (before cross-linking) from HeLa nuclear 
extract assembled on MINX pre-mRNA. Interactome network was constructed based on the 
information from the experiments. The structural and functional relationships are shown as edges 
that are connecting individual proteins (nodes). Nodes were labeled according to the gene names 
as reported by STRING database (Jensen et al., 2009). Mapping of Protein-Protein interactions 
revealed a network with 493 nodes and 1865 edges. Analysis of various attributes of the 
interaction map presented an average degree of 7.57 having a network diameter of 19. Average 
path length was calculated to be 6.29. Graph density was found to be 0.008. 299 components 











Figure 6.63: Interactome of isolated RNP complex (before cross-linking) from HeLa nuclear 
extract assembled on PM5 pre-mRNA. Interactome network was constructed based on the 
information from the experiments. The structural and functional relationships are shown as edges 
that are connecting individual proteins (nodes). Nodes were labeled according to the gene names 
as reported by STRING database (Jensen et al., 2009). Protein-Protein Interaction (PPI) analysis 
of complex assembled on PM5 pre-mRNA produced a network with 596 nodes and 2603 edges. 
Network over view rendered an average degree of 4.37 with the network diameter of 14. 364 
components were found to be strongly connected in the network. Average path length presenting 
the average distance between pairs of nodes was calculated to be 4.98. Graph density was found 
to be 0.007. Average clustering coefficient is the overall indication of how the nodes are 
embedded in the neighborhood with in the network and was calculated to be 0.169.  
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